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A fixed population of oocytes within primordial follicles, established prior to or just 
after birth has been firmly believed to support the postnatal mammalian ovary 
throughout an individual’s reproductive lifespan. However, the identification and 
isolation of cells from adult mammalian ovaries characterised by the expression of 
both germ and stem cell markers, suggest the presence of mitotically active cells, 
termed oogonial stem cells (OSCs) that may have the potential to produce new 
oocytes in the postnatal mammalian ovary. Putative OSCs have been isolated from 
adult tissues of several mammalian species, including rodents and humans. Upon re-
introduction to the ovarian niche, human and rodent OSCs have generated new 
oocyte like structures which, at least in rodents, have generated functional oocytes 
capable of fertilisation and subsequent embryonic development to produce healthy 
offspring.  
We hypothesised that OSCs could be isolated from adult bovine ovaries and upon 
establishment within the appropriate ovarian niche could initiate successful 
oogenesis.  
To investigate this hypothesis, we have utilised fluorescently activated cell sorting 
(FACS) to isolate putative bovine OSCs (bOSCs) and an ovarian aggregate model, in 
vitro and in vivo to explore the oogenic potential of these cells.  
Putative bOSCs were successfully isolated by FACS based on the cell surface 
expression of germ cell marker DDX4 and established in culture. Pluripotency 
(LIN28 and OCT4) and germ (IFITM3, PRDM1, C-KIT and DAZL) cell associated 
genes were expressed in putative bOSCs established in culture. However, DDX4 
transcripts were not consistently observed throughout bOSC culture.  
Aggregation of putative bOSCs with neonatal murine ovarian somatic cells to form 
chimeric ovarian aggregates, cultured in a hanging drop model for 7 days maintained 
germ cell phenotype, marked by DAZL expression. A subpopulation of putative 
bOSCs showed a spherical morphology, an increase in cell size and an association 
with neighbouring cells. Xenotransplantation of chimeric ovarian aggregates to the 
kidney capsule of immune deficient mice for 21 days generated multi-laminar 




pre-primordial follicle-like structures). RNA Scope was unsuccessful in determining 
the origin of oocytes within chimeric ovarian aggregates. However, oocytes from 
pre-antral follicles in chimeric ovarian aggregates (n=6; 60.93.6m, mean  SEM) 
were significantly (P<0.0001) larger than murine oocytes (n=38; 34.51m, mean  
SEM) aggregated with murine ovarian somatic cells as positive controls, suggesting 
that these oocytes are undergoing different growth dynamics. 
This work has shown that putative bOSCs characterised by the expression of 
pluripotency and germ cell associated genes are present within adult bovine ovarian 
tissue and can be isolated using FACS and established in culture. These data also 
suggest that putative bOSCs may have the potential to undergo oogenesis and 







Until recently it was firmly believed that women could not produce new eggs (also 
known as oocytes) as adults. However, cells with apparent germ line stem cell 
characteristics (oogonial stem cells (OSC)), have been found in ovaries of women 
and other mammals. These cells appear capable of producing new oocytes under the 
right conditions. Supporting cells, known as somatic cells are essential to help create 
an oocyte which is able to grow and develop, and be successfully fertilised by sperm. 
Research into OSCs and their supporting cells that may combine to produce new 
oocytes is essential to assess the potential of these cells in development of fertility 
treatments.  
We have used cow (bovine) oogonial stem cells (bOSCs) as a model to investigate 
the ability of these specialised cells to create new oocytes. We hypothesised that 
bOSCs would be able to produce new eggs with the appropriate somatic cell support. 
bOSCs were removed from adult bovine ovaries using a cell sorting method. bOSCs 
were initially studied in the laboratory and were unable to produce new oocytes 
without somatic cell support. Using experimental models where supporting somatic 
cells from the ovary could be used to aid bOSCs, we found that oocytes and cells like 
early oocytes were observed. However, we were unable to determine conclusively 
whether these oocytes were derived from the bOSCs.  
Although still early in the experimental stages of research, this study suggests that 
bOSCs can produce new oocytes when combined with the appropriate somatic cell 
support. These results also show that the supporting somatic cells are essential to 
support oogonial stem cells and should be considered in future research. From these 
results, oogonial stem cells may have the potential to provide new fertility 
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1 Literature Review 
1.1 Introduction 
The mammalian ovary is a highly dynamic organ which undergoes cyclical changes 
to produce a meiotic and developmentally competent oocyte(s) each estrous or 
menstrual cycle. A population of oocytes contained within somatic cells to form 
ovarian follicles are established just prior to or shortly after birth in mammalian 
ovaries. The formation of oocytes in the fetal ovary is orchestrated by various 
extrinsic factors and the temporal switching on and off, of regulatory genes 
(summarised in Figure 1.1). These controlled processes were believed to generate a 
fixed population of primordial follicles capable of maintaining fertility throughout an 
individual’s reproductive lifespan without postnatal follicular renewal.  
This theory formed a central dogma of ovarian biology for the latter half of the 20th 
Century. However, evidence in 2004 suggested that a mitotic germ cell may 
contribute to oocyte and follicle renewal in the postnatal murine ovary (Johnson et 
al., 2004). These observations renewed interest in mammalian neo-oogenesis. The 
examination of putative oogonial stem cells and their oogenic potential is essential to 
better understand ovarian biology, the process of oogenesis and may offer the 
potential of new artificial reproductive technologies (ART) to assist those unable to 






Figure 1.1: Temporal expression of cell markers during oogenesis. Germ cell development is a 
tightly controlled process, regulated by the temporal expression of essential genes, depicted here, and 
their corresponding proteins. These markers are used to characterise the stage of germ cell 
development during oogenesis and artificial gametogenesis. Solid lines represent consistent gene 
expression and dashed lines represent intermittent gene expression. Figure adapted from Schuh-Huerta 
and Pera (2011). 
1.2 Mammalian prenatal oogenesis 
The formation of fetal germ cells takes place within the wider context of the 
developing embryo where differentiation of a group of specialised totipotent cells, 
which can give rise to all the tissues of the developing embryo and extra-embryonic 
tissues, determines germ cell fate to a small proportion of cells. The differentiation of 
these cells into committed daughter cells is controlled by intrinsic and extrinsic 
factors, detailed below. Germ cell formation is coordinated in synchronisation with 
the development of other cell types and tissues. The surrounding soma can influence 
germ cell fate and is essential to coordinate germ-cell formation, entry into meiosis, 
maintenance of meiotic arrest, follicle growth and development and the resumption 
of meiosis. The synergistic communication between developing germ cells and the 





1.2.1 Formation of germ cells, migration and colonisation of the 
developing gonads 
The specification of germ cells occurs in the proximal epiblast in the post 
implantation embryo. Cells expressing Wnt3 are exposed to BMP (Bmp2, Bmp4 and 
Bmp8b) signalling from the neighbouring extra-embryonic tissues at approximately 
E5.75 (Lawson et al., 1999; Ying et al., 2000; Ying et al., 2001; Ying and Zhao, 
2001). Bmp’s act to inhibit somatic cell associated genes (e.g. Hoxb1 and Hoxa1), 
maintain pluripotency genes (e.g. Oct4, Nanog and Sox2) and activate germ cell 
genes (e.g. Dppa3, Prdm1 and Prdm14) through SMAD signalling pathways 
(Avilion et al., 2003; Chambers et al., 2007; Saitou et al., 2002; Sato et al., 2002; 
Scholer et al., 1990). All epiblast cells in a developing embryo have the potential to 
commit to the germline lineage, however approximately 40 PGCs are specified to the 
germline by E7.5 from a population of Ifitm3 expressing cells (Saitou et al., 2002; 
Tanaka and Matsui, 2002), through BMP signal gradients and inhibitory signal 
gradients (e.g. Cer1, Dkk1 and Lefty1) (Ohinata et al., 2009; Tam and Zhou, 1996). 
Primordial germ cells are identified by the co-expression of Ifitm3 and Dppa3 
(Saitou et al., 2002; Sato et al., 2002).  
PGC specification is also regulated by Prdm1, Prdm14 and Tcfap2c (encodes AP2) 
expression, known as the tripartite transcriptional network (Magnusdottir et al., 
2013). Together the expression of these transcription factors coordinate an 
interdependent transcriptional network to ensure PGC specification (Magnusdottir et 
al., 2013). Mutations in any of the three key transcription factors (Prdm1, Prdm14 
and Tcfap2c) causes loss of PGCs or phenotypes more similar to neighbouring 
somatic cells in mice (Ohinata et al., 2005; Weber et al., 2010; Yamaji et al., 2008). 
Furthermore, ectopic expression of Prdm1 in an embryonic carcinoma cell line 
(P19EC) induced expression of PGC genes (Dppa3, Tcfap2c and Prdm14) and 
maintained expression of Oct4. Expression of the tripartite transcriptional network in 
the cell line further demonstrated the repression of somatic cell genes (Magnusdottir 
et al., 2013), suggesting that the induction and repression of the appropriate genes for 
PGC specification is a complex process requiring multiple regulators. In human 





upregulation of PRDM1, PRDM14 and TCFAP2C (Irie et al., 2015). SOX17 
expression was also increased in human PGC-like cells (PGCLCs) and SOX17 
knockdown repressed the expression of PRDM1 and TCFAP2C suggesting that 
SOX17, which has known roles in the murine endoderm (Kanai-Azuma et al., 2002), 
is a key regulator of human germ cell fate (Irie et al., 2015). Therefore, BMP 
signalling is essential for mammalian germ cell specification, however the key 
regulators which are activated to control PGC fate have similarities and differences 
between mammalian species. 
Following germ cell specification, PGCs migrate to the developing gonads from 
E7.5-E11.5. Mechanisms underlying the initiation of mammalian PGC migration are 
yet to be identified, however a strict pathway to the genital ridges is followed by 
PGCs. Although some get lost in transition, PGCs travel through the posterior 
primitive streak along the hindgut to the mesoderm where they migrate bilaterally 
into the gonadal ridges (reviewed by Richardson and Lehmann (2010)). PGC 
migration is regulated by Kit ligand, expressed by somatic cells and its receptor c-Kit 
which is expressed on the surface of PGCs. Aberrant PGC migration was observed in 
Kit-/- mice and cells along the migratory route expressed KIT in a temporal manner to 
coordinate the migration of PGCs (Gu et al., 2009). Artificial inhibition of Kit ligand 
in cultured bisected embryos caused a reduction in PGC velocity. Inhibition of c-Kit 
signalling also resulted in clumping of PGCs (Gu et al., 2009), which may have 
contributed to decreased cell motility. PGCs interact through long processes during 
migration forming networks of PGCs undergoing mass migration which may 
facilitate the migration of the entire population. Cells cease migration in conjunction 
with the loss of intercellular processes (Gomperts et al., 1994), suggesting that these 
facilitate the migration of PGCs. The genital ridge also expresses the chemoattractant 
Sdf1 (stromal derived factor 1) which interacts with PGCs through their expression 
of the receptor Cxcr4 (chemokine receptor 4) and facilitates their migration to the 
developing gonads (Ara et al., 2003). Adhesion molecules are also implicated in 
PGC migration. Disruption of E-cadherin expression in PGCs resulted in failure of 
PGCs to colonise the genital ridges (Anderson et al., 1999). These results illustrate 





As PGCs migrate through the developing embryo they maintain pluripotency and are 
exposed to various factors which may cause inappropriate differentiation into 
somatic cell types. PGC specification is protected through cellular mechanisms 
including epigenetic reprogramming, which is also essential to produce correctly 
imprinted gametes. In PGCs, Prdm1 binds to maternal chromatin to protect from 
demethylation (Nakamura et al., 2012) and Prdm14 functions to repress Glp (G9a-
like protein) a histone methyl transferase (Yamaji et al., 2008), both serving to 
preserve the epigenetic imprinting of PGCs. PGC’s also undergo global repression of 
transcription through the de-phosphorylation of RNA Polymerase II (Seki et al., 
2007). Together these mechanisms ensure germ cell fate is maintained in PGCs while 
migrating through various somatic environments in the developing embryo.  
PGCs arrive in the sexually ambiguous developing genital ridges from E10.5 
(Lawson and Hage, 1994; Molyneaux et al., 2001) and undergo germ cell licensing 
to reach a sexually competent state. Dazl and Ddx4 expression is associated with 
post-migratory PGCs and represents their ability to commit to gametogenesis. PGCs 
in Dazl-/- fail to differentiate and retain their PGC phenotype despite the maintenance 
of Ddx4 expression (Gill et al., 2011), suggesting that Dazl and Ddx4 expression are 
independent and that Dazl functions as a regulator of germ cell licensing. Germ cell 
licensing coincides with the arrival of PGCs at the genital ridges which are marked 
by the expression of Gata4. Prevention of genital ridge formation through genetic 
knockout models (Gata4 cKO, Wt1 KO and Osr1 KO) inhibits Dazl and Ddx4 
expression and consequently, PGCs fail to undergo germ cell licensing and retained a 
PGC phenotype (Hu et al., 2015). Therefore, the ability of PGCs to become 
gametogenesis competent cells is dependent on exposure to the genital ridges which 
induces expression of Dazl which acts intrinsically to regulate translation of genes to 
commit cells to gametogenesis.  
PGCs proliferate from specification, throughout migration and continue upon arrival 
in the gonads resulting in approximately 20,000 in the murine ovary at E13.5 
(Byskov, 1986; Lawson and Hage, 1994; Tam and Snow, 1981). Factors including 
Kit ligand (Dolci et al., 1991; Pesce et al., 1993), fibroblast growth factors (FGFs) 





inhibitory factor or interleukin 6 (IL-6); (De Felici and Dolci, 1991; Matsui et al., 
1991) have been implicated in PGC proliferation. Although PGCs continue to 
proliferate in the developing gonads they lose their ability to migrate (De Felici et al., 
1992; Gomperts et al., 1994) ensuring that they remain in the correct niche for sex 
determination and subsequent gametogenesis.  
1.2.2 Sex determination 
When PGCs arrive in the genital ridges the developing gonads are sexually 
ambiguous. PGCs are also bipotential with the ability to initiate either oogenesis or 
spermatogenesis (Adams and McLaren, 2002). The expression of sex-determining 
region Y (Sry) gene in gonadal somatic cells instigates Sertoli cell differentiation and 
testis formation and in its absence, WNT signalling, Foxl2 and Rspo1 expression in 
XX somatic cells drives the development of ovaries (reviewed by Eggers and 
Sinclair (2012); summarised in Figure 1.2). Wnt4 expression in somatic cells is 
essential for ovarian development as Wnt4-/- mice failed to form ovaries and 
developed structures which expressed enzymes associated with testosterone 
production (Vainio et al., 1999), indicating the onset of testis formation, although 
complete sex reversal was not observed. Wnt4 signals through β-catenin pathways to 
regulate the transcription of downstream targets. Follistatin (Fst) and Bmp2 were 
identified as potential targets of Wnt4, as expression of both genes show 
downregulation in the absence of Wnt4 in Wnt4-/- mice (Yao et al., 2004). WNT4 
also acts as a repressor of the male specification pathway through suppression of 
Sox9 expression (Kim et al., 2006). However, ectopic overexpression of Wnt4 in XY 
embryos did not cause complete sex-reversal but disrupted testis-specific vasculature 
and inhibited testosterone production (Jordan et al., 2003). Thus, Wnt4 is not the sole 







Figure 1.2: Summary of the genes and factors involved in sex determination and the 
corresponding germ cell developmental stages to form an ovary. In the absence of Sry expression 
the ovarian developmental pathway is initiated marked by the expression of Wnt4, Rspo1 and Foxl2, 
which regulate downstream pathways to induce oogenesis in germ cells. 
R-spondin 1 (Rspo1) is a secreted protein which can stabilise β-catenin, a factor in 
the WNT signalling pathway. Partial sex reversal is observed in Rspo1-/- mice 
(Chassot et al., 2008; Tomizuka et al., 2008) and RSPO1 null and mutated humans 
(Parma et al., 2006; Tomaselli et al., 2008), and share a phenotype similar to Wnt4 
null mice. Stabilisation of β-catenin expression in ovarian somatic cells resulted in 
phenotype rescue (Chassot et al., 2008), which suggests β-catenin acts downstream 
of RSPO1. Wnt4, Fst and Bmp2 were also downregulated in the ovaries of Rspo1-/- 
mice, suggesting Rspo1 is a positive regulator of Wnt4 expression and therefore 
indirectly regulates expression of Fst and Bmp2 (Chassot et al., 2008; Tomizuka et 
al., 2008). β-catenin ectopic over expression in XY embryos causes partial sex 





and has been implicated in human 46 XY disorders of sex development where no 
apparent mutations in sex-determining genes are identified (Maatouk et al., 2008). 
Therefore β-catenin is a pro-ovarian signalling molecule in WNT signalling 
pathways.  
Forkhead box L2 protein (Foxl2) is also essential in regulating the development of 
the mammalian ovary. Foxl2 functions to repress the expression of the pro-testis 
gene Sox9. Elimination of Foxl2 expression in the embryonic ovary causes a 
decrease in Fst and Bmp2 expression and results in partial sex reversal (Ottolenghi et 
al., 2007). These results are similar to those observed in Wnt4-/- mice, however, the 
expression of Fst and Bmp2 did not recover in Foxl2-/-, which had been reported in 
Wnt4-/- mice, suggesting that Foxl2 is required to maintain the expression of these 
ovarian genes (Ottolenghi et al., 2007). Foxl2 and Bmp2 demonstrated cooperative 
upregulation of Fst expression in in vitro cultures (Kashimada et al., 2011). 
Furthermore, conditional knockout of Foxl2 in adult mice caused ovaries to 
transdifferentiate into testis-like structures with tubular features and Sertoli-like cells, 
changes which were mediated by the increased expression of Sox9 (Uhlenhaut et al., 
2009). These results illustrate that Foxl2 is essential for both ovarian differentiation 
and maintenance. Experimental evidence suggests that the role of Foxl2 to supress 
Sox9 expression is carried out in cooperation with estrogen receptor 1 and 2 
(Er1/Er2) through binding of sequences within the enhancer region of Sox9 (Bagheri-
Fam et al., 2010). 
Ovarian development was traditionally viewed as the default gonadal developmental 
pathway (Jost, 1947), however, the experimental evidence suggests that the ovarian 
pathway is an active process regulated by the active expression of ovarian genes 
(Wnt4, Rspo1 and Foxl2) and the repression of testis specific genes (Sox9).  
1.2.3 Entry into meiosis and meiotic arrest 
During sex determination, PGCs become oogonia, marked by morphological 
changes. Oogonia are larger than PGCs and spherical in shape and can be identified 
by globular mitochondria and expression of Ddx4 (Gondos et al., 1986; Stoop et al., 
2005). Oogonia undergo proliferation with incomplete cytokinesis to form germ cell 





surrounded by somatic cells which the dividing oogonia interact with forming 
ovarian cords (Byskov, 1986).  
Oogonia transition from mitotic division and initiate meiosis by entering a pre-
meiotic state from approximately E12.5 and enter meiosis at E13.5 in the mouse 
(Borum, 1961; Menke et al., 2003) and from 11 and 13 weeks gestation, respectively 
in the human (Baker and Franchi, 1967; Motta et al., 1997), which can be identified 
by the expression of meiotic genes such as Sycp3 (Di Carlo et al., 2000). Meiotic 
initiation occurs in an anterior to posterior wave in a synchronised fashion in the 
mouse (Menke et al., 2003) and in a slower, more progressive manner in larger 
mammals including humans, with many oogonia remaining mitotically active as 
neighbouring follicles form (Anderson et al., 2007).  
Entry into meiosis in fetal oogonia is determined by germ cell extrinsic and intrinsic 
factors (summarised in Figure 1.3). Retinoic acid (RA), the biologically active 
variant of vitamin A, has been identified as the key germ cell extrinsic regulator in 
meiotic entry in both the ovary and testis (Anderson et al., 2008; Bowles et al., 2006; 
Koubova et al., 2014; Koubova et al., 2006). RA derives from the embryonic 
mesonephros in the mouse (Anderson et al., 2008; Bowles et al., 2006; Koubova et 
al., 2006) and the ovary in humans (Childs et al., 2011; Le Bouffant et al., 2010). RA 
accumulates through the downregulation of its metabolizing protein Cyp26b1 under 
the control of follistatin signalling (Bowles et al., 2006). In germ cells RA signalling 
activates the expression of Stra8 and Rec8 to initiate meiosis (Anderson et al., 2008; 
Bowles et al., 2006; Koubova et al., 2014; Koubova et al., 2006). Antagonism of RA 
action decreased the expression of both Stra8 and Rec8 in vitro and caused a 
decrease in germ cells entering meiosis (Bowles et al., 2006; Koubova et al., 2014). 
However, Stra8-/- mice maintain the expression of Rec8 (Baltus et al., 2006) and 
Rec8-/- mice maintain the expression of Stra8 in germ cells (Koubova et al., 2014). 
Therefore, RA action upon the meiotic genes Stra8 and Rec8 is independent of each 
other. Stra8-/- mice are infertile, with no oocytes observed in the adult ovary and 
embryonic Stra8-/- ovaries demonstrated a decrease in Spo11 and Dmc1, which are 
required to form and repair DNA double-strand breaks (DSBs) essential for meiotic 





DNA replication (Baltus et al., 2006). Therefore, Stra8 plays a critical role in 
premeiotic DNA replication and subsequent entry into meiotic prophase. As such 
Stra8 has been described as the gatekeeper of germ cell meiosis. In contrast, Rec8-/- 
deficient mice initiate meiosis but errors in chromosome synapsis result in an 
infertile phenotype (Xu et al., 2005). Thus, Stra8 regulates meiosis at an earlier stage 
than REC8, however both independently regulate meiosis in response to an 
extracellular RA signal.  
 
Figure 1.3: Summary of germ cell extrinsic and intrinsic factors which regulate the initiation of 
meiosis in fetal ovaries. Retinoic acid (RA) accumulates in the extracellular space as a consequence 
of follistation signal which inhibits the production of CYP26B1 (P450 cytochrome enzyme) 
responsible for the degradation of RA. RA acts to induce the expression of Stra8 and Rec8 
independently, which then act upon downstream targets to induce meiosis. Dazl is an intrinsic meiotic 
competence factor and works in tandem with RA to initiate meiosis in oogonia.  
Dazl expression is crucial to commit PGCs to gametogenesis (Gill et al., 2011), 
acting as a germ cell intrinsic regulator of meiotic entry (Lin et al., 2008). Dazl-/- 
mice are infertile (Saunders et al., 2003) and DAZL mutations are associated with 
sub-fertility in humans (Reijo et al., 1995). Germ cells in Dazl-/- ovaries did not 
demonstrate chromosome condensation and failed to initiate meiotic recombination 





downstream targets Spo11 and Dmc1, and Sycp3 and Rec8, suggesting that DAZL is 
a master regulator of germ cell meiosis and acts upstream of Stra8, Sycp3 and Rec8 
(Lin et al., 2008). Experimental evidence suggests that Dazl is a meiotic competence 
factor and its expression within germ cells and extrinsic RA signalling are both 
necessary for the initiation of meiosis and work cohesively to ensure meiotic entry in 
fetal ovarian germ cells.  
Following initiation of meiotic prophase I germ cells progress through leptotene 
(chromosome condensation), zygotene (chromosomal pairing), pachytene (initiation 
of recombination and arrest in diplotene (chromosomes start to separate but remain 
attached) (Baillet and Mandon-Pepin, 2012). Once meiosis has initiated, germ cells 
can no longer proliferate generating a fixed population of oocytes.  
1.2.4 Germ cell nest breakdown and primordial follicle formation 
Meiosis initiates in germ cells within germ cell nests, which must undergo 
breakdown to produce oocytes which form primordial follicles with the surrounding 
pre-granulosa cells. Germ cell nest breakdown is associated with a dramatic decrease 
in oocyte numbers, with loss of up to 80% of oocytes (Pepling and Spradling, 2001). 
Three mechanisms of oocyte loss have been proposed to account for such large-scale 
decline in cell number; apoptosis, autophagy and oocyte expulsion from the ovarian 
surface epithelium.  
Large numbers of oocytes undergo apoptosis, marked by the expression of members 
of the caspase family which have been observed in the ovaries of different 
mammalian species including humans (De Felici et al., 2008; Fulton et al., 2005; 
Ghafari et al., 2007; Jefferson et al., 2006; Lobascio et al., 2007; Pepling and 
Spradling, 2001). Disruption of caspase 2 caused an increase in the number of 
primordial follicles in postnatal murine ovaries (Bergeron et al., 1998). Elimination 
of other members of the apoptotic pathway (reviewed by Hutt (2015)) also causes an 
increase in primordial follicle numbers, with 3 times the number of primordial 
follicles observed in Bax-/- mice compared to wild type mice (Perez et al., 1999). Pro-
apoptotic factor Bax is activated through the actions of the aryl hydrocarbon receptor 
(AHR) and subsequently binds to Bcl2 allowing formation of an apoptosome in the 





resulting in apoptosis (Wei et al., 2001). Bax functions through dimerization with 
Bad to increase mitochondrial permeability, forming large channels in targeted cells 
which results in the release of cytochrome c from mitochondria, activating caspases 
and inducing apoptosis (Cory and Adams, 2002; Wei et al., 2001).  
Germ cell nest breakdown is also regulated by extrinsic factors to promote oocyte 
apoptosis. In the mouse germ cell nest breakdown and primordial follicle formation 
is initiated postnatally and is at least in part regulated by the elimination of the 
estrogenic signal fetal ovaries are exposed to in the maternal environment (Chen et 
al., 2009; Iguchi and Takasugi, 1986; Kezele and Skinner, 2003). Postnatal exposure 
of estrogen caused increased oocyte survival and resulted in a greater proportion of 
multi-oocyte follicles (Jefferson et al., 2002), whereas premature removal of estrogen 
causes early primordial follicle formation in murine ovaries (Chen et al., 2007). 
Larger mammals undergo germ cell nest breakdown in utero, therefore elimination 
of maternal estrogen cannot account for induction of oocyte apoptosis. However, an 
estrogen deprived baboon model demonstrated a reduction in the number of 
primordial follicles (Zachos et al., 2002), indicating a potential role for estrogen 
signalling in germ cell nest breakdown in larger mammals in addition to rodents. The 
developing fetal bovine ovary produces an internal supply of estrogen which declines 
at the onset of primordial follicle formation, suggesting an important role in either 
germ cell nest breakdown and/or primordial follicle formation in the bovine (Nilsson 
and Skinner, 2009; Yang and Fortune, 2008). 
Signalling pathways activated in pre-granulosa cells have also been implicated in 
facilitating oocyte apoptosis. Elimination of Notch2 expression in pre-granulosa cells 
through a Notch-/- mouse demonstrated an increase in number of oocytes, but a 
decrease in fertility associated with multi-oocyte follicles (Xu and Gridley, 2013), 
due to a decrease in oocyte apoptosis. Perturbation of NOTCH signalling in in vitro 
postnatal ovarian culture also demonstrated failure of germ cell nest breakdown 
(Trombly et al., 2009). Although exact mechanisms have not been elucidated, it has 
been hypothesised that somatic cells communicate with oocytes through 
JAGGED/NOTCH interactions to induce germ cell nest breakdown (Trombly et al., 





Females expressing only a single isoform of Fst (Fst-288) had increased numbers of 
primordial follicles in early postnatal life but demonstrated an accelerated loss of 
these follicles (Kimura et al., 2011). Germ cell apoptosis was reduced in these mice 
compared to wild types and the length of germ cell nest breakdown was extended. 
These results show that germ cell nest breakdown through apoptosis is necessary for 
healthy primordial follicle formation and suggests that high levels of apoptosis are 
observed to eliminate sub-standard oocytes. 
It has been hypothesised that the purpose of producing ‘unnecessary’ oocytes is to 
generate additional nutrients and organelles such as mitochondria which are donated 
to the surviving oocyte(s) within a germ cell nest by autophagy. This theory has been 
supported by the observation that apoptosis cannot solely account for the amount of 
germ cell death (De Felici et al., 2008; Lobascio et al., 2007), furthermore 
mitochondria have been identified within the cytoplasmic bridges between oogonia 
(Pepling and Spradling, 2001), suggesting that oogonia share nutrients and 
organelles. Loss of autophagy genes (Becn1 or Atg7) causes decrease in germ cell 
numbers in postnatal murine ovaries (Gawriluk et al., 2011), thus autophagy plays a 
role in maintaining the endowment of oocytes in mammalian ovaries through 
controlled cell death. Germ cells are also extruded from the ovarian surface epithelial 
into the peritoneal cavity, for unknown reasons (Motta and Makabe, 1986).  
As germ cell nests breakdown, surviving oocytes interact and associate with the 
surrounding pre-granulosa cells to form primordial follicles. Cytoplasmic bridges 
between oogonia retract/degrade during this process which is facilitated by proteases 
(Tingen et al., 2009). Only Foxl2 positive pre-granulosa cells invade germ cell cysts 
(Pepling et al., 2010). Proliferation of pre-granulosa cells is essential in preparation 
for primordial follicle assembly and expression patterns suggest Lgr5 expressing 
cells in the OSE are a potential source of Foxl2 positive pre-granulosa cells (Mork et 
al., 2012; Rastetter et al., 2014). Oocytes which fail to associate with supporting 
somatic cells are lost (Byskov, 1986; Pepling and Spradling, 2001). Primordial 
follicles then become separated from the surrounding mesenchymal stromal cell 
environment by enclosure in a basement membrane (Rajah et al., 1992). The 





follicle and between follicles and the surrounding stromal environment is essential to 
maintain the follicle, and support it through subsequent folliculogenesis.  
The ovarian surface epithelium OSE is a modified pelvic mesothelium covering the 
ovary and is comprised of a single layer of flat-to-cuboidal epithelial cells. It is 
derived from celomic epithelium in the developing embryo (Auersperg et al., 2001). 
At approximately 10 weeks of human gestation the fetal OSE undergoes several 
changes from flat-to-cuboidal simple epithelium and reverts to a monolayer by term.  
The OSE has been implicated as a potential source of Foxl2 positive pre-granulosa 
cells (Mork et al., 2012; Rastetter et al., 2014) during murine fetal development and 
was previously referred to as the ‘germinal epithelium’, as it was believed that it 
could give rise to new germ cells (Waldeyer, 1870). More recently it has been 
suggested as a potential source and niche of mammalian oogonial stem cells (OSCs) 
postnatally (Bukovsky et al., 2005; Parte et al., 2011; Virant-Klun et al., 2009; 
Virant-Klun et al., 2008). The oogenic capability of the ovarian surface epithelium 





1.3 Postnatal oogenesis 
In males, germ cell production is maintained in the testis via the ongoing presence of 
spermatogonial stem cells throughout adult life. In contrast the female ovary appears 
to have evolved different strategies for oocyte production. Invertebrate and lower 
vertebrate species, including a number of model organisms such as Caenorhabditis 
elegans, Drosophila melanogaster and Xenopus laevis, maintain oocyte production 
from a germ line stem cell population during adult life (Lin, 1997). However, 
mammalian ovaries with the exception of some prosimian primates (Loris 
tardigragus lydekkerianus (Duke, 1967) and Nycecticebus coucang, (David et al., 
1974)) and bat species (Artibeus jamaicensis, Glossophaga soricina and Sturnira 
lilium, (Antonio-Rubio et al., 2013)), were believed to cease oogenesis prior to or 
just after birth, based on mathematic modelling of follicle growth and atresia 
(Zuckerman, 1951).  
1.3.1 Postnatal oogenesis in invertebrates and lower vertebrates 
Germ line stem cells are a common feature of ovaries in invertebrate and lower 
vertebrate species. Female germline stem cells (FGSCs) must maintain a population 
of undifferentiated stem cells and give rise to oocytes during the reproductive 
lifespan of the organism. Two gametogenic strategies have evolved to maintain these 
processes in species with FGSCs (Lin, 1997):  
1. Individual stem cells through asymmetric divisions that produce a daughter stem 
cell and a differentiated daughter cell (e.g. Drosophila melanogaster and Xenopus 
laevis). 
2. Collective behaviour of mitotic cells in the gonad maintains a steady source of the 
germline without individual germ cells undergoing asymmetric division (e.g. 
Caenorhabditis elegans).   
Drosophila ovaries contain approximately 18 ovarioles which are responsible for 
oocyte production. Within each ovariole is a structure known as the germarium 
which hosts the terminal filament, a somatic structure which is anterior to cap cells 
which adhere to the germline stem cells. As germline stem cells divide, one daughter 





contrast the other daughter cell (termed a cystoblast) is displaced from the niche and 
becomes committed to oocyte differentiation. The cystoblast then undergoes several 
rounds of mitosis supported by escort cells to form a cyst comprising of 16 cells 
(cystocyte) which transitions into the next chamber of the germerium. Supported by 
follicle cells, cystocytes form egg chambers within which the cystocyte cells 
differentiate into one meiotic oocyte and 15 nurse cells (overview of Drosophila 
oogenesis provided in Bastock and St Johnston (2008); Marca and Somers (2014); 
Roth (2001)). Similar observations have been seen in Xenopus laevis where 
premeiotic interphase to late pachytene oocytes are found in nests of 16 
interconnected cells (Coggins, 1973), which are presumed to be as a consequence of 
4 sequential mitotic divisions of a single oogonium.  
In contrast, the hermaphrodite C. elegans produces oocytes form a population of 
germline stem cells with a shared common cytoplasm located within the proliferative 
zone at the distal tip of the organism. Mitotic proliferation of FGSCs in C. elegans is 
under the regulation of the distal tip cell, which if ablated results in meiotic initiation 
in all proliferating FGSCs (Kimble and White, 1981). As FGSCs move through the 
proliferation zone into the transition zone their mitotic ability is reduced and they 
initiate meiosis to form oocytes (overview in Lin (1997)). Other invertebrates such as 
Hydra oligactis and Hydra magnipapillata are believed to produce oocytes in a 
similar fashion.  
Despite differences between the mechanisms in which invertebrate and lower 
vertebrate species maintain oogenesis throughout reproductive life and the processes 
share commonality in maintaining a germline stem cell. FGSCs also appear to 
maintain their undifferentiated state as a consequence of the niche within which they 
are located and differentiation of daughter cells is due to their displacement from the 
niche.  
1.3.2 Postnatal oogenesis in mammals 
Prior to the mathematical modelling of ovarian dynamics undertaken by Baron 
Solomon Zuckerman in 1951 (Zuckerman, 1951), the ability of mammalian ovaries 
to undergo neo-oogenesis was disputed. Evidence both for and against mammalian 





Waldeyer (1870) proposed that oocytes originate from the germinal epithelium after 
birth and several descriptive studies of mammalian ovaries from different species 
suggested that oogenesis was not restricted to prenatal life (Allen, 1923; Evans and 
Swezy, 1931; Kingery, 1917; Sneider, 1940). Two germ cell proliferative phases 
were observed in the murine ovary, the first during fetal development and the second 
after birth which ceased just prior to sexual maturity. Oocytes produced prior to birth 
appeared to degenerate and did not contribute to the population of oocytes ovulated 
(Kingery, 1917). Similar observations have been observed recently in murine 
ovaries, where oocytes established prenatally do not contribute to ovulation whereas 
oocytes established in primordial follicles in early postnatal life support ovulation 
(Mork et al., 2012). Furthermore, oogenesis was observed to be cyclical in post-natal 
rat ovaries, with increased numbers of new oocytes derived from the germinal 
epithelium, approximately every 10 days (Sneider, 1940). New oocyte formation was 
thought to compensate for loss of degenerating follicles in postnatal rodent ovaries to 
maintain constant oocyte numbers in young adult ovaries (Allen, 1923).  
The assessment of oocyte numbers in mammalian ovaries predicted that pre-natal 
oogenesis was sufficient to support ovarian development through to ovarian 
quiescence (Zuckerman, 1951). The author noted their observations applied to all 
mammalian ovaries examined with the exception of lemurs. Since, histological 
analysis of ovaries from several other species has identified mitotically active germ 
cells in postnatal ovaries (David et al., 1974; Duke, 1967). Non-follicular germ cell 
nests in the ovarian cortex of the adult slender loris (Loris tardigradus 
lydekkerianus) demonstrated mitotic activity and were observed to contribute to the 
population of primordial follicles, however it is unknown whether these cells 
contributed to the ovulatory population (David et al., 1974). Ovaries of several bat 
species (Artibeus jamaicensis, Glossophaga soricina and Sturnira lilium) also 
contain mitotically active cortical germ cells (Antonio-Rubio et al., 2013).  
The physiological contribution of mitotically active germ cells within mammalian 
ovaries remains unknown, however some experimental evidence is suggestive of 
active oogenesis in the postnatal mammalian ovary. Cell depth lineage analysis of 





in life had undergone more mitotic divisions than their younger counterparts. Oocyte 
depth was further increased in ovaries of mice following unilateral ovariectomy, 
suggesting post-natal renewal of oocytes to compensate for ovarian loss (Reizel et 
al., 2012). In human patients treated with adriamycin, bleomycin, vinblastine and 
dacarbazine (ABVD) combined chemotherapy treatment, a greater follicle density 
was observed when compared to age matched control healthy women (McLaughlin 
et al., 2017). These results suggest that ABVD treatment caused the formation of 
new oocytes/follicles in this patient group, although the underlying mechanism for 
this is yet to be elucidated. Together these results indicate that germ cell renewal may 
be possible in post-natal mammalian ovaries under certain physiological or 
pathophysiological conditions.  
Investigations into the rates of oocyte atresia in the murine ovary revealed 
inconsistencies between the levels of cell death and the reproductive lifespan 
(Johnson et al., 2004). It was postulated that post-natal follicular renewal was 
necessary to maintain ovulation throughout the murine reproductive life span. The 
generation of new oocytes in the post-natal mammalian ovary would require the 
presence of a progenitor germline stem cell, similar to those observed in invertebrate 
and lower vertebrate species. The lack of a candidate progenitor cell within postnatal 







1.4 Mammalian oogonial stem cells (OSCs) 
Following the establishment of the follicle reserve in the fetal mammalian ovary, this 
reserve undergoes depletion in early postnatal life. The depletion of primordial 
follicles can be attributed to their initiation of growth, oocyte apoptosis, follicular 
atresia and also their expulsion from the ovary into the peritoneal cavity (Motta and 
Makabe, 1986). However, several studies have demonstrated consistent numbers of 
primordial follicles over the first several weeks and months in murine ovaries 
(Johnson et al., 2004; Kerr et al., 2006). Furthermore, fetal and neonatal ovaries 
transplanted to recipient mice did not show significant reduction in the mean number 
of primordial follicles from 2-8 weeks after transplantation (Cox et al., 2000). The 
lack of follicle depletion in the postnatal murine ovary identified in these studies was 
not found to be associated with a reduction in oocyte apoptosis (Johnson et al., 2004) 
and or decrease in recruitment to the growing population (Cox et al., 2000; Kerr et 
al., 2006). These observations are suggestive of follicular renewal to compensate for 
follicular loss to maintain primordial follicle numbers within the juvenile and early 
adult ovary. However, the lack of a candidate progenitor cell within mammalian 
ovaries to support the continual renewal of germ cells suggested that this was 
perhaps unlikely in postnatal mammalian ovaries.  
However, the identification of a mitotically active germ cell marked by the co-
expression of Ddx4 and BrdU in adult murine ovaries is indeed supportive of a 
population of putative female germline stem cells (Johnson et al., 2004). This work 
contradicted one of the central dogmas of ovarian biology and instigated a wealth of 
research into putative oogonial stem cells. 
1.4.1 Work to date with mammalian oogonial stem cells: for and 
against their existence and oogeneic capability 
Work on mitotically active germ cells in mammalian ovaries, often described as 
female germline stem cells (FGSCs) or oogonial stem cells (OSCs), over the last 
decade or so has generated inconsistent results, with evidence for and against their 
existence and their functional capabilities to produce new oocytes. Johnson and 
colleagues work in 2004 initially elicited criticisms (Albertini, 2004; Gosden, 2004; 





study and provided alternative explanations to the results observed. The mitotic germ 
cells identified in the surface epithelium were suggested to be germ cells extruding 
from the ovary into the peritoneal cavity (Gosden, 2004), a phenomenon previously 
identified in early postnatal life (Motta and Makabe, 1986). Furthermore, the 
chimeric follicles observed following ovarian transplantation were interpreted as a 
result of cellular ‘re-shuffling’ following the procedure (Gosden, 2004). However, 
the expression of early meiotic genes (Sycp3, Spo11 and Dmc1) and proteins (Sycp3) 
not associated with oocytes held in meiotic arrest indicate new germ cell formation in 
the adult murine ovary (Johnson et al., 2004).  
In contrast, gene expression analysis of adult human ovaries showed no expression of 
early meiotic markers (SYCP1, SPO11 and PRDM9) (Liu et al., 2007) and SYCP3 
staining was absent from both adult human and monkey ovaries of different ages 
(Liu et al., 2007; Yuan et al., 2013). Analysis of human ovaries from fetal 
development through to early adulthood (5 weeks post conception - 32 years old), 
showed that the expression SSEA-4, a pluripotency associated protein was restricted 
to pre-natal and early post-natal life (up to 2 years of age) (Byskov et al., 2011). 
Furthermore, proliferating cell nuclear antigen (Pcna), which is essential for DNA 
replication and mitosis, was not found to co-localise with germ cells in the post-natal 
murine ovary (Tan and Fleming, 2004). Taken together these results suggest that the 
post-natal mammalian ovary does not actively produce new germ cells and is void of 
mitotically active germ cells or progenitor germ cells. However, it is not 
inconceivable that mammalian oogonial stem cells may lay dormant within the 
postnatal ovary and only activate under the correct physiological and/or 
pathophysiological conditions, which these histological studies may have 
overlooked. In atrophic mouse ovaries, where histology confirmed complete oocyte 
depletion, Dazl and Stra8 expression was detected (Niikura et al., 2009), suggesting 
the presence of germ cells entering meiosis. Stra8 positive cells were identified in the 
ovarian surface epithelium (OSE) of these ovaries (Niikura et al., 2009). In the 
ovaries of infertile and post-menopausal women, cytokeratin staining indicated 
putative stem cells in the OSE (Virant-Klun et al., 2008). These results suggest the 
OSE as a source of putative OSCs and indicates that putative OSCs may only 





Cultures of ovarian surface epithelial cells from the postnatal ovaries of rabbit, 
sheep, monkey and human developed oocyte-like cells (OLCs) (Bukovsky et al., 
2005; Parte et al., 2011; Virant-Klun et al., 2009; Virant-Klun et al., 2008). These 
cells resembled oocytes, sharing a spherical morphology and were large cells (up to 
200m) in all species studied. As rabbit, sheep, monkey and human OLCs became 
larger they appeared to develop a zona pellucida-like structure (Bukovsky et al., 
2005; Parte et al., 2011; Virant-Klun et al., 2009; Virant-Klun et al., 2008) and 
human OLCs appeared to associate with other cells to form follicle-like structures 
(Bukovsky et al., 2005). Human and sheep OLCs were found to express markers 
associated with germ cells and oocytes (OCT4, C-KIT, DDX4, DAZL, GDF9, ZP2 
and ZP4), however meiotic markers were not observed in OLCs of either species 
(SYCP3) (Parte et al., 2011; Virant-Klun et al., 2009; Virant-Klun et al., 2008), 
suggesting abnormal oocyte development. Extended culture of rabbit, sheep, monkey 
and human OLCs derived from OSE cells generated were observed to extrude polar 
body like structures and embryo-like structures were observed in sheep and human 
cultures. This data suggests that sheep and human OLCs had undergone 
parthenogenetic activation, however only morphological information on these 
structures was provided, although multiple cells within the structures was confirmed 
by DNA staining (Parte et al., 2011; Virant-Klun et al., 2009). These data show that 
cells from the ovarian surface epithelium of several mammalian species have 
spontaneously generated oocyte-like cells during in vitro culture and may indicate 
the presence of a progenitor germline stem cell contained within these cell 
populations.  
Isolation of putative oogonial stem cells from the postnatal ovaries of rodents and 
humans was successfully achieved using magnetic and fluorescent based cell sorting 
technologies utilising the cell surface expression of germ cell associated markers 
(Ddx4/DDX4 and Ifitm3 (commonly known as Fragilis)) (Imudia et al., 2013; Park 
et al., 2013; White et al., 2012; Zhou et al., 2014; Zou et al., 2009) and GFP 
expression driven by the Oct4 promoter (Pacchiarotti et al., 2010). Putative OSCs 
consistently expressed germ cell (Dazl/DAZL, Ddx4/DDX4, Prdm1/PRDM1, 
Ifitm3/IFITM3 and Dppa3/DPPA3) and pluripotency (Oct4/OCT4, Nanog/NANOG 





White et al., 2012; Zhou et al., 2014; Zou et al., 2009). Crucially putative OSCs did 
not express oocyte associated genes (Gdf9/GDF9, Zp3/ZP3 and Nobox/NOBOX) 
(White et al., 2012), suggesting that these cells are a distinct population of germ cells 
within the ovary. Cells exhibited high telomerase activity and positively stained for 
alkaline phosphatase staining (Zou et al., 2009), characteristics associated with stem 
cells, further indicating that these are germline stem cells. Putative OSCs were 
estimated to constitute approximately 0.014%  0.002% cells in murine ovaries 
(White et al., 2012) and cells expressing GFP under the control of the Oct4 promoter 
were found to make up 0.05% of the adult murine ovary (Pacchiarotti et al., 2010). 
Therefore, putative oogonial stem cells appear to be a unique and small population of 
cells within the adult mammalian ovary, which can be isolated, cultured long term 
and maintain their characteristics.  
In culture, rodent and human putative OSCs rarely differentiated into OLCs with 
characteristic features of oocytes including large size (60m), spherical morphology 
and zona pellucida-like structures (Pacchiarotti et al., 2010; White et al., 2012; Zhou 
et al., 2014). Gene expression analysis showed that OLCs expressed oocyte-specific 
genes, including those associated with the zona pellucida (Gdf9/GDF9, Zp1/ZP1, 
Zp2/ZP2 and Zp3/ZP3). Rodent OLCs derived from OSCs showed the expression of 
Sycp3 (Pacchiarotti et al., 2010; Zhou et al., 2014), furthermore, human OLCs co-
expressed meiotic markers LHX8 and YBX2 with DDX4 (White et al., 2012), 
suggesting that these cells have initiated meiosis. Ploidy analysis of human OSC 
cultures showed the presence of haploid cells, illustrating that a population of cells 
had completed meiosis (White et al., 2012). These results reflect abnormal meiotic 
progress, as oocytes do not fully reach haploid status in situ as meiosis does not 
resume until fertilisation, when the cell will contain a maternal and paternal set of 
DNA to form a zygote. The absence of somatic cell support for spontaneous OLC 
differentiation in vitro may explain the abnormalities observed. In some cases OLCs 
appeared in association with other smaller cells and when cultured with granulosa 
cells generated follicle-like structures (Pacchiarotti et al., 2010), suggesting that 
somatic cell support may assist OLC development. The functional potential of in 
vitro derived OLCs to undergo successful fertilisation has not been reported. The 





determine whether these cells are oocytes. Thus, further research is essential to 
investigate the full potential of OLCs.  
Introduction of fluorescently labelled rodent OSCs into healthy and sterile recipient 
ovaries resulted in the formation of GFP expressing oocytes identified within GFP 
negative follicles (White et al., 2012; Zhou et al., 2014; Zou et al., 2009). The 
introduction of OSCs into chemotherapy ablated ovaries also rescued endogenous 
early stage oocytes when compared to control chemotherapy ablated ovaries (Zou et 
al., 2009). These results suggest that putative OSCs can form oocytes within an 
ovarian niche, but may also indicate a potential function in ovarian repair. GFP 
positive oocytes were retrieved following superovulation, which were capable of 
fertilisation and subsequent embryonic development using IVF (White et al., 2012). 
Furthermore, GFP oocytes contributed to in vivo ovulation and achieved successful 
fertilisation following natural matings (Zhou et al., 2014; Zou et al., 2009), showing 
their ability to contribute to oogenesis in vivo. It has been suggested that the 
characteristics associated with putative OSCs and their oogenic capabilities are an 
artefact of in vitro culture (Dunlop et al., 2013), however similar gene expression 
characteristics have been observed in freshly isolated putative OSCs (Imudia et al., 
2013), which would suggest that these cells may have these qualities in situ.  
The use of genetic mouse models has allowed investigations to determine whether 
putative OSCs contribute to in vivo oogenesis. Lineage-tracing using tamoxifen 
induced YFP expression showed the absence of adjacent YFP and Ddx4 expressing 
cells in clusters, suggesting that postnatal ovaries do not undergo germ cell divisions 
(Lei and Spradling, 2013), whereas tamoxifen exposure at E10.5 generated adjacent 
lineage marked germ cells in the adult ovary as a consequence of mitotic divisions. 
All YFP and Ddx4 positive cells were found to be oocytes, thus no other germ cells 
were identified. Tamoxifen exposure by injection into the ovary caused a localised 
response only labelling a small proportion of cells; given that putative OSCs are 
thought to make up an extremely small number of cells within the postnatal ovary it 
is conceivable that putative OSCs were not labelled. An alternative approach, utilised 
the expression of three reporter fluorescent proteins (RFP, OFP and CFP) under the 





cells from these mice showed RFP positive cells unable to undergo mitosis (Zhang et 
al., 2012), however their morphology would indicate that these cells are oocytes, 
therefore would not be able to undergo mitosis. The authors concluded that no 
mitotically active germ cells are present in the postnatal murine ovary. This model 
has great potential and use for investigating putative OSCs however the authors 
failed to describe cells expressing OFP or CFP and their potential. Given that any of 
the fluorescent colours could be expressed under the control of Ddx4, this appears 
like an important oversight and could exclude potential putative OSCs from 
investigation. These results suggest that postnatal mammalian ovaries do not undergo 
neo-oogenesis and therefore do not possess putative OSCs. This further indicates that 
the potential of putative OSCs isolated from postnatal mammalian ovaries to develop 
into oocytes previously described may be a consequence of in vitro culture.  
Alternative sources for germline progenitor cells were also investigated. The 
haemapoietic system was indicated as a source for new postnatal germ cell 
production when bone marrow and/or peripheral blood transplantation rescued 
oocyte production in sterile mice (Johnson et al., 2005). However, subsequent 
parabiosis studies which achieved high levels of haematopoietic chimerism, have 
illustrated in healthy and sterile mice that bone marrow derived cells do not 
contribute to oocyte production in the postnatal murine ovary (Eggan et al., 2006). 
Furthermore, investigators failed to test the functional potential of oocytes thought to 
be derived from haemapoietic cells (Telfer et al., 2005), thus it is unlikely that the 
haemapoietic system contributes to oogenesis in vivo, but may reflect the permissive 
nature of haemapoietic stem cells.  
The evidence suggests that putative mammalian oogonial stem cells can be isolated 
from postnatal ovaries and following in vitro culture and introduction into an 
appropriate ovarian niche can undergo oogenesis to form oocytes capable of 
fertilisation, embryonic development (White et al., 2012) and can produce healthy 
fertile offspring (Zhou et al., 2014; Zou et al., 2009). However, the physiological 
contribution of these cells is yet to be determined. Current evidence using genetic 
models (Zhang et al., 2012), lineage tracing (Lei and Spradling, 2013), follicular 





2012) is contradictory. Thus, it is difficult to interpret the role, if any, of putative 
oogonial stem cells in vivo and further investigations are essential to elucidate their 
potential. 
1.4.2 Controversy surrounding the existence of oogonial stem 
cells in mammalian ovaries 
Several groups have reported the isolation of putative OSCs from adult mammalian 
ovaries (Imudia et al., 2013; Park et al., 2013; White et al., 2012; Zhou et al., 2014; 
Zou et al., 2009). Following in vitro culture these cells have demonstrated the 
potential to generate new oocytes that are meiotically and developmentally 
competent and have resulted in healthy fertile offspring (Zhou et al., 2014; Zou et al., 
2009). However, controversy surrounding the existence of mammalian oogonial stem 
cells and their oogenic capacity continues. 
It has been suggested that the ability of these cells to undergo successful oogenesis is 
acquired as a consequence of in vitro culture (Dunlop et al., 2013). Pluripotency 
maintenance factors, such as LIF (leukaemia inhibitory factor, reviewed by Onishi 
and Zandstra (2015)) can be added to cell cultures to ensure pluripotent cells 
maintain their phenotype and have been utilised in putative OSC cultures. The effect 
of in vitro culture on putative OSCs has not been elucidated, furthermore, the in vivo 
potential of putative OSCs has not been determined. Thus, it is currently unclear 
whether putative OSCs are artificially transformed in vitro, causing changes that 
enable oogenesis, however gene expression analysis of freshly isolated murine OSCs 
shared similar expression patterns to those in culture, suggesting maintenance of cell 
characteristics rather than alteration (Niikura et al., 2009).  
Putative OSCs have been isolated from adult mammalian ovaries based on the cell 
surface expression of Ddx4/DDX4 or Ifitm3 (White et al., 2012; Zhou et al., 2014; 
Zou et al., 2009). Ifitm3 is a transmembrane cell surface protein associated with a 
role in the immune system. In contrast Ddx4 is a germ cell associated RNA helicase, 
with a cytoplasmic location. Therefore, its use as a cell-surface epitope to isolate 
putative OSCs has been controversial. Computational analysis has generated 
conflicting data regarding the possibility of a transmembrane variant of Ddx4 with 





et al., 2016).  Isolation of viable putative oogonial stem cells relies on their 
identification using a C-terminus antibody. The use of a N-terminus antibody failed 
to yield cells, however could recognise putative OSCs once permeablised (White et 
al., 2012). Cell surface expression of Ddx4 has also been identified in a population of 
cells within the adult pig testes (Kakiuchi et al., 2014). Furthermore, Ddx4 cell 
surface expression can be induced in cell populations following plasmid transfection 
(Kakiuchi et al., 2014).  These results suggest that Ddx4 is capable of cell-surface 
expression and that the use of a C-terminus antibody confounds specificity to this 
variant. However, it has also been suggested that antibody cross-reactivity may 
underlie the results observed and the antibody does not identify true Ddx4 cell 
surface expression (Hernandez et al., 2015).  
The ovarian quiescence observed after the menopause is based upon the depletion of 
ovarian follicles, resulting in age related infertility. However, the presence of 
putative oogonial stem cells in adult mammalian ovaries and the suggestion that 
these cells can contribute to oogenesis in postnatal life reignites the question of how 
the menopause can occur. Should neo-oogenesis occur in the mammalian ovary, how 
does the ovary deplete its stocks of follicles? This question has been a primary 
argument against the existence of putative mammalian oogonial stem cells (Horan 
and Williams, 2017). Stem cells are a specialised cell with the capabilities of self-
renewal and differentiation, these abilities are maintained by the stem cell niche. 
Elimination of the stem cell niche causes differentiation of all female germline stem 
cells in the ovary of C.elegans (Kimble and White, 1981). Furthermore, displacement 
of FGSCs from the stem cell niche causes the initiation of oogenesis in lower 
vertebrate and invertebrate species (Lin, 1997). These results illustrate that the stem 
cell niche plays an essential role in determining cell fate. Thus, should OSCs 
contribute to oogenesis in the adult mammalian ovary, failure of their niche may 
ultimately result in the depletion of ovarian follicles. Transplantation of aged murine 
ovaries into young recipients caused an increase in the number of follicles observed 
in the aged tissue, suggesting that systemic factors may play a role in maintaining 
ovarian function (Niikura et al., 2009). In addition, parabiosis of old and young mice 
showed comparable numbers of immature follicles in ovaries of both age groups, in 





immature follicles when compared with those xeno-grafted into young hosts (Niikura 
et al., 2009). These results indicate that age-related systemic changes may affect the 
potential physiological role of putative OSCs in the mammalian ovary.  
Oogonial stem cells are a recent discovery in ovarian biology, and significant 
questions regarding their existence and physiological role remain to be answered. 
However, they provide an interesting avenue for further research in ovarian biology, 
oogenesis and have the potential for major clinical applications in reproductive 






1.5 Artificial gametogenesis 
The process of mammalian oogenesis in vivo is a tightly regulated process requiring 
the transient switching on and off, of regulatory genes and molecular processes. Due 
to the difficult nature of studying oogenesis in the developing embryo, our 
knowledge of the underlying mechanisms is limited. Replication of oogenesis in 
vitro from precursor cells would provide insights into the basic biology of oogenesis, 
folliculogenesis and meiosis. This avenue of research may also offer potential for 
new artificial reproductive technologies (ART), where there is increasing demand for 
novel therapies involving the generation of artificial gametes for same sex couples 
and patients lacking functional germ cells (Hendriks et al., 2016).  
Stem cells are undifferentiated or differentiation limited, self-renewing cells within a 
distinct niche. These cells are responsible for renewal and regeneration within tissues 
with the potential to generate different daughter cell types. Pluripotent stem cells 
have the capacity to differentiate into all the cells of the developing mammalian 
embryo, thus have the potential to generate germ cells. In tetraploid complementation 
assays embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) have 
both successfully contributed to the germ cell lineage, illustrating their ability to 
successfully undergo gametogenesis (Boland et al., 2009; Zhao et al., 2010).  
1.5.1 Oogenesis using embryonic stem cells (ESCs) 
Embryonic stem cells are pluripotent stem cells derived from the inner cell mass of a 
developing blastocyst (Evans and Kaufman, 1981). They have successfully been 
cultured in vitro where they have shown the ability to differentiate into numerous cell 
types, including hematopoietic, endothelial, muscle and neuronal cells (Keller, 
1995). Thus, ESCs are candidate progenitor cells for in vitro artificial oogenesis.  
In the absence of feeder cells and leukaemia inhibitory factor (LIF), a growth factor 
known to facilitate the maintenance of pluripotency in vitro (Onishi and Zandstra, 
2015), murine embryonic stem cells (mESCs) appear to initiate germ cell 
differentiation (Hubner et al., 2003; Lacham-Kaplan et al., 2006; Novak et al., 2006; 
Qing et al., 2007; Salvador et al., 2008). mESCs formed large colonies resembling 





2006; Qing et al., 2007; Salvador et al., 2008), when removed from a pluripotency 
maintaining environment. These structures expressed germ cell associated genes 
including Oct4, Ddx4, cKit, Dppa3 and Dazl (Hubner et al., 2003; Lacham-Kaplan et 
al., 2006; Novak et al., 2006; Qing et al., 2007; Salvador et al., 2008), suggesting the 
active differentiation of mESCs into germ cells under these circumstances.  
OCT4 expression is associated with pluripotency in stem cells, however in the 
developing embryo, OCT4 expression becomes restricted to the germ line. Germ cell 
specific Oct4-GFP was expressed in 25% and 40% of mESCs after 7 and 8 days in 
feeder free and LIF free culture to induce differentiation, respectively (Hubner et al., 
2003), illustrating their entry into germ cell lineage. c-Kit expression, associated with 
migratory primordial germ cells was also reported in a subpopulation of these 
(Hubner et al., 2003), and had been observed as early as 48 hours after the initiation 
of differentiation (Lacham-Kaplan et al., 2006). Ddx4 expression is switched on in 
post-migratory germ cells and its expression continues throughout oogenesis and has 
been identified in differentiating mESCs (Hubner et al., 2003; Lacham-Kaplan et al., 
2006). During differentiation of mESCs, using these germ cell markers (Oct4, c-Kit 
and Ddx4), 3 populations of germ cells were identified associated with various stages 
of germ cell development (pre-/migratory primordial germ cells, early post-migratory 
germ cells and post-migratory germ cells prior to meiotic prophase 1) (Hubner et al., 
2003). Meiotic markers (Dmc1 and Sycp3), were absent from these cells, illustrating 
their pre-meiotic status. Further culture of cell aggregates produced follicle-like 
structures, with large central cells (>40m), resembling oocytes, and were GFP 
positive in accordance with Oct4 re-expression in meiotically arrested oocytes 
(Hubner et al., 2003).  
OLCs derived from mESCs have been described based on morphological 
characteristics (large spherical cells) and expression of oocyte-specific genes (Gdf9, 
Zp1, Zp2 and Zp3) (Hubner et al., 2003; Lacham-Kaplan et al., 2006; Novak et al., 
2006; Qing et al., 2007; Salvador et al., 2008). Zona pellucida genes were often 
expressed in OLCs, but zona pellucida structures were frequently absent from the 
surface of these cells (Lacham-Kaplan et al., 2006; Qing et al., 2007), and where 





due to the failed expression of one or more zona pellucid proteins (Hubner et al., 
2003). Furthermore, the expression of meiotic marker SYCP3 was reported in OLCs 
(Hubner et al., 2003; Novak et al., 2006), suggesting entry in meiosis. However, 
investigations into the meiotic potential of OLCs derived from murine ESCs have 
produced conflicting results. Observations of polar body-like structures further 
indicates entry into and progression through meiosis of OLCs (Hubner et al., 2003; 
Salvador et al., 2008). In contrast, fluorescent in situ hybridisation (FISH) of OLCs 
detected 2 signals for murine chromosome 1 which did not co-localise with Sycp3 
signal (Novak et al., 2006). This observation suggests that despite Sycp3 expression, 
ESC derived OLCs have failed to enter meiosis. This was further supported by a lack 
of expression of other meiotic associated proteins (including Sycp1, Sycp2, Rec8, 
Stag3 and Smc1-) in OLCs (Novak et al., 2006).  
During in vivo oogenesis, cells transition through several different described cell 
stages including epiblast cells, primordial germ cells and oogonia from 
undifferentiated embryonic stem cells, prior to the formation of oocytes. In situ these 
processes are regulated and mediated by the surrounding somatic cells (Wear et al., 
2016). The spontaneous differentiation of mESCs reported in the absence of feeder 
cells and pluripotency maintenance factors did not consistently appear to replicate 
the transition of cells through each stage of germ cell differentiation. eGFP 
expression under the regulation of Gdf9 was detected in large spherical cells within 
24 hours of mESC differentiation culture (Salvador et al., 2008). This rapid 
differentiation of pluripotent stem cells to germ cells in vitro may reflect 
abnormalities in germ cell differentiation in the absence of the appropriate somatic 
cell support. OLC formation was often reported in conjunction with the presence of 
follicle-like structures (Hubner et al., 2003; Lacham-Kaplan et al., 2006; Novak et 
al., 2006), suggesting that somatic cells co-differentiate from pluripotent cells to 
support germ cell differentiation. Co-culture of differentiating mESCs with neonatal 
ovarian granulosa cells generated follicle-like structures, with OLCs expressing 
oocyte associated genes (Gdf9, Fig, Zp1, Zp2 and Zp3) derived from mESCs. In 
contrast, culture with granulosa cell conditioned medium showed no expression of 
oocyte associated genes (Qing et al., 2007), suggesting that cell-cell interactions are 





Taken together these results suggest that while mESCs appear to initiate 
differentiation into cells similar to oocytes in vitro, these cells do not have the 
capacity of fully functional oocytes and may reflect abnormal germ cell formation 
under these conditions. They also indicate that somatic cells are a necessary 
component for successful germ cell differentiation. Tighter regulation of this process 
and step-wise co-ordination of the differentiation of pluripotent stem cells may 
produce functional artificial gametes.  
Reconstitution of the mouse germ cell specification pathway in vitro via extrinsic 
manipulation using growth factors to activate cellular pathways in pluripotent stem 
cells to initiate germ cell differentiation in a step wise manner may better replicate 
the process of oogenesis. Primordial germ cells are derived from the epiblast cells of 
the developing embryo. A cocktail of supplements, consisting of Activin A, bFGF 
and knockout serum replacement (KSR), has been shown to support the 
differentiation of male and female murine embryonic stem cells into cells resembling 
epiblasts (Hayashi et al., 2012; Hayashi et al., 2011; Hayashi and Saitou, 2013). 
These cells shared morphological features and genetic characteristics with epiblasts, 
demonstrated by the downregulation of genes associated with ESCs (e.g. Prdm14) 
and upregulation of genes associated with epiblast cells (e.g. Wnt3, Fgf5 and 
Dnmt3b) (Hayashi et al., 2012; Hayashi et al., 2011; Hayashi and Saitou, 2013). 
Furthermore, genes associated with cells of the endoderm were downregulated 
(Gata4, Gata6 and Sox17) (Hayashi et al., 2012; Hayashi et al., 2011; Hayashi and 
Saitou, 2013). These cells were subsequently termed epiblast-like cells (EpiLCs).  
BMP4 is known to co-ordinate PGC differentiation from epiblasts in vivo (Lawson et 
al., 1999), and in response to Bmp4, floating EpiLCs differentiated into primordial 
germ cell-like cells (PGCLCs) expressing Prdm1, Dppa3 and Nanos3 (Hayashi et al., 
2012; Hayashi et al., 2011; Hayashi and Saitou, 2013). BMP4 has also induced a 
primordial germ cell-like phenotype in ESCs in a dose dependent manner, which 
could be inhibited by NOGGIN, a Bmp4 antagonist (Wei et al., 2008). These results 
could be replicated by addition of Wnt3A, a mesoderm promoting factor (Wei et al., 
2008) and provide evidence to suggest that extrinsic factors are pivotal to facilitate 





To test the ability of PGCLCs to generate functional oocytes, XX PGCLCs were 
FACS isolated based on the cell surface expression of Ssea-1 and Integrin-3 and 
subsequently aggregated with fetal (E12.5) ovarian somatic cells to form 
reconstituted ovaries (Hayashi et al., 2012; Hayashi and Saitou, 2013). PGCLCs 
within cultured reconstituted ovaries showed imprinting patterns and X chromosome 
activation similar to PGCs in E12.5 murine ovaries, suggesting that PGCLCs have 
calibrated with the ovarian somatic cell environment, to coordinate their 
development appropriately with the surrounding soma. Sycp3 staining suggested that 
PGCLCs in cultured reconstituted ovaries were in the zygotene stage of meiotic 
prophase 1, indicating their potential meiotic capacity (Hayashi et al., 2012; Hayashi 
and Saitou, 2013). However, no further development was reported in vitro. In 
contrast, xeno-transplanted reconstituted ovaries contained multi-laminar follicles 
containing PGCLC derived OLCs. Oocytes retrieved from reconstituted ovaries 
could successfully undergo fertilisation and embryo transfer to foster mothers 
resulted in the birth of live healthy offspring (Hayashi et al., 2012; Hayashi and 
Saitou, 2013). However, abnormalities were observed in oocytes derived from 
PGCLCs at an increased rate compared to wild type oocytes. These abnormalities 
included increased proportion of denuded oocytes upon retrieval and oocytes with 
elliptical shape. Approximately half of zygotes derived from PGCLC oocytes also 
exhibited 3 pro-nuclei following fertilisation, speculated to be as a result of failure to 
extrude a 2nd polar body (Hayashi et al., 2012). Thus, while functional oocytes can be 
derived from murine embryonic stem cells, these results also suggest that the process 
of ESC differentiation into oocytes has not fully recapitulated in vivo processes 
resulting in a proportion of abnormal oocytes. Furthermore, the use of an in vivo 
model to support the differentiation of ESCs beyond the PGCLC stage provides little 
insight into the mechanisms and processes required to facilitate oogenesis, but does 
reveal that the somatic cells are pivotal in facilitating this process. 
Functional oocytes have not been differentiated from embryonic stem cells of any 
other species to date, however, oocyte-like cells have been reported in buffalo ESCs 





Genes associated with primordial germ cell formation (DAZL, VASA and PLZF) 
meiosis (SYCP3, MLH1, TNP1/2 and PRM2) and oocytes (GDF9, ZP2 and ZP3) 
were observed in buffalo EBs derived from ESCs (Shah et al., 2015), and a similar 
pattern of protein expression was also observed. The expression of these markers was 
facilitated by the addition of BMP4 to cultures, which has previously been implicated 
in PGC formation during fetal development (Lawson et al., 1999) and could be 
inhibited by NOGGIN, a BMP4 antagonist. Thus suggesting that BMP4 promotes the 
differentiation of buffalo ESCs into germ cells. Large (30-50m) oocyte-like cells 
were observed in cultures which stained positive for the presence of a zona pellucida. 
These cells appeared to extrude a polar body during semi-attached development and 
appeared to undergo parthenogenetic activation to form structures resembling 2-cell, 
4-cell and 8-cell embryos during attached development (Shah et al., 2015). These 
results have not investigated the potential of buffalo OLCs to undergo successful 
fertilisation but do show evidence of the cells developmental ability through 
parthenogenetic activation, however this paper has since been retracted due to 
concerns over control images.  
Embryoid bodies derived in non-adherent human ESC cultures, showed an increase 
in germ cell marker expression, including C-KIT, VASA and DAZL (Aflatoonian et 
al., 2009; Xuemei et al., 2013). This was observed in conjunction with a decrease in 
expression of pluripotency associated genes (OCT4 and SSEA3). Retinoic acid (RA), 
a metabolite of vitamin A, has been shown to be a determining regulator in germ cell 
specification in the developing ovary (Bowles et al., 2006). When added to human 
embryoid body cultures, RA caused an increase in germ cell marker expression 
(Aflatoonian et al., 2009; Xuemei et al., 2013), suggesting that RA may promote the 
initiation of germ cell development in an artificial environment. Co-culture of hESCs 
with human fetal gonadal cells increased the proportion of induced-primordial germ 
cells, marked by the enrichment of PRMD1, DPPA3 and DAZL, which could be 
isolated by the cell-surface co-expression of SSEA-1/KIT/VASA (Park et al., 2009). 
These results suggest that extrinsic factors provided by the fetal gonadal somatic 
environment may be required to propagate germ cell differentiation in vitro. Work on 
murine ESCs showed that PGCLCs could be identified and isolated from EBs using 





Using similar protocols, 0.5-1% of cells in human embryoid bodies were positive for 
both markers, suggesting that these cells were human PGCLCs (Aflatoonian et al., 
2009). Further culture of these cells resulted in large cells with morphological 
resemblance to oocytes, however immunohistochemical analysis was not possible on 
these cells, thus it is difficult to ascertain whether these oocyte-like cells also exhibit 
other features associated with oocytes. However, gene expression analysis of 
differentiating hESCs showed expression of oocyte specific markers (GDF9 and 
ZP1) and meiotic markers (SYCP3) (Aflatoonian et al., 2009; Xuemei et al., 2013). 
These results show that oocyte-like cells, determined by morphological assessment 
and gene expression analysis, have been generated from human embryonic stem 
cells. However, full analysis of human OLCs is yet to be undertaken. It is unclear 
whether these cells possess other features of oocytes, such as an intact zona 
pellucida, and the meiotic and developmental competence of these cells has not been 
established. To fully explore the potential of these cells would require investigations 
into the ability of human OLCs to achieve fertilisation and subsequent embryonic 
development. The creation and destruction of viable human embryos to generate 
artificial oocytes, raises prominent ethical questions. Somatic-cell nuclear transfer of 
ESCs would provide infertile individuals with genetic gametes however do not 
circumvent the ethical issues surrounding the use of ESCs. Thus, alternative cell 
sources should be used to investigate artificial oogenesis. 
1.5.2 Oogenesis using reprogrammed cells (e.g. induced 
pluripotent stem cells; iPSCs) 
Differentiated cells can regain pluripotency under the expression of 4 crucial 
pluripotency associated genes Oct3/4, Klf4, Sox2 and c-Myc. Induced pluripotent 
stem cells (iPSCs) have been generated in rodents and humans (Takahashi et al., 
2007; Takahashi and Yamanaka, 2006). iPSCs do not raise the same ethical concerns 
as ESCs and may provide a better clinical precursor cell for artificial gametogenesis. 
In tetraploid complementation assays murine iPSCs have demonstrated their 
potential to generate functional germ cells (Boland et al., 2009; Zhao et al., 2010).  
Murine iPSCs could be induced to generate EpiLCs and PGCLCs in vitro using 





Hayashi and Saitou, 2013). When introduced into an ovarian niche iPSC derived 
PGCLCs formed OLCs in vitro and functional oocytes capable of fertilisation to 
produce healthy offspring when reconstituted ovaries were transplanted in vivo 
(Hayashi et al., 2012; Hayashi et al., 2011; Hayashi and Saitou, 2013). These results 
suggest that like ESCs, iPSCs can function to produce meiotically and 
developmentally competent oocytes.  
Less success has been achieved with human iPSCs. Co-culture with human fetal 
gonadal stromal cells caused the induction of primordial germ cell-like cell fate in 
XY human iPSCs (Park et al., 2009). Induced primordial germ cells from human 
iPSCs were identified based upon the combined expression of cell surface markers 
SSEA-1/KIT/VASA, characteristic markers of primordial germ cells. These results 
indicate that germ cell differentiation can be initiated from human iPSCs, although 
further work into female (XX) iPSCs is still required. Assessment of the epigenetic 
status of these cells showed abnormal imprinting erasure compared to control PGCs 
and hESC derived PGCs (Park et al., 2009), suggesting that PGCLCs derived from 
human iPSCs may be epigenetically compromised. Artificial oocytes or OLCs from 
human iPSCs have not yet been reported, thus more investigations are required to 
elucidate whether iPSCs provide an alternative precursor cell to generate oocytes as a 
method for assisted reproductive technologies. Further knowledge of their epigenetic 
stability, tumorigenicity and subsequent safety of any future offspring must be well 
assessed before their use in clinical practice.  
The cell plasticity model suggests that cells possess the ability to cross traditional 
lineage barriers previously defined by the hierarchical stem cell differentiation model 
(Estrov, 2009). Trans-differentiation (conversion of a differentiated cell of one 
lineage to a differentiated cell of another lineage without reinstating pluripotency) of 
somatic cells in vitro into germ cells may also provide a pathway to artificial 
gametogenesis. Murine skin derived stem cells (SDSCs) collected from neonates 
formed aggregates in culture which contained Ssea-1 positive cells which upon 
isolation were found to express germ cell associated proteins Dppa3, Dazl and Ddx4, 
and had imprinting patterns characteristic of PGCs (Sun et al., 2015). Addition of 





epiblasts (Dnmt3a, Dnmt3b and Wnt3) and subsequently caused an increase in 
PGCLC formation, in a dose-dependent manner (Sun et al., 2015). These results 
suggest that Activin A promotes PGCLC formation through the formation of EpiLCs 
which then initiate germ cell differentiation. Murine skin derived stem cells also 
generated oocyte-like cells following aggregate formation (Dyce et al., 2011). OLCs 
were large (30-40m), expressed germ cell (Oct4, Vasa, and Dazl), oocyte-specific 
(Gdf9b, ZP1 and ZP2) and meiosis specific genes (Scp3 and Dmc1) and were coated 
in a zona pellucida-like structure, suggesting these cells had become oocytes. 
Transplantation of SDSC aggregates to ovariectomised recipient immune-deficient 
mice generated oocyte-like cells developing within follicles, including antral follicles 
(Dyce et al., 2011), further suggesting that skin stem cells can differentiate into new 
oocytes, however, the fertilisation potential of these new oocyte-like cells was not 
described. In the presence of follicular fluid, fetal porcine skin stem cells initiated 
germ cell development (Dyce et al., 2006). Following aggregate formation, OCT4 
positive OLCs were observed within cultures surrounded by cells expressing P450 
aromatase, suggesting these structures are follicles. OLCs showed parthenogenetic 
activation and blastocyst-like structures were detected. However, OLCs failed to 
undergo successful fertilisation following in vitro fertilisation (Dyce et al., 2006), 
suggesting that OLCs generated from skin cells are abnormal.  
Human fetal skin derived stem cells have also formed aggregates in culture which 
have shown increased expression of DAZL, VASA and SyCP3 over time. SYCP3 
staining was punctate and elongated suggesting that these cells had entered into 
meiosis (Ge et al., 2015). A small proportion of cells were also found to be haploid 
by FACS and FISH analysis, suggesting completion of meiosis in these cells. The 
presence of haploid cells in these cultures suggests abnormal oocyte development as 
oocytes fail to achieve haploid status in situ, as a consequence of meiotic completion 
following successful fertilisation. The derivation of OLCs from skin derived stem 
cells in several species suggests that cells from somatic lineages can 
transdifferentiate into the germ cell lineage, however abnormalities with epigenetic 
reprogramming and meiosis suggest that the underlying mechanisms coordinating 





Oocyte-like cells were also identified in rat pancreatic stem cell cultures. These were 
observed in association with smaller cells forming follicle-like structures. Oocyte-
like cells expressed germ cell (OCT4 and VASA), oocyte (GDF9) and meiotic 
associated proteins (Sycp3 and Dmc1) (Danner et al., 2007). However, no further 
analysis was conducted on the meiotic potential of these cells to elucidate their germ 
cell potential.  
Human amniotic fluid stem cells have also generated oocyte-like cells following 
embryoid body formation (Yu et al., 2014) or exposure to follicular fluid (Cheng et 
al., 2012). These cells expressed oocyte specific genes (BMP15, GDF9 and ZP2) and 
meiotic genes (SCP3 and DMC1) (Cheng et al., 2012; Yu et al., 2014) and were 
found in association with smaller cells to form follicle-like structures (Yu et al., 
2014). Markers of estrogen biosynthesis were detected, suggesting that somatic cells 
have co-differentiated to support OLCs and these cells have the potential to produce 
ovarian steroids (Yu et al., 2014). Haploid cells were detected in differentiating 
amniotic fluid stem cells (Yu et al., 2014) and embryo-like structures were observed, 
suggesting parthenogenetic activation (Cheng et al., 2012). These results suggest that 
human amniotic fluid stem cells can generate OLCs in vitro, however the evidence 
suggests that these cells have undergone abnormal differentiation. 
Cells of several different lineages and species have shown potential to generate germ 
cells using both in vitro and in vivo methodologies. Evidence of successful oogenesis 
from murine pluripotent cells provides the first indication that gametogenesis can be 
artificially recapitulated, although this still requires an in vivo period. Differentiation 
using human cells has been limited thus far, and greater understanding of the 
underlying mechanisms and more extensive analysis into the functionality of human 
OLCs is necessary prior to their use in a clinical setting. All avenues of research have 
identified the importance of the ovarian microenvironment, including paracrine 
factors and cell-cell interactions, as a regulator in germ cell differentiation, such that 
in many cases, ovarian somatic cells co-differentiate in conjunction with oocyte-like 
cells from precursor populations. Thus, the application of artificial gametogenesis as 
a tool to investigate the mechanisms and pathways underlying oogenesis may reveal 





1.6 Models and systems used for the study of oogenesis and 
folliculogenesis 
Various models and methodologies have been employed to expand our 
understanding of ovarian biology and in particular the processes that underlie 
oogenesis and folliculogenesis. Genetic rodent models have revealed roles for 
particular factors and signalling pathways in various aspects of folliculogenesis and 
identified the importance of these in regulating the production of a developmentally 
and meiotically competent oocyte. The recapitulation of oogenesis and 
folliculogenesis in vitro and in vivo allows for the manipulation of these processes to 
further enhance our understanding of the mammalian ovary.  
1.6.1 In vitro follicle culture systems  
Ovarian follicles comprise of an oocyte and supporting somatic granulosa cells and 
theca cells. It is well established that these cell-cell interactions are essential to 
coordinate oocyte and follicle growth in vivo. Thus, successful in vitro systems are 
likely to be able to maintain these interactions. Furthermore, the requirements of 
growing follicles are complex and change with advancing developmental stages. 
Various extrinsic factors are required to support growing follicles and alterations in 
medium content throughout culture, therefore multi-step culture systems have been 
developed to support the changing requirements of growing follicles (Cortvrindt et 
al., 1996; Eppig and O'Brien, 1996; Lenie et al., 2004; McLaughlin and Telfer, 2010; 
O'Brien et al., 2003; Telfer et al., 2008). Multi-step culture systems may utilise one 
or more culture technique such as whole tissue culture followed by individual follicle 
culture and will also supplement media appropriately for the follicle requirements.  
Two-dimensional (2D) attachment cultures of ovarian tissue and follicles have had 
success in producing functional oocytes capable of undergoing meiosis and 
fertilisation (Cortvrindt et al., 1996; Eppig and O'Brien, 1996; Lenie et al., 2004; 
O'Brien et al., 2003). Within a 2D culture system follicles undergo structural 
remodelling, with follicle cells flattening out, which allows better oxygenation and 
nutrient supply to all cells within the structure, although it has been shown that 
interactions between the oocyte, granulosa cells and theca cells are maintained 





from the follicle structure as a consequence of basal membrane rupture (Cortvrindt et 
al., 1996).  
In contrast 3D culture techniques maintain tissue architecture, which is particularly 
important in follicle development. Interference with cell-cell interactions within a 
follicle has caused disrupted folliculogenesis in mice. Gap junctions between 
granulosa cells and oocytes are mediated by the expression of connexin 43 and 
connexin 37 respectively. Elimination of either of these connexins in mice causes 
aberrant folliculogenesis through disruption of the bidirectional communication 
between oocyte and granulosa cells (Ackert et al., 2001; Simon et al., 1997). 
Therefore, use of 3D culture systems may better support folliculogenesis through 
maintenance of follicle structure.  
3D culture techniques to investigate folliculogenesis have utilised whole tissue, 
suspension or encapsulation methods. Whole ovary tissue and ovarian cortical 
culture have been utilised to support the activation of primordial follicles in vitro 
(Eppig and O'Brien, 1996; McLaughlin and Telfer, 2010; O'Brien et al., 2003; Telfer 
et al., 2008), however development beyond pre-antral stages is not supported 
(O'Brien et al., 2003). Porous membranes have been utilised in whole tissue culture 
which allow better oxygenation, nutrient supply and waste removal to provide better 
experimental outcomes (Morgan et al., 2015).  
Suspension techniques, such as hanging drops, rotating vessels and low attachment 
culture plates, promote maintenance of follicle structure in a scaffold free system 
with direct access to nutrients and factors within the medium. Gentle orbital 
movements in rotating vessels prevent cell adhesion to the surface of the culture 
surface. Their use in 3D follicle culture successfully prevented adhesion (Heise et al., 
2005; Rowghani et al., 2004), but the rotation rate required to inhibit adhesion 
appeared to cause follicle degeneration (Rowghani et al., 2004). In contrast, follicles 
suspended within micro-drops of medium achieved oocytes capable of fertilisation 
and subsequent embryonic development, demonstrating their meiotic and 
developmental competence (Bishonga et al., 2001). Inversion of micro-drop cultures, 
also known as a hanging drop, have successfully maintained individual follicles and 





conventional micro-drop cultures (Wycherley et al., 2004). Metaphase II oocytes 
have been achieved from hanging drop cultures of murine secondary follicles (Choi 
et al., 2013) and human spermatogenesis has been supported for up to 14 days in 
hanging drop cultures (Jorgensen et al., 2014), therefore hanging drop cultures have 
been successfully used to support gametogenesis in vitro.  
Encapsulation techniques utilise hydrogels or synthetic polymers to provide a 3D 
scaffold for tissue culture. They support the transfer of oxygen, nutrients and waste 
products between the medium and tissue. Hydrogels such as collagen, fibrin and 
alginate are preferentially used in tissue culture due to their biocompatibility and 
ability to support dynamic remodelling of growing cells which is essential for follicle 
growth (Butcher and Nerem, 2004; Eyrich et al., 2007; Heise et al., 2005). Alginate 
hydrogels have successfully served as a 3D scaffold for individual follicle 
development (Amorim et al., 2009; Camboni et al., 2013; Hornick et al., 2013) and 
ovarian tissue in culture (Laronda et al., 2014). Various concentrations of alginate 
can be utilised to provide either a firmer or less rigid structure dependent on the 
culture requirements. More rigid alginate hydrogels have been shown to better 
support early follicle development whereas larger follicles require more flexibility to 
support dynamic follicle growth (Hornick et al., 2013). However, transfer of larger 
molecules to encapsulated tissue may be hindered in more concentrated alginate 
hydrogels (Heise et al., 2005).  
Although 3D culture techniques have been utilised successfully to support follicle 
and oocyte development, tissue necrosis is often associated with long term culture 
and cell viability has been shown to decrease after 5 days in culture (reviewed by 
Edmondson et al. (2014)).  
1.6.2 Xeno-graft models for follicle growth 
Xeno-transplant models eliminate many of the problems associated with in vitro 
culture systems. Through the development of vasculature to transplanted tissue, a 
constant nutrient supply and waste disposal system is established (Edmondson et al., 
2014). The development of immune deficient rodents has provided the opportunity to 
investigate oogenesis and folliculogenesis of different species in vivo (Aubard, 





the kidney and the ovarian bursa. The kidney has previously been used due to its rich 
vasculature, which facilitates the vascularisation of transplants which is estimated to 
occur within 48 hours of transplant (Dissen et al., 1994), furthermore its capsule and 
location within the body protects any transplanted tissue from potential interference. 
The ovarian bursa has also been used for similar reasons in addition to placing 
transplanted tissue into a physiologically relevant location.  
Ovarian cortical tissue from cats (Gosden et al., 1994), ewes (Gosden et al., 1994), 
cows (Hernandez-Fonseca et al., 2005), elephants (Gunasena et al., 1998) and 
humans (Gook et al., 2001; Oktay et al., 1998) amongst other species, has been 
successfully xeno-grafted to the kidney capsule of immune deficient rodents. The 
host’s hormonal and systemic environments appear to support the initiation of 
follicle growth and development beyond pre-antral stages. In the absence of a 
functional hypothalamic-pituitary-gonadal axis, human follicles could not progress 
past two layers of granulosa cells, however treatment of recipient mice with FSH 
supported progression to antral development (Oktay et al., 1998). Marmoset ovarian 
tissue transplanted to nude mice was able to produce estrogen which was capable of 
inducing alterations within host vaginal cells, observed by vaginal smears (Candy et 
al., 1995). These results suggest that xeno-grafted ovarian tissues establish a cross-
talk with the host tissues. Castrated male mice have also been utilised as recipients 
for ovarian tissue transplantation. Bovine ovarian tissue initiated follicular growth in 
male mice despite gender and species differences. Oocytes collected from 
transplanted bovine ovarian tissue have achieved meiotic and developmental 
competence to successfully fertilise following IVF (Campos-Junior et al., 2016; 
Senbon et al., 2005).  
Despite species differences between donor tissue and recipient, these appear not to be 
detrimental to the initiation of follicle growth, subsequent follicle development, and 
crucially do not inhibit oocyte acquirement of meiotic and developmental 
competence. These data suggest that xeno-graft models provide an opportunity to 
study oogenesis and folliculogenesis of any mammalian species within the rodent 
model, allowing for genetic and chemical manipulation of the tissue environment 





1.6.3 Bovine ovarian model 
The bovine ovary is of a similar size to the human ovary, is mono-ovulatory and 
polycyclic, furthermore the length of folliculogenesis and the resulting size of 
follicles and functional oocytes is similar (Adams and Pierson, 1995). These 
similarities between human and bovine ovaries has indicated that the bovine ovary is 
a good model for the human ovary and human folliculogenesis (Adams and Pierson, 
1995; Campbell et al., 2003; Yapura et al., 2011). Human tissue is often scarce and 
difficult to source, this is particularly prevalent with ovarian tissue, which is often 
collected from patients undergoing hysterectomy, gender reassignment surgery or 
cancer treatment, meaning the tissue may be compromised in some way, for example 
exposure to hormone treatment for gender reassignment. Although a number of 
research groups now collect ovarian tissue from women undergoing caesarean 
section surgery, this tissue is also uniquely representative of the ovary during 
pregnancy rather than at any other physiological state. In contrast, bovine ovarian 
tissue can be easily collected as a waste product of agricultural enterprise and is 
reflective of a young, healthy population. Several groups, including our own have 
utilised bovine ovarian tissue as a model for the human ovary, therefore the use of 
bovine ovarian tissue as a source of mammalian oogonial stem cells may provide 






1.7 Hypothesis and aims   
A population of primordial follicles are established just prior to or shortly after birth 
in the mammalian ovary, which has been believed to be fixed and as such determined 
the reproductive life span of an individual. However, a population of putative 
oogonial stem cells (OSCs) have now been identified in adult mammalian ovaries of 
several species including rodents and humans. Putative OSCs appear to have 
undergone oogenesis following isolation from adult ovaries to generate oocyte-like 
cells (OLCs). Furthermore, rodent OSCs have contributed to the population of 
ovulatory oocytes and have successfully generated live offspring.  
Hypothesis 
Putative oogonial stem cells can be isolated from adult bovine ovarian tissue and 
when combined with somatic cell support can undergo neo-oogenesis and 
folliculogenesis in a re-aggregation model both in vitro and in vivo. 
Aims 
 To isolate, characterise and label bovine oogonial stem cells from adult 
ovarian cortical tissue. 
 To investigate the ability of bovine OSCs to undergo neo-oogenesis and 
folliculogenesis when combined with somatic cell support both in vivo and in 
vitro. 
o To develop an in vitro ovarian aggregation culture model to support 
bOSC differentiation and folliculogenesis. 
o To utilise a xeno-transplant model to examine the oogenic potential of 
bOSCs when combined with ovarian somatic cells from the same 
species and other species in vivo.  




2 General Materials and Methods 
2.1 Bovine Tissue 
2.1.1 Tissue collection 
Adult bovine ovaries were collected by John Binnie from the local abattoir (Longleys 
Farm, Bridge of Allan, Stirling, FK9 4NE) and transferred at 33-38oC to the 
laboratory in HEPES-buffered M199 medium (Life Technologies) supplemented 
with amphotericin B (2.5µg/ml; Life Technologies), pyruvic acid (25µg/ml), 
penicillin G (75µg/ml) and streptomycin sulphate (50µg/ml; all chemicals from 
Sigma-Aldrich). The ovaries were rinsed in 70% ethanol and dissected under laminar 
flow conditions with a sterile scalpel blade. Fine cortical strips were dissected from 
the ovaries and placed in holding medium (Leibovitz medium, Life Technologies) 
supplemented with sodium pyruvate (2 mM), glutamine (2 mM; both obtained from 
Life Technologies), BSA (Fraction V, 3 mg/ml), penicillin G (75 μg/ml) and 
streptomycin (50 μg/ml; All chemicals from Sigma-Aldrich). Tissue pieces were then 
examined under light microscopy and any damaged, haemorrhaged or excess stromal 
tissue was excised, prior to further use. 
2.1.2 Tissue vitrification 
After dissection bovine cortical ovarian fragments were prepared for vitrification as 
described by Kagawa et al. (2009), with slight modification. The bovine cortical 
ovarian fragments were initially equilibrated in vitrification medium 1 (Section 2.12) 
at room temperature for 25 minutes followed by a 15 minutes equilibration in 
vitrification medium 2 (Section 2.12). The fragments were then placed onto 
30mmx0.25mm acupuncture needles (AcuMedic) and submerged in liquid nitrogen. 
Frozen ovarian cortical strips were transferred to a cryovial (Greiner Bio-one) and 
placed into a liquid nitrogen tank for long term storage. 
2.1.3 Tissue thawing 
Prior to use, bovine ovarian cortical tissue fragments were thawed as described by 
Kagawa et al. (2009). Briefly, ovarian fragments were placed in pre-warmed thaw 
medium 1 (Section 2.12) for 1 minute followed by a 5 minute incubation in thaw 




medium 2 (Section 2.12) at 37oC. Tissue was then washed twice in holding medium 
(Section 2.12) for 10 minutes at 37oC. 
2.2 Isolation of bOSCs using fluorescently activated cell sorting 
(FACS) 
Bovine oogonial stem cells were isolated from adult bovine ovarian cortex based 
upon the expression of germ cell marker DDX4 (Dead-box helicase 4) as described 
by White et al. (2012) with slight modification (illustrated in Figure 2.1). 
2.2.1 Digestion of ovarian tissue 
Adult bovine ovarian cortical tissue previously collected from the local abattoir 
(section 2.1.1) and stored (section 2.1.2), was thawed as described in section 2.1.3. 
Tissue was then cut into pieces approximately 2x2x1mm in size with sterile scalpels 
(Swan-Morton) and transferred to sterile gentleMACS C-tubes (Miltenyi Biotec Ltd) 
with 3ml of pre-warmed collagenase/DNAse solution (600 Units/ml of collagenase 
type IV and 1 g/ml DNAse, both supplied by Sigma-Aldrich, in Hanks balanced 
salt solution (HBSS) without calcium and magnesium, Life Technologies). Tissue 
was then dissociated using a gentleMACS dissociator (Miltenyi Biotec Ltd) using 3 
pre-set programs (1-H_tumor_01.01, 1-H_tumor_02.01 and 1-H_tumor_03.01) with 
20 minute incubations placed in a MACSmic Tube Rotator (Miltenyi Biotech Ltd) at 
37oC with humidified air and 5% CO2 between programs. Once completed, tissue 
was gently pipetted up and down with a sterile 5ml borocilicate glass pipette 
(Corning Incorporated) until the majority of tissue was dispersed and filtered through 
a 100M cell filter (Sysmex Partec) into a 15ml falcon tube (Corning Incorporated), 
the filtrate was then made up to 10ml with pre-warmed HBSS and centrifuged at 
300RCF for 5minutes. The supernatant was discarded and the cell pellet was gently 
re-suspended in a total of 10ml pre-warmed HBSS and centrifuged at 300RCF for 
5minutes before non-specific blocking (section 2.2.2). 





Figure 2.1: A diagrammatic representation of the preparation of bovine tissue for FACS 
isolation of bOSCs. Adult bovine ovarian cortex was manually dissected into pieces approximately 
1x1x2mm in size then enzymatically digested using collagenase IV and DNAse. Following digestion, 
the disaggregated tissue was filtered through 100uM cell filter to remove large cells and undigested 
tissue to create a single cell suspension. To prevent non-specific binding of the secondary antibody, a 
blocking serum was applied to the single cell suspension prior to primary antibody exposure. An anti-
DDX4 antibody was used to identify bOSCs in the cell suspension, an APC conjugated goat anti-
rabbit secondary antibody was then utilised to amplify this signal. 




2.2.2 Non-specific blocking 
To prevent non-specific binding of the secondary antibody tissue was blocked with 
FACS blocking solution (2% goat serum and 2% bovine serum albumin (Sigma-
Aldrich) in HBSS without calcium and magnesium) for 20minutes on ice. To 
establish the parameters of the cell sorting the appropriate negative controls were 
utilised. 10% of the sample was used as a negative control (primary and secondary 
antibody omitted) and remained on ice until section 2.2.5, and a further 10% of the 
sample was used as a secondary antibody only control (primary antibody omitted) 
and remained on ice until section 2.2.4, see Figure 2.2. The remaining sample was 
exposed to the primary antibody (section 2.2.3) and utilised for the isolation of 
bOSCS. 
 
Figure 2.2: Diagram of controls and samples used in FACS to isolate bOSCs. Two controls were 
used to develop gating strategies to isolate bOSCs using FACS, a negative control (left hand panel) 
with both primary and secondary antibodies omitted, and a secondary antibody only control (centre 
panel) with only the primary antibody was omitted. The sample (right hand panel) was exposed to 
both primary and secondary antibodies to identify bOSCs within adult bovine ovary. 
2.2.3 Primary Antibody 
After non-specific blocking the sample was made up to 10ml with chilled (4oC) 
HBSS and centrifuged at 300RCF. The supernatant was then discarded and the 
sample was re-suspended in a total of 100L of Rabbit anti-DDX4 (Abcam, 
ab13840) diluted 1:10 in FACS blocking solution (as described in section 2.2.2) for 
20 minutes on ice. The sample was then washed with 10ml chilled HBSS and 
centrifuged at 300RCF for 5 minutes. The supernatant was discarded and the sample 
washed again. 




2.2.4 Secondary Antibody 
The sample and secondary antibody only control were both washed in chilled HBSS, 
centrifuged at 300RCF for 5 minutes. The supernatants were then discarded and both 
samples were re-suspended in a total of 250L of Goat anti-rabbit IgG conjugated to 
allophycocynan (APC; Stratech Scientific Limited, 111-136-144-JIR) diluted 1:250 
in FACS blocking solution (as described in section 2.2.2) for 20 minutes on ice. The 
samples were then washed in 10ml chilled HBSS and centrifuged at 300RCF for 
5minutes. The supernatants were discarded and the sample and secondary antibody 
only control washed again.  
2.2.5 Fluorescently activated cell sorting 
All samples (see Figure 2.2) were washed in 10ml chilled HBSS and centrifuged at 
300RCF for 5minutes. The supernatants were discarded and the sample and both 
controls were re-suspended in 500L FACS buffer (50L of FBS in 5ml HBSS). 
Fluorescently activated cell sorting (FACS) was carried out on a BD FACS Aria II at 
the Queens Medical Research Institute Flow Cytometry Facility and was conducted 
by a cytometry specialist, Will Ramsey. Both the negative and secondary antibody 
only control +/- DAPI (1:1000 dilution, (Sigma-Aldrich), to assess cell viability) 
were used to determine the gates used, illustrated in Figure 2.2 and Figure 2.3. Cells 
identified as viable and DDX4 positive were isolated and sorted into OSC media 
(section 2.12) for propagation in culture (section 2.6.1.1) 





Figure 2.3: FACS gating strategy developed to isolate bOSCs. (A) All events detected by FACS 
are represented by dots and are initially sorted based on the cell granularity and size, events 
determined to be cells based on this criteria, are represented in red and then sorted based entirely on 
size (B) to identify single cells shown in purple. (C, D, E) Single cells were assessed for viability 
based on DAPI uptake and DDX4 expression based on APC detection. Cells that appear above the 
horizontal dotted line on the plots show DAPI uptake and are non-viable, cells to the right of the 
vertical dotted line show APC expression thus are DDX4 positive. (C) Negative control sample, 
shows viable (green) and non-viable cells all DDX4 negative. (D) Secondary antibody only control, 
illustrates viable (green) and non-viable cells, DDX4 negative, several cells also appear slightly 
DDX4 positive and these represent background staining and are used to determine collection gates for 
DDX4 positive cells in the sample to eliminate false positives. (E) Sample, illustrates non-viable 
DDX4 negative and positive cells (purple) and viable DDX4 negative cells (green) and viable DDX4 
positive cells (pink). Examples of sorting gates are shown as black outlines on each of the panels and 
represent the parameters of the gating strategy.  
2.3 Derivation of fetal bovine ovarian somatic cells 
Fetal bovine ovaries (gestational age 163.5 days) were received from the local 
abattoir as described in section 2.1.1. Each ovary was placed in a sterile dimple slide 
with 50L of Collagenase type IV (10mg/ml in HBSS; Sigma-Aldrich) and pulled 
apart with 19 gauge needles (Becton Dickenson). Tissue and collagenase mix from 




both ovaries were transferred to a 1.5ml tube (Eppendorf UK Ltd) with an additional 
400l of collagenase solution and placed in a thermomixer (Eppendorf UK Ltd) at 
37oC, shaking at 1000rpm for 10 minutes. 50l of DNAse I (7mg/ml in HBSS, 
Sigma-Aldrich) was added to the tissue mix and returned to the thermomixer for a 
further 5minutes shaking at 37oC. The cell suspension was then centrifuged at 600g 
for 5minutes and the cell pellet was washed twice with 1ml of HBSS. The cell pellet 
was then re-suspended in fetal ovarian somatic cell media (section 2.12) and filtered 
through a 70m filter (Becton Dickenson), centrifuged at 600g and re-suspended in 
1ml media. The cells were split between an appropriate number of wells in a 12 well 
plate and the volume of each well made up to 1ml with fetal somatic cell media. 
The following day, cells were washed twice with pre-warmed PBS (Life 
Technologies) and new fetal somatic cell media was added (section 2.12). Cells were 
maintained as described in section 2.6.1.2.  
2.4 Murine Tissue 
2.4.1 Tissue collection 
Neonatal (CD-1, B6SJLF1 or B6;129-Gt(ROSA)26) female mice (postnatal day 0 - 
5) were culled by cervical dislocation and ovaries collected for fixation (see section 
2.8.1) or disaggregation (see section 2.5.1). 
Immune deficient mice (C.B-17/IcrHan Hsd-Prkdc scid), recipients of ovarian 
aggregates (section 2.5.4) xenotransplanted to the kidney, were culled by lethal 
exposure to CO2 and tissues were collected either 7 or 21 days after transplant. 
2.5 Ovarian Aggregation Model 
We utilised and developed an ovarian aggregation model based on a model 
previously published by Eppig and Wigglesworth (2000) to investigate the 
developmental potential of bovine oogonial stem cells, the methodology is described 
and illustrated (Figure 2.4) below. 




2.5.1 Disaggregation of neonatal mouse ovaries 
Neonatal (postnatal day 0 - 5; minimum number of 20 ovaries were used to achieve 
required cell yield) female mice (CD-1, B6SJLF1 or B6;129-Gt(ROSA)26) were 
culled by cervical dislocation and ovaries were dissected out and transferred to pre-
warmed PBS (Life Technologies) supplemented with 1mg/ml BSA (Sigma-Aldrich). 
Ovaries were then removed from their bursa and added to 2ml pre-warmed 
trypsin/EDTA/DNAse solution (Trypsin (0.05%) with EDTA (Thermo Fisher 
Scientific) and 0.02% DNAse I (Sigma-Aldrich) in a 35mm culture dish (Corning 
Incorporated) for disaggregation. Ovaries were incubated at 37oC with humidified air 
and 5% CO2 for 15 minutes. Ovaries were then mechanically dissociated by gentle 
pipetting up and down and returned to the incubator for a further 5 minutes, twice. 
The enzymatic digestion was neutralised equal volumes with sterile M199 media 
supplemented with 1x penicillin-streptomycin, 110μl Sodium Lactate and 10% FBS 
(all supplements from Sigma-Aldrich) and filtered through 22m filter (Millipore 
Ltd). Cell suspension was centrifuged at 450 RCF for 5minutes, supernatant removed 
and cells re-suspended in 1ml fresh M199 media with supplements as described 
earlier. Cells were plated in 35mm culture dishes and volumes made up to 3ml in 
each culture dish. Cells were cultured overnight at 37oC with humidified air and 5% 
CO2.  
2.5.2 Separation of germ and somatic cells 
Germ and somatic cells from neonatal mice were initially separated based on their 
adhesive potential (Somatic cells will adhere to the base of a culture plate, whereas 
germ cells will float in the media). Germ cells were aspirated off the somatic cell 
monolayer and placed in a new 35mm culture dish. The somatic cell monolayer was 
then washed with 2ml of pre-warmed PBS supplemented with 1mg/ml BSA, twice, 
to remove any remaining germ cells and cell debris. 2ml of pre-warmed 
trypsin/EDTA/DNAse was added to the somatic cells for 5minutes at 37oC, then 
neutralized with equal volumes of M199 with supplements and filtered through a cell 
filter (size 30m or 20m, (Sysmex)). Somatic cells were then centrifuged at 450 
RCF for 5minutes, supernatant discarded and cells re-suspended in M199 with 




supplements and placed in a new culture dish and returned to 37oC, with humidified 
air and 5% CO2 for 5-6 hours.  
Following a second incubation, the murine neonatal ovarian somatic cells were 
washed with 2 ml pre-warmed PBS, twice. 2ml of pre-warmed 
trypsin/EDTA/DNAse was added to the somatic cells for 5minutes at 37oC, then 
neutralized with equal volumes of M199 with supplements and filtered through a cell 
filter (size 30m, 20m or 10m, (Sysmex)). Cells were centrifuged at 450 RCF for 
5minutes, supernatant discarded and cells re-suspended in an appropriate volume of 
media for cell counting, prior to aggregation (section 2.5.4). 
2.5.3 Culture of neonatal murine somatic cells 
Some populations of CD-1 murine neonatal somatic cells were cultured longer term 
for use in ovarian aggregates. Cells were briefly washed twice with pre-warmed PBS 
(Life Technologies) and cultured with fetal somatic cell media previously developed 
for human cells (Bayne et al., 2016), Dulbecco’s Modified Eagles Medium (DMEM; 
without Phenol red) supplemented with 10% Fetal Bovine Serum (FBS), 2mM L-
glutamine, 1x MEM Non-Essential Amino Acids (NEAA) and 1x 
penicillin/streptomycin/amphotericin (all supplements supplied by Life 
Technologies). Once confluent cells were split using Trypsin (0.05%) with EDTA 
(Life Technologies) at an appropriate ratio. 
2.5.4 Aggregation of ovarian cells 
All cell populations used for aggregations were trypsinised, neutralised with equal 
volumes of media and centrifuged at 450 RCF for 5 minutes and re-suspended in 
Waymouths media (Life Technologies) with 1xpenicillin-streptomycin (Sigma-
Aldrich) and 10% FBS (Life Technologies). Cell populations were manually counted 
using a haemocytometer. Cells were then combined in the appropriate ratio and 
combination to create different aggregates (Figure 2.4). Cells were placed into 0.5ml 
eppendorfs in the desired ratio/concentration and 35g Phytohaemagluttanin (PHA, 
Sigma-Aldrich), a natural plant lectin, which promotes mammalian cell 
agglutination, was added. Between 100,000 – 200,000 cells were used to create 
aggregates. Cells were mixed by a brief vortex and the centrifuged in a 




microcentrifuge at 11,200 RCF for 30 seconds, the 0.5ml eppendorfs were then 
rotated 180o and cells were centrifuged at 11,200 RCF for 30 seconds a second time. 
Cell pellets (aggregates) were then transferred with 30l of Waymouths media with 
supplements to a hanging drop culture overnight at 37oC with humidified air and 5% 
CO2 to encourage cell interaction and adhesion.   
 
Figure 2.4: Illustration of the ovarian aggregation model. bOSCs were isolated via FACS from 
adult bovine ovaries and cultured prior to aggregation with other cell populations. Murine neonatal 
ovaries were collected and enzymatically disaggregated with Trypsin/EDTA, to achieve a single cell 
suspension, which was cultured overnight in M199 media with supplements. Murine ovarian somatic 




cells were then separated from germ cells based on their adhesive potential. Germ cells were washed 
off the somatic cell monolayer. Somatic cells were also filtered through cell filters (30M, 20M or 
10M). Cells were then combined together in the desired numbers/ratios with 35g PHA and 
centrifuged prior to an overnight culture in a hanging drop to facilitate adhesion of cells. 
2.5.4.1 Positive control ovarian aggregate 
Positive control aggregates recombined neonatal murine somatic cell and germ cell 
populations at varying ratios (Figure 2.4). Positive control aggregates were then 
either cultured as described in section 2.6.4 or xeno-transplanted as described in 
section 2.7.1. 
2.5.4.2 Negative control ovarian aggregate 
To investigate the quality of our separation technique, negative control aggregates 
were generated, aggregating together mouse neonatal ovarian somatic cells only 
(Figure 2.4). Negative control aggregates were generated alongside every chimeric 
aggregate. Negative control aggregates were then either cultured as described in 
section 2.6.4 or xeno-transplanted as described in section 2.7.1. 
2.5.4.3 Chimeric ovarian aggregate 
bOSCs isolated (see section 2.2) and cultured (see section2.6.1.1) were aggregated 
together with neonatal mouse ovarian somatic cells at a ratio of 1:10 respectively 
(Figure 2.4). Chimeric aggregates were then either cultured as described in section 
2.6.4 or xeno-transplanted as described in section 2.7.1. 
Chimeric ovarian aggregates were also generated using freshly isolated bOSCs 
which were frozen (see section 2.6.1.3) until required and thawed before aggregation 
with neonatal mouse ovarian somatic cells. bOSC viability was assessed using trypan 
blue (Thermo Fisher Scientific) as a marker of dead cells. An equal volume of 0.4% 
trypan blue solution was added to 10l cell suspension. Cells were then loaded onto 
the haemocytometer and counted. The percentage of viable cells was calculated and 
the appropriate number of live bOSCs added to neonatal mouse ovarian somatic cells 
at a ratio of 1:10 respectively. Chimeric ovarian aggregates were then xeno-
transplanted as described in section 2.7.1. 




2.5.5 Bovine ovarian aggregates 
bOSCs were also aggregated with fetal bovine ovarian somatic cells (isolated as 
described in section 2.3 and cultured as described in section 2.6.1.2) at a ratio of 1:10 
respectively. Bovine aggregates were then either cultured as described in section 
2.6.4 or xeno-transplanted as described in section 2.7.1. 
2.6 Mammalian cell and tissue culture 
2.6.1 Cell maintenance 
All cell culture was conducted under sterile laminar flow conditions and cells were 
cultured and maintained at 37oC with humidified air in 5% CO2. 
2.6.1.1 Culture of bOSCs 
Upon isolation from adult ovarian cortex (Section 2.2), bovine oogonial stem cells 
were placed into pre-warmed OSC medium (Section 2.12) in a single well of a 24 
well culture plate (Corning Incorporated). Cells were cultured at 37oC with 
humidified air in 5% CO2 and were refreshed with 100µl of new medium every 48 
hours. Once confluent cells were passaged using Trypsin (0.05%) with EDTA (Life 
Technologies). Trypsin was added to cells for 5 minutes and returned to the 
incubator to accelerate their detachment. Trypsin was neutralised with pre-warmed 
OSC medium (Section 2.12) and cells were spun down for 5 minutes at 112 RCF 
before the supernatant was discarded and the cells were re-suspended in pre-warmed 
OSC medium (Section 2.12) and split at an appropriate ratio. 
2.6.1.2 Culture of FBSCs 
Following derivation of the fetal bovine ovarian somatic cells (FBSCs, see section 
2.3), cell medium was changed on alternate days. Cells were briefly washed twice 
with pre-warmed PBS (Life Technologies) and fresh medium (Dulbecco’s Modified 
Eagles Medium (DMEM; without Phenol red) supplemented with 10% Fetal Bovine 
Serum (FBS), 2mM L-glutamine, 1x MEM Non-Essential Amino Acids (NEAA) and 
1x penicillin/streptomycin/amphotericin (all supplements supplied by Life 
Technologies)). Once confluent cells were split using Trypsin (0.05%) with EDTA 
(Life Technologies) at an appropriate ratio.  




2.6.1.3 Freezing and Storage of cells 
To store bOSCs long term, cells were cryopreserved. Following trypsinisation, cells 
were re-suspended in OSC medium (section 2.12) and centrifuged (112 RCF). The 
supernatant was discarded and cells were re-suspended in 50% OSC media and 50% 
cryopreservation media (60% FBS (Life Technologies), 20% DMSO (Sigma) and 
20% OSC media) and placed into a cryovial (Sigma). Cryovials were then placed 
within a Nalgene Mr Frosty (Sigma), filled with isopropyl alcohol and placed in a -
80oC freezer overnight and then transferred to liquid nitrogen for long term storage. 
FBSCs were trypsinised and the reaction neutralised with equal volumes of fetal 
ovarian somatic cell medium (section 2.12). The cell suspension was centrifuged at 
450 RCF and cells were re-suspended in 1ml Bambanker (AlphaLaboratories), 
transferred to a cryovial (Sigma). Cryovials were then placed within a Nalgene Mr 
Frosty (Sigma), filled with isopropyl alcohol and placed in a -80oC freezer overnight 
and then transferred to liquid nitrogen for long term storage. Neonatal murine 
somatic cells were frozen in the same fashion. 
Cells were thawed by heating cryovials to 37oC in a pre-warmed water bath. The cell 
suspensions were then centrifuged at the appropriate speed. Cells were then re-
suspended in the appropriate medium and placed in a culture dish and cultured at 
37oC in humidified air with 5% CO2.  
2.6.2 Cell labelling 
To investigate bOSCs in subsequent experiments, cells were labelled fluorescently 
for tracking. Several methods were used to label bOSCs and the success of these 
labelling techniques were assessed using visual assessment of the fluorescent labels 
(section 2.9.2) and cell growth through assessment of passage frequency. 
2.6.2.1 Lentivirus transduction 
bOSCs at 50% confluency were transfected with an mCherry lentivirus under the 
SFFV promotor (Lv-cppt-SFFV-IRES-mCherry-opre; designed by Pamela Brown of 
the Biomolecular Core) for labelling and subsequent tracking. Lv-cppt-SFFV-IRES-
mCherry-opre was added to fresh pre-warmed OSC media at concentrations which 
represented ratios of either 1:1. 5:1 or 10:1 of virus:bOSCs, respectively then applied 




to cells. Polybrene (Sigma-Aldrich) was also added to media at a final concentration 
of 6g/ml to facilitate viral transfection of cells. Cells were cultured for 48 hours at 
37oC with humidified air and CO2. Viral media was then removed, cells washed 
twice with pre-warmed PBS and replaced with pre-warmed OSC media. 
2.6.2.2 Cell tracker dyes 
bOSCs were labelled with 5-chloromethylfluorescein diacetate (CMFDA; Thermo 
Fisher Scientific, C7025) for 30 minutes or 1 hour according to manufacturer’s 
instructions. Briefly, 50g CMFDA was re-suspended in 50l DMSO and then 
added to 15ml OSC medium (section 2.12). 1ml CMFDA labelled OSC media was 
added to bOSCs for 30 minutes or 1 hour. Medium was then washed off with pre-
warmed PBS and then replaced with pre-warmed fresh OSC media. Cells were then 
visualised as described in section 2.9.2 to visualise CMFDA uptake. 
2.6.2.3 Fluorescent Dextrans 
Media was aspirated off bOSCs and cells were washed twice with pre-warmed PBS 
(Life Technologies) and fresh medium with 100g/ml Rhodamin Dextrans (Thermo 
Fisher Scientific, D1824; 10,000 MW) was added to the cells. Cells were incubated 
at 37oC, with humidified air and 5% CO2, overnight. Following culture with 
Rhodamine Dextrans, cell medium was aspirated and cells washed twice with pre-
warmed PBS then fresh OSC media added. Cells were visualised as described in 
section 2.9.2, for rhodamine dextran uptake. If necessary, this process was repeated 
to achieve a high uptake of dextrans. 
2.6.3 Immunostaining of cells 
To investigate protein expression and characterise our cells of interest, cells were 
fixed and immunocytochemistry carried out to identify antigens within the cells. 
2.6.3.1 Seeding of Chamber slides 
Chamber slides (Thermo Fisher Scientific) were coated with poly-L-lysine (Sigma-
Aldrich) for 10 minutes, then washed twice with PBS and left to air dry for 2 hours 
in a sterile laminar flow hood. Cells were then seeded directly onto chamber slides 




and cultured as described in section 2.6.1 until confluent and then fixed (section 
2.6.3.2). 
2.6.3.2 Cell Fixation 
Cells were either fixed using a 50:50 Methanol:Ethanol solution or using NBF, 
methodology is detailed in each chapter.  
For methanol:ethanol fixation, cells in their culture wells or previously seeded on 
chamber slides were firstly washed with ice cold PBS (Life Technologies) twice, 
then ice cold methanol:ethanol solution (ratio 50:50) was added to cells, and 
incubated at -20oC for 10 minutes. An equal volume of room temperature PBS was 
then added to the methanol:ethanol solution and aspirated off the cells. Cells were 
then washed with fresh room temperature PBS twice and an appropriate amount of 
PBS added to the cells and were then stored at 4oC. This methodology did not require 
separate permeabilisation of the cells and proceeded with non-specific blocking 
(section 2.6.3.3).  
Cells fixed with NBF were washed twice with pre-warmed PBS and NBF added to 
the cells for 10minutes at room temperature. NBF was then removed and cells were 
washed twice with PBS. Cells fixed with NBF were permeabilised using 0.5% Triton 
X-100 (Sigma-Aldrich) in PBS for 10 minutes at room temperature, then washed 
twice with PBS and then an appropriate amount of PBS added to the cells and were 
then stored at 4oC. 
2.6.3.3 Non-specific blocking 
To prevent non-specific blocking of the secondary antibody, cells were blocked with 
normal serum (NS, serum used was based on the species the secondary antibody was 
raised in) diluted in PBS (1:4 respectively) with 5% bovine serum albumin (BSA, 
Sigma-Aldrich), NS/PBS/BSA for 30minutes at room temperature.  
When using tyramide as the detection method, the blocking serum was immediately 
replaced with primary antibody (section 2.6.3.4), however when using a streptavidin 
conjugated alexaflour, endogenous biotin activity must be blocked. This was done 
using a streptavidin/biotin blocking kit (Vector Laboratories), according to 
manufacturer’s instructions. Briefly, streptavidin block was diluted 1:4 with PBS and 




added to cells for 15minutes at room temperature, then washed with PBS twice and 
then the biotin block, diluted 1:4 in PBS, was added for 15minutes at room 
temperature and washed twice in PBS.  
2.6.3.4 Primary antibody 
Following non-specific blocking, the primary antibody was added to samples diluted 
in blocking serum (NS/PBS/BSA). Primary antibody concentrations were optimised 
by titration to find the optimum level of detection lacking non-specific background 
staining. Table 2.1 below describes the antibodies used and their corresponding 
dilutions. Primary antibodies were applied to the cells and incubated overnight at 
4oC. Negative controls (primary antibody omitted) were also included. 
Table 2.1: Primary antibodies used in immunocytochemistry 
Antibody Dilution Species 
Detection 
method Supplier 
Tetramethylrhodamine  1:3000 Rabbit Tyramide Life Technologies 
DDX4 1:300 Rabbit Streptavidin Abcam 
DAZL 1:800 Mouse Streptavidin AbDSerotec 
C-KIT 1:100 Rabbit Streptavidin DAKO 
LIN28 1:500 Rabbit Streptavidin Abcam 
OCT4 1:250 Mouse Streptavidin Santa Cruz 
IFITM3 1:500 Rabbit Streptavidin Abcam 
 
2.6.3.5 Secondary antibody 
Primary antibodies were washed off with two washes of PBS and secondary 
anitbodies were diluted 1:200 in blocking serum and applied to the cells for 30 
minutes at room temperature in a humidity chamber. Secondary antibodies were 
selected based on their specificity for the primary antibodies and also in accordance 
with the normal serum used in the blocking step (2.6.3.3). Secondary antibodies are 
listed in Table 2.2. Chambers on the slides were removed at this stage according to 
manufacturer’s instructions. 




Table 2.2: Secondary antibodies used in immunocytochemistry 
2.6.3.6 Visualisation of secondary antibody 
Slides were washed in PBS twice for 5minutes to remove any unattached secondary 
antibody. The secondary antibody is then visualised using either streptavidin or 
tyramide detection. 
For streptavidin detection, alexfluors conjugated to streptavidin (listed in Table 2.3) 
were diluted 1:200 in PBS and incubated on cells for 1 hour at room temperature in a 
dark humidity chamber. Slides were then washed twice in PBS for 5minutes in an 
opaque chamber to prevent fluorescent bleaching. 
Table 2.3: Streptavidin conjugated alexafluors for immunocytochemistry 
Streptavidin Supplier 
Alexafluor 488 Molecular Probes Inc 
Alexafluor 555 Molecular Probes Inc 
  
In contrast, for tyramide detection (Perkin Elmer Incorporated) after washing the 
peroxidase secondary antibody off with PBS, slides were incubated in tyramide, 
diluted 1:50 in the prescribed buffer in accordance with the manufacturer’s 
instructions, for 10 minutes in a dark humidity chamber. Slides were then washed in 
PBS to remove the tyramide, in an opaque chamber to prevent bleaching of the 
fluorescence. 
2.6.3.7 Counterstaining 
Nuclei of cells were counterstained with either DAPI (Sigma-Aldrich) or Sytox 
Green (Molecular Probes Incorporated), to compliment the fluorescent colours used 
in the immunocytochemistry. Both counterstains were diluted 1:1000 in PBS and 
added to cells for 10minutes, maintained in the dark and at room temperature. 
Antibody Supplier 
Goat anti Rabbit Vector 
Chicken anti Rabbit Santa Cruz 
Chicken anti Mouse Santa Cruz 




Following counterstaining, cells were washed with PBS twice and mounted with 
glass coverslips (CellPath Ltd) using permaflour (Thermo Fisher Scientific). Slides 
were then maintained at 4oC in the dark until visualisation (section 2.9.4). 
2.6.4 In vitro culture of ovarian aggregates 
Ovarian aggregates generated as described in section 2.5 were cultured using two 
different methods described below after an initial overnight hanging drop culture to 
promote cell interaction. 
2.6.4.1 Alginate 
Ovarian aggregates were transferred from a hanging drop culture to 50l pre-warmed 
1% alginate (Sigma-Aldrich) gel in sterile PBS (Life Technologies) and was dropped 
into pre-warmed 100M CaCl2 (VWR) solution for 10minutes, maintained at 37
oC to 
cross-link the alginate. Alginate beads containing ovarian aggregates were then 
washed twice in pre-warmed Waymouths media with supplements as described 
earlier (section 2.5.4), the beads were then placed singularly in a well of a 24 well 
plate (Corning Incorporated) with 1ml of pre-warmed Waymouths media with 
supplements and incubated at 37oC with humidified and 5% CO2. 50% of media was 
replaced with fresh media on alternate days of culture. 
2.6.4.2 Hanging drop 
Ovarian aggregates were also cultured in a hanging drop continuously for the whole 
culture period. Aggregates were transferred to fresh medium on alternate days of 
culture. Briefly, 30l of pre-warmed Waymouths medium with supplements (Section 
2.12) was placed on the internal surface of a 10cm culture plate lid (Corning 
Incorporated) and aggregates were transferred to the new medium drop using sterile 
curved forceps. The culture plate lid was then inverted and placed over the culture 
dish containing sterile PBS (Life Technologies) and incubated at 37oC with 
humidified air and 5% CO2.  
2.7 Animal Procedures 
All animal experiments were conducted under a UK Home Office licence in line with 
the Animals Scientific Procedure Act (1986).  




SCID (C.B.17/IcrHan Hsd-Prkdc) Mice were obtained from Envigo laboratories and 
CD-1 mice from Charles River laboratories. Mice were allowed a minimum of 6 
days to acclimatise to their new environment prior to the start of any experimental 
work. Mice maintained in a 12 hour light/dark cycle, in a pathogen free environment 
and SCID mice were housed in individually ventilated cages (IVCs). Food and water 
were available ad libitum.  
CD-1 male and female mice were mated and resulting female pups were used for the 
generation of ovarian aggregates (section 2.4.1). 
2.7.1 Xeno-transplant surgery 
SCID (C.B.17/IcrHan Hsd-Prkdc) mice underwent bilateral ovariectomy and 
unilateral kidney xeno-transplantation. SCID mice were anaesthetised with 
isofluorane (Abbott Laboratory Limited) (5% for induction and 2.5% for 
maintenance) in oxygen. Once anaesthetised, a patch of hair just below the hump of 
the back was shaved and the skin then sterilised using surgical scrub (Vetasept). 
Mice were then provided with a subcutaneous injection of saline around the hind leg 
and a subcutaneous injection of vetergesic (Abbott Laboratory Limited), at a dose of 
0.03mg/ml in 100l around the neck. A vertical incision along the skin was made in 
the middle of the back and the ovaries located through the body wall. Skin was held 
in place using bull dog clamps (R&D Slaughter), and a small incision was made in 
the body wall directly above the ovary. Using forceps the ovary and ovarian fat pad 
were removed from the body cavity. Blood circulation to the ovary was clamped by 
forceps then the ovary and ovarian bursa was removed. Using the ovarian fat pad as a 
guide the kidney was pulled out of the body cavity with forceps. Sterile PBS was 
dropped onto the surface of the kidney to keep it hydrated. A tiny incision was made 
in the kidney capsule using a sterile needle. Using a pulled glass pipette, aggregates 
were transferred through the hole in the capsule to the surface of the kidney. 
Aggregates were moved away from the incision to ensure its security when returning 
the kidney to the body cavity. The kidney and associated tissue is then returned to the 
body cavity, and the body wall sutured using number 5 polyglactin sutures. The 
ovary on the opposite side is then also removed following the same procedure. Once 
the bilateral ovariectomy and unilateral xeno-transplantation was completed, the skin 




incision was closed using wound clips (Scientific Laboratory Supplies). Mice were 
then transferred to individual cages which were maintained at 30oC while they 
recovered. Mice were maintained as described in section 2.7 for 21 days until tissue 
collection.  
2.7.2 Tissue collection 
7 or 21 days after xeno-transplantation of the tissue, mice were culled by lethal 
exposure to CO2 and tissues were collected and fixed in 4% NBF for 6 hrs and then 
transferred to 70% ethanol prior to embedding in paraffin blocks for histological 
analysis (section 2.8).  
2.8 Histological Techniques 
2.8.1 Tissue fixation, embedding and sectioning 
All tissues not derived from B6;129-Gt(ROSA)26 mice were fixed in natural 
buffered formalin (NBF), control adult ovarian tissue (bovine and mouse) were fixed 
for 24 hours and aggregated ovaries (in vitro and in vivo) for 6 hours. After fixation, 
tissues were transferred to 70% ethanol (VWR). In vitro cultured ovarian aggregates 
were then embedded within a 2% agarose gel to allow easy visualisation of the 
tissue. 
Tissues containing cells from B6;129-Gt(ROSA)26 mice were fixed with a 0.2% 
Glutaraldehyde fixative (0.2% glutaraldehyde and 0.05% 1M MgCl2 in PBS, all 
reagents sourced from Sigma) for 20 minutes then washed 3 times for 15 minutes 
each, in a detergent rinse (0.2% 1M MgCl2, 0.01% sodium deoxycholate, 0.02% NP-
40 in PBS, all reagents sourced from Sigma). Tissues were then stained with an X-
Gal solution (2% (w/v) X-Gal (5-bromo-4-chloro-3-indolyl--D-
galactopyranaoside), 2% 250mM potassium ferricyanide, 2% 250mM potassium 
ferrocyanide, 0.2% 1M MgCl2, 0.01% sodium deoxycholate, 0.02% NP-40, 0.02% 
Tris in PBS, all reagents sourced from Sigma) for 24-48 hours, dependent on tissue 
size, at 37oC. Following staining tissues were washed in detergent rinse for 15 
minutes, three times, before wax embedding (section 2.8.2). 




2.8.2 Tissue embedding and sectioning 
Tissue was embedded in wax using an automated Leica TP1050 processor. Tissue 
embedded in wax blocks were sectioned at 5M and mounted onto electrostatically 
charged glass slides (Leica) and maintained at 50oC overnight in a slide oven to 
ensure tissue adherence to the slide surface.  
2.8.3 Dewaxing and tissue rehydration 
To assess tissue histology slides were de-waxed by two 5-minute exposures to xylene 
(VWR), followed by rehydration through decreasing concentrations of ethanol 
(100%, 100%, 95%, 80% and 70% for 20 seconds each). 
2.8.4 Haematoxylin and eosin staining 
Tissue histology was analysed by haematoxylin and eosin staining, sections were 
firstly de-waxed and rehydrated as described in section 2.8.3, followed by a brief 
wash in running tap water. Tissue was then stained in haematoxylin (CellPath) for 2 
minutes, washed in running water, dipped in acid alcohol (CellPath), washed in 
running water, placed in Scotts Tap Water for 20 seconds, washed in running water 
and dipped in Eosin (Cell Path) and washed in running water. Excess water was 
removed from slides prior to dehydration and mounting (section 2.8.5).  
Tissues containing B6;129-Gt(ROSA)26 cells were only counterstained with eosin. 
Sections were dewaxed and rehydrated (section 2.8.3), washed in running tap water 
and dipped into eosin briefly and washed in running water again prior to dehydration 
and mounting (section 2.8.5).  
2.8.5 Dehydration and mounting 
Slides were dehydrated through increasing concentrations of ethanol (70%, 80%, 
95%, 100% and 100%) for 20 seconds each and then placed in Xylene twice for 5 
minutes. Slides were maintained in Xylene until mounting with glass cover slips 
(CellPath Limited) using Pertex (Histolab) as an adhesive. Air pockets were pushed 
away from tissue sections with the application of pressure and were left to dry in a 
fume hood and subsequently stored in dry storage at room temperature.  





To assess tissue antigens slides were dewaxed and rehydrated (section 2.8.3) prior to 
antigen retrieval. To detect proteins possibly masked by the fixation process, tissues 
were exposed to pH change and high temperature. Slides were placed in 200ml of 
0.01M citrate buffer (pH 6.0) in an instant pot (Amazon) with 1500ml dH2O and 
heated to 125oC, the instant pot was then set to venting and slides were left to cool 
for 20 minutes then washed and cooled in water 3 times.  
2.8.6.1 Non-specific blocking 
To prevent non-specific blocking of the primary and secondary antibody, slides were 
blocked with peroxidase blocking solution (Dako), for 10minutes at room 
temperature in a humidified chamber. Slides were then washed twice in phosphate-
buffered saline (PBS). 
To inhibit any non-specific binding of the secondary antibody, slides were incubated 
in a blocking solution of normal serum (NS) diluted 1:4 in PBS with 5% bovine 
serum albumin (BSA) (NS/PBS/BSA) for 30 minutes at room temperature in a 
humidity chamber. The serum chosen was dependent on the species in which the 
secondary antibody was raised in. 
2.8.6.2 Primary antibody 
Primary antibodies (listed in table Table 2.4) were diluted in NS/PBS/BSA to an 
optimum concentration, previously determined by titration on control tissues, which 
resulted in the maximum level of detection without non-specific staining. Diluted 
primary antibodies replaced the blocking serum (NS/PBS/BSA) and were incubated 
on tissue sections overnight at 4oC in a humidity chamber.  
Negative controls (primary antibody omitted) were always used and positive controls 
were used where applicable and appropriate. 
Table 2.4: Primary antibodies used in Immunofluorescence 
Antibody Dilution Species Supplier 




Cleaved Caspase 3 1:100 Rabbit Cell Signalling 
Technology 
DAZL 1:800 Mouse AbDSerotec 
-GAL 1:800 Mouse Promega 
Tetramethylrhodamine  1:3000 Rabbit Life 
Technologies 
 
2.8.6.3 Secondary antibody 
Following an overnight incubation, the primary antibody was washed off with PBS 
for 5minutes, twice. The appropriate secondary antibodies (listed in Table 2.5) were 
selected based on the primary antibody of choice, secondary antibodies are raised 
against a species-specific sequence on the primary antibody, and diluted 1:200 in 
blocking serum (NS/PBS/BSA) and applied to slides for 30minutes at room 
temperature in a humidity chamber.  
Table 2.5: Secondary antibodies used in Immunofluorescence 
Antibody Supplier 
Chicken anti Rabbit Santa Cruz 
Chicken anti Mouse Santa Cruz 
 
2.8.6.4 Visualisation of secondary antibody 
Alexafluor conjugated secondary antibodies do not require further detection and 
samples can be counterstained (section 2.8.6.5) after washing off the secondary 
antibody with PBS, in an opaque chamber to prevent bleaching of the fluorescence. 
In contrast, tyramide detection (Perkin Elmer) requires an additional step. After 
washing the peroxidase secondary antibody off with PBS, slides were incubated in 
tyramide, diluted 1:50 in the prescribed buffer in accordance with the manufacturer’s 
instructions, for 10 minutes in a dark humidity chamber. Slides were then washed in 
PBS to remove the tyramide, in an opaque chamber to prevent bleaching of the 
fluorescence before counterstaining and mounting (section 2.8.6.5). 




2.8.6.5 Counterstaining and mounting 
Slides were counterstained with DAPI (Sigma-Aldrich) diluted 1:1000 in PBS for 
10minutes at room temperature in a dark humidity chamber. Slides were then washed 
with PBS twice for 5minutes each then mounted with glass coverslips (CellPath 
Limited) using permafluor (Thermo Fisher Scientific) as an adhesive. Slides were 
then stored in the dark at 4oC until visualisation (section 2.9.4).  
2.8.7 RNA Scope 
RNA Scope analysis was carried out by Aquila HistoPlex, University of Edinburgh. 
Briefly, tissue sections were dewaxed and rehydrated (section 2.8.3) and allowed to 
air dry for 5 minutes at room temperature. Tissues were then treated with hydrogen 
peroxidase block for 10 minutes at room temperature and washed in deionised water. 
Target RNA’s were then retrieved by exposure of slides to changes in pH (retrieval 
buffer, used according to manufacturer’s instructions Advanced Cell Diagnostics) 
and high temperatures (100oC) for 8minutes. Tissue was permeabilised using 
protease digestion (Protease Plus, Advanced Cell Diagnostics) at 40oC for 15 
minutes. Slides were then washed in deionised water and incubated with pre-warmed 
(40oC) probe (Bt-ATP5b or Mm-UBC) for 30 minutes at 40oC, then washed with 
buffer for 2 minutes at room temperature. The signal was then amplified using 
amplification solutions (Advanced Cell Diagnostics); amplification solution 1 was 
applied for 30 minutes at 40oC, amplification solution 2 for 15 minutes at 40oC, 
amplification solution 3 for 30 minutes at 40oC, amplification solution 4 for 15 
minutes at 40oC, amplification solution 5 for 30 minutes at room temperature and 
amplification solution 6 for 15 minutes at room temperature. Slides were washed 
between each amplification with wash buffer twice for 2 minutes at room 
temperature. DAB was then applied to slides at room temperature for 10 minutes, to 
detect the signal. Slides were then washed in deionised water and tissue 
counterstained with Harris haematoxylin for two minutes followed by acid alcohol 
for 5 seconds, and Scott’s tap water for 10 seconds. Slides were then dehydrated and 
mounted (section 2.8.5). All reagents were sourced from Advanced Cell Diagnostics 
by Aquila HistoPlex, University of Edinburgh. 





2.9.1 Light microscopy 
Tissue histology was imaged with a Provis AX70 (Olympus) or a Zeiss Imager Z1 
both fitted with a AxioCam HRc camera (Zeiss) using the Zeiss software which also 
generated the image scale bars. 
2.9.2 Live cell and tissue imaging 
Live cell and tissue imaging was conducted using an Axiovert 200 fitted with a 
AxioCam HRc camera and a Hamamatsu camera for collection of images including 
fluorescent images. Cells and tissue were maintained at 37oC with 5% CO2 
throughout live imaging.   
2.9.3 Whole tissue microscopy 
Whole tissue images were captured using a Leica MZF III with a RS Photometrics 
camera. 
2.9.4 Fluorescent microscopy 
Sections were visualised using a Zeiss LSM 780 confocal microscope and scale bars 
were embedded in the images using Zeiss software. 
2.9.5 Image analysis 
All image analysis, measurements and cell counting was carried out using ImageJ 
software. 
2.10 cDNA Synthesis and RT-PCR 
Bovine Oogonial Stem cells were analysed using conventional polymerase chain 
reaction (PCR) to assess their gene expression. bOSCs were trypsinised and 
centrifuged as described above, and re-suspended in 350L of RLT buffer (Qiagen) 
and homogenized. RNA was extracted using the RNeasy Micro Kit (Qiagen) with 
on-column DNase digestion according to manufacturer’s instructions. Reverse 
transcription was performed using Maxima 1st strand cDNA synthesis kit (Life 
Technologies), with oligo(dT)18 and random hexamer primers utilised to prime 
synthesis of first strand cDNA according to the manufacturer’s instructions.  





0.5μg of RNA was used in each reaction and negative control samples (RT-) lacking 
the transcription enzyme were also synthesised to identify contamination in further 
experiments.  
Target-specific PCR was performed using MyTaq HS Red Mix (Bioline) to identify 
the presence or absence of specific gene transcripts. 1μl of either the RT+ or RT- 
cDNA reaction was added to RT-PCR reaction mix (Table 2.6) for a total reaction 
volume of 25μl. Primer pairs and corresponding annealing temperatures and product 
sizes can be found in Table 2.7 and PCR cycling conditions are detailed in Table 2.8. 
PCR products were run on agarose gels (1-2.5%, Bioline) with a 100bp ladder 
(Bioline Reagents Limited) using electrophoresis.  
Table 2.6  RT-PCR Reaction Mix 
Reagent Amount Used Manufacturer 
MyTaq HS Red Mix 12.5μl Bioline 
Forward Primer 0.5μl Integrated DNA Technologies 
Reverse Primer 0.5μl Integrated DNA Technologies 
H2O 10.5μl Qiagen 
 
  















































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 2.8  PCR Cycling Conditions 
Action Temperature (oC) Time   
Initial denaturation 95 1 minute 
Denaturation 95 15 seconds Repeat 
cycle 35 
times 
Annealing Primer specific see Table 2.7 30 seconds 
Extension 72 30 seconds 
Final extension 72 10 minutes  
 
2.11 Statistical Analysis 
Statistical analysis was conducted using Graphpad Prism 6 software. One-way 
ANOVA analysis with post-hoc Tukeys multiple comparisons testing was used 
where three or more groups were compared when only one variable was present. 
Where only two groups were present a t-test was used to determine differences 
between groups. 
Corrected total cell fluorescence (CTCF) was calculated using the equation below, to 
assess the amount of fluorescence in cells. Analysis was conducted using ImageJ and 
Graphpad Prism 6 software. 
𝐶𝑇𝐶𝐹 = 𝐼𝑛𝑡𝑒𝑔𝑟𝑎𝑡𝑒𝑑 𝐷𝑒𝑛𝑠𝑖𝑡𝑦
− (𝐶𝑒𝑙𝑙 𝑎𝑟𝑒𝑎 𝑥 𝑀𝑒𝑎𝑛 𝑏𝑎𝑐𝑘𝑔𝑟𝑜𝑢𝑛𝑑 𝑓𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒 )  
Mean background fluorescence was calculated based on 5 random background 
readings within each image. 
Data are presented as Mean  SEM throughout. 
2.12 Commonly Used Solutions 
Acid Alcohol  
Acid alcohol was prepared using 70% ethanol with 1% concentrated hydrochloric 
acid. 





Normal serum (Biosera) was diluted 1:4 in PBS with 5% BSA (Sigma-Aldrich) 
Citrate Buffer 
42.02g Citric acid monohydrate was diluted in 900ml distilled water and brought to 
pH 6.0 using NaOH. 
Fetal ovarian somatic cell medium 
Fetal bovine ovarian somatic cells (FBSCs) were cultured in Dulbecco’s Modified 
Eagles Medium (DMEM; without Phenol red) supplemented with 10% Fetal Bovine 
Serum (FBS), 2mM L-glutamine, 1x MEM Non-Essential Amino Acids (NEAA) and 
1x penicillin/streptomycin/amphotericin (all supplements supplied by Life 
Technologies) 
Holding medium 
Bovine tissue was held in Leibovitz medium (Life Technologies) supplemented with 
sodium pyruvate (2 mM), glutamine (2 mM; both obtained from Life Technologies), 
BSA (Fraction V, 3 mg/ml), penicillin G (75 μg/ml) and streptomycin (50 μg/ml; All 
chemicals from Sigma-Aldrich). 
Oogonial Stem Cell (OSC) Medium  
bOSCs were cultured in αMEM (Life Technologies) supplemented with 10% FBS 
(Life Technologies), 1mM sodium pyruvate (Life Technologies), 1mM non-essential 
amino acids (Life Technologies), 103 units/ml leukemia inhibitory factor (LIF; 
Millipore), 10 ng/ml recombinant human epidermal growth factor (rhEGF; Life 
Technologies), 1 ng/ml basic fibroblast growth factor (bFGF; Life Technologies), 40 
ng/ml recombinant human glial cell-derived neurotrophic factor (rhGDNF; R & D 
Systems), 1x-concentrated N-2 supplement (R & D Systems) and 1x-concentrated 
penicillin-streptomycin-glutamine (Life Technologies), filtered through a 0.22µM 
filter (Millipore).  
Phosphate-Buffered Saline (PBS) 




PBS used for immunofluorescence was prepared by adding 1 PBS tablet (Sigma-
Aldrich) with 0.01M phosphate buffer, 0.0027M potassium chloride and 0.137M 
NaCl with a pH of 7.4 to 200ml distilled water.  
Scotts Tap Water  
2g of sodium bicarbonate and 20g magnesium sulphate 20g were dissolved in 1L of 
deionised water to make Scotts Tap water. 
Thaw medium 1 
To thaw cryopreserved ovarian tissue, tissue was placed in holding medium (see 
above) supplemented with 1M sucrose (Sigma-Aldrich) pre-warmed to 37oC. 
Thaw medium 2 
Thawing of cryopreserved ovarian tissue was continued by placing tissue in holding 
medium (see above) supplemented with 0.5M sucrose (Sigma-Aldrich) pre-warmed 
to 37oC. 
Vitrification medium 1 
Vitrification of ovarian tissue was initiated by incubation in Leibovitz medium (Life 
Technologies) supplemented with 7.5% Dimethyl sulfoxide (Sigma-Aldrich) and 
7.5% Ethylene Glycol (Sigma-Aldrich). 
Vitrification medium 2 
Vitrification of ovarian tissue was continued by incubation in Leibovitz medium 
(Life Technologies) supplemented with 20% Dimethyl sulfoxide (Sigma-Aldrich), 
20% Ethylene Glycol (Sigma-Aldrich) and 0.5M sucrose (Sigma-Aldrich). 
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3 Isolation and Characterisation of bovine Oogonial Stem 
Cells (bOSCs) 
3.1 Introduction 
A candidate cell within mammalian ovaries capable of self-renewal and 
differentiation into new oocytes has, until recently, remained unidentified. Alongside 
numerical data illustrating the disparity between follicle atresia and the murine 
reproductive lifespan, Johnson et al. (2004) were the first to identify a mitotic germ 
cell in adult mouse ovaries, illustrated by co-localisation of Dead-box helicase 4 
(Ddx4) and BrdU. Together these results suggest that mammalian ovaries contain 
putative oogonial stem cells capable of supporting neo-oogenesis.  
To investigate the characteristics of this cell, its isolation from adult mammalian 
ovaries has been essential. Since 2004, several groups have used cell sorting 
techniques (magnetic and fluorescent) to isolate this putative population of oogonial 
stem cells using germ cell markers such as Ddx4/DDX4 and Ifitm3 (Interferon-
induced transmembrane protein 3) (Hernandez et al., 2015; White et al., 2012; Zhou 
et al., 2014; Zou et al., 2009). Ifitm3 is a cell surface protein, identified as one of the 
earliest markers of germ cell specification in embryonic stem cells (ESCs) (Saitou et 
al., 2002; Tanaka and Matsui, 2002). Whereas Ddx4 is an RNA helicase with 
restricted expression in the germline (Castrillon et al., 2000; Toyooka et al., 2000) 
marking all germ cells from post-migratory primordial germ cells (PGCs). The use of 
Ddx4 to identify and isolate OSCs is however controversial as it is understood to 
have a traditional cytoplasmic location. The nature of magnetic and fluorescently 
activated cell sorting utilises cell surface proteins to separate different populations of 
cells. Critics (Hernandez et al., 2015; Pacchiarotti et al., 2010; Zhang et al., 2015) 
have suggested that due to the traditional cytoplasmic localisation of Ddx4, it is an 
unsuitable epitope to isolate OSCs from mammalian ovaries. Although 
computational analysis of the structure of Ddx4 has yielded conflicting evidence to a 
possible transmembrane domain (White et al., 2012; Zarate-Garcia et al., 2016), cell 
surface expression of DDX4 has been identified in a population of cells within the 
adult pig testes (Kakiuchi et al., 2014). Furthermore, Ddx4/DDX4 has been utilised 
in several studies to isolate OSCs from adult ovaries of different species (Hernandez 
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et al., 2015; White et al., 2012; Zou et al., 2009), suggesting that Ddx4/DDX4 may 
have a cell surface location in putative oogonial stem cells. Our lab has previously 
utilised and amended FACS isolation techniques based on protocols described by 
White et al. (2012) to isolate OSCs from adult bovine ovaries.   
Putative OSCs isolated from rodents, rhesus macaque monkeys and humans are 
reported to express genes and proteins associated with both germ (e.g. Dazl/DAZL, 
Ifitm3/IFITM3 and Prdm1/PRDM1) and stem (e.g. Oct4/OCT4, Nanog/NANOG and 
Lin28/LIN28) cells (Pacchiarotti et al., 2010; White et al., 2012; Zhou et al., 2014; 
Zou et al., 2009). Crucially these cells do not express oocyte specific markers, such 
as Zp3/ZP3 and Gdf9/GDF9 (White et al., 2012), therefore are a distinct population 
of cells within the mammalian ovary. Further characterisation of these cells has 
shown high telomerase activity, a characteristic associated with stem cells (Zou et al., 
2009). The initial aim of this thesis was to isolate oogonial stem cells (OSCs) from 
adult bovine ovary and characterise this putative cell population. 
To trace oogonial stem cells in subsequent investigations, researchers have used 
labelling methods such as fluorescent protein expression directed by virus 
incorporation into the genome (White et al., 2012; Zhou et al., 2014; Zou et al., 
2009) and stem cell promoter driven fluorescent protein expression (Pacchiarotti et 
al., 2010). We aimed to investigate the potential of several different methods of cell 
labelling to identify which best suited the study of putative bovine oogonial stems 
cells.   
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3.2 Materials and Methods 
Tissue collection 
Adult bovine ovaries were collected and transported to the lab as described in section 
2.1.1. Tissue was then vitrified (section 2.1.2) for long term storage until required.  
Fluorescently activated cell sorting (FACS) of bovine oogonial 
stem cells (bOSCs) 
Vitrified adult bovine ovarian cortical tissue was thawed (section 2.1.3), then 
enzymatically and mechanically digested (section 2.2.1) to a single cell suspension. 
This suspension was then treated with FACS blocking solution (2% goat serum and 
2% bovine serum albumin in HBSS without calcium and magnesium) to prevent 
non-specific binding of the secondary antibody (section 2.2.2). Samples were then 
exposed to the DDX4 primary antibody (section 2.2.3) followed by the secondary 
antibody (goat anti-rabbit conjugated with APC; section 2.2.4). Two negative control 
samples (no antibodies and secondary antibody only) were also utilised. Cells were 
sorted using a BD FACS Aria machine (BD Bioscience), details of this protocol are 
outlined in section 2.2.5, and the gating strategy described in Figure 2.3. Cells were 
placed in culture for propagation and establishment of a colony (section 2.6.1.1) 
Fluorescently labelled bOSCs were also analysed for the presence of the fluorescent 
marker. Cells were trypsinised and re-suspended in 500μL FACS buffer (50L of 
FBS in 5ml HBSS) with 0.5μL DAPI to distinguish between live and dead cells. The 
single cell suspensions were sorted by a BD FACS Aria machine to distinguish 
between fluorescently labelled and unlabelled bOSCs. Cells were returned to culture 
after cell sorting (section 2.6.1.1).  
Derivation of fetal bovine somatic cells 
Fetal bovine somatic cells were derived from fetal bovine ovaries (gestational age 
163.5 days) immediately following delivery from the local abattoir (section 2.1.1) as 
described in section 2.3 and cultured according to section 2.6.1.2. Briefly, ovaries 
were enzymatically and mechanically digested with Collagenase type IV (10mg/ml 
in HBSS) and 19 gauge needles. Tissue and collagenase mix were placed in a 
thermomixer at 37oC, shaking at 112 RCF for 10 minutes. 50l of DNAse I (7mg/ml 
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in HBSS) was added to the tissue mix and returned to the thermomixer for a further 
5minutes shaking at 37oC. The cell suspension was then centrifuged at 600g for 
5minutes and the cell pellet was washed twice with 1ml of HBSS. Cells were then 
suspended in fetal ovarian somatic cell media (section 2.12) and filtered through a 
70m filter (Becton Dickenson), centrifuged at 600g and re-suspended in 1ml fetal 
ovarian somatic cell media and split between an appropriate number of wells in a 12 
well plate and the volume of each well made up to 1ml with fetal somatic cell media. 
Cells were washed twice with pre-warmed PBS (Life Technologies) and new fetal 
somatic cell media was added (section 2.12) after overnight culture and maintained 
as described in section 2.6.1.2.  
RNA extraction, cDNA synthesis and RT-PCR 
To determine the expression of mRNA transcripts characteristic of germ and 
pluripotent cells, RT-PCR was performed. RNA extraction, cDNA synthesis and RT-
PCR protocols are outlined in section 2.10 and primer pairs detailed in Table 3.1. 
mRNA transcripts investigated are detailed in the chapter (section 3.3.2). 
Table 3.1: PCR primer pairs used to characterise putative bOSCs 
Gene Target Forward Primer Reverse Primer 
-ACTIN CTCTTCCAGCCTTCCTTCCT   GGGCAGTGATCTCTTTCTGC 
OCT4 CGAAGCTGGACAAGGAGAAG AGAGAACCCCCAGGGTGAG 
LIN28 GGCCGTGGAGTTCACCTTTA GTGGCAGTTTGCACTCCTTG 
IFITM3 CACATCCCAGCCCTTGTTCA TGTTGAACAGGGACCACACG 
PRDM1 CAAATGCCAGACGTGCAACA GTGCACAAACTGCGTGAACT 
DDX4 TATATGGGGGAACCCAGTTG CATATCCAGCATGCGATC 
DAZL GAAGGCAAAATCATGCCAAACAC CTTCTGCACATCCACGTCATTA 
C-KIT AACACAATGGGACGGTGGAG AGGGTGTGAGCATGGATTTGT 
 
Immunocytochemistry 
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Expression of proteins (details in Table 3.2) within bOSCs were analysed by 
immunocytochemistry (section 2.6.3) after cell fixation using 50:50, 
Ethanol:Methanol (section 2.6.3.2) and permeabilisation.  
Table 3.2: Antibodies used in immunocytochemistry of cells 
Antibody Dilution Species 
Detection 
method Supplier 
Tetramethylrhodamine  1:3000 Rabbit Tyramide Life Technologies 
DDX4 1:300 Rabbit Streptavidin Abcam 
DAZL 1:800 Mouse Streptavidin AbDSerotec 
C-KIT 1:100 Rabbit Streptavidin DAKO 
LIN28 1:500 Rabbit Streptavidin Abcam 
OCT4 1:250 Mouse Streptavidin Santa Cruz 
IFITM3 1:500 Rabbit Streptavidin Abcam 
 
Fetal bovine somatic cells (FBSCs) labelled with rhodamine dextrans were fixed 
with NBF (section 2.6.3.2) and immunostained for the presence of rhodamine using a 
tetramethylrhodamine antibody (details in Table 3.2) to assess the viability of the 
dextrans to trace cells post fixation (section 2.6.3). 
Slides were visualised using a Zeiss LSM 780 confocal microscope and scale bars 
were embedded in the images using Zeiss software. 
Labelling of cells 
bOSCs were labelled with either fluorescent lentivirus (section 2.6.2.1), cell tracker 
dye (section 2.6.2.2) or fluorescent dextrans (section 2.6.2.3) for further assessment. 
The viability of these methods for long term assessment of bOSCs were analysed by 
visual assessment of the cells and their fluorescent label using live cell imaging 
(section 2.9.2), cell growth was monitored following labelling and compared to 
unlabelled cells. FBSCs were also labelled with Rhodamines dextrans in culture as 
described in section 2.6.2.3. 
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To assess the amount of fluorescence in cells, corrected total cell fluorescence 
(CTCF) was calculated using the equation below. Analysis was conducted using 
ImageJ and Graphpad Prism 6 software. 
𝐶𝑇𝐶𝐹 = 𝐼𝑛𝑡𝑒𝑔𝑟𝑎𝑡𝑒𝑑 𝐷𝑒𝑛𝑠𝑖𝑡𝑦
− (𝐶𝑒𝑙𝑙 𝑎𝑟𝑒𝑎 𝑥 𝑀𝑒𝑎𝑛 𝑏𝑎𝑐𝑘𝑔𝑟𝑜𝑢𝑛𝑑 𝑓𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒 )  
Mean background fluorescence was calculated based on 5 random background 
readings within each image. 








3.3.1 Isolation and in vitro culture of putative bovine oogonial 
stem cells from adult bovine ovary using FACS against 
DDX4 
Putative bovine oogonial stem cells were consistently isolated from pooled adult 
bovine ovaries (15 ovarian cortical pieces per experiment) using FACS against the 
epitope DDX4. A representative sort is shown in Figure 3.1. The parameters for the 
isolation of bOSCs were established using two control populations of disaggregated 
bovine ovarian cells; unstained control sample and secondary antibody only control 
(primary antibody was omitted). Single cells were assessed for their uptake of DAPI 
to determine viability and APC for DDX4 expression. Control samples (unstained 
and secondary antibody only) contained only viable and non-viable APC negative 
cells, thus omission of the primary antibody resulted in no cells identified as DDX4 
positive (Figure 2.1. G, H, J and K).  
The addition of the DDX4 antibody to samples identified DDX4 positive cells within 
ovarian bovine cell populations. DDX4 positive cells were further sub-divided into 
two populations based on size. The first population (Q4, outlined in red in Figure 
3.1.I) of cells were smaller in size but greater in number than the second (Q4.1, 
outlined in red in Figure 3.1.L) population which were larger in size and fewer in 
number. DDX4 positive cells constituted a small proportion of the total ovarian 
cortical cell population assessed, 3.6%  1.64% and 2.4%  1.41% for Q4 and Q4.1 
respectively. 
Both DDX4 positive cell populations established in culture and no differences were 
observed between the two populations. Both populations were used in subsequent 
experiments.  
 




Figure 3.1: Fluorescently activated cell sorting of putative bovine oogonial stem cells. A 
representative plot of the isolation of bOSCs from adult bovine ovarian cortex. Left hand panels 
(unstained, A, D, G and J) represent an unstained sample, where both the primary and secondary 
antibodies are omitted. Centre panels (secondary antibody only, B, E, H and K) represent a negative 
control where the primary antibody is omitted and the right hand panels (C, F, I and L) are 
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representative of a complete sort. All events (A, B and C) are shown as dots and cells selected based 
on size and granularity (P1 and P4), and are then sorted as single cells (P2) based on cell size on 
forward and side scatter (D, E and F). Cells are then determined as live/dead based on DAPI uptake 
(y-axis) and DDX4 negative or positive based on APC detection (x-axis) shown in panels G, H and I. 
A larger cell population (P4) was also identified during the initial sort and were also sorted (J, K and 
L). The red boxes identify putative bOSC populations determined by FACS isolation against DDX4. 
Following isolation, DDX4 positive cells were cultured long term and were visually 
assessed to detect any visual phenotypical changes. Figure 3.2 shows putative bOSCs 
across a range of passages (5-20); no phenotypical changes were observed in these 
cells during culture. Putative bOSCs were maintained in culture long term (> 
6months) and underwent several passages (>20). 
 
Figure 3.2: Bovine Oogonial Stem Cells visualised live in culture. bOSCs were cultured long term 
in OSC media following isolation and were maintained at 37oC in humidified air with 5% CO2. 
bOSCs are shown here at passage 5 (A & D), 10 (B & E) and 20 (C & F) at two different 
magnifications (Top panels imaged at x10 magnification and bottom panels imaged at x20 
magnification.). Scale bars represent 200m. 
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3.3.2 Putative bOSCs express pluripotency and germ cell 
markers 
RT-PCR was performed on putative bOSCs in culture across different passages to 
determine the presence and maintenance of mRNA transcripts associated with 
pluripotency and germ cell lineage, throughout culture. Attempts were made to 
analyse the expression of genes in putative bOSCs immediately after isolation, 
however, low cell numbers and total RNA failed to detect housekeeping genes within 
these samples therefore gene expression analysis was not possible. 
Transcripts encoding pluripotency and germ cell associated genes were present in 
fetal bovine ovary, which served as a positive control (Figure 3.3.A). Pluripotency 
genes, LIN28 and OCT4 were consistently observed to be expressed in putative 
bOSCs throughout culture. Furthermore, genes restricted to the germ line were also 
expressed. IFITM3 and PRDM1, markers of early primordial germ cells (PGCs) 
during mammalian embryogenesis were consistently detected in cultured putative 
bOSCs (Figure 3.3.A). Expression of C-KIT, a PGC marker associated with 
migration was also detected in bOSCs (Figure 3.3.A). However, the post-migratory 
PGC markers DAZL and DDX4, showed little or no expression in putative bOSCs 
respectively (Figure 3.3.A). DAZL expression is established in PGCs upon 
colonization of the developing gonads and is essential for germ cell competence. Its 
expression precedes DDX4 in developing PGCs. Therefore, these results suggest that 
putative bOSCs maintain gene expression profiles similar to late migratory and/or 
early post-migratory PGCs. Housekeeping gene, -ACTIN, was expressed in all 
samples assessed. 
Putative bOSCs were isolated from adult bovine ovaries based on the cell surface 
expression of DDX4. However, it was not possible to examine DDX4 expression in 
isolated cells due to low numbers. The absence of DDX4 expression from cultured 
putative bOSCs, may suggest loss of expression from during in vitro culture or may 
indicate the absence of DDX4 expression in putative bOSCs entirely. Negative 
controls (samples with reverse transcriptase omitted samples and water controls), 
showed no detectable transcripts.  
  




Figure 3.3: Putative bOSCs express markers associated with pluripotency and germ cell lineage. 
Cultured bovine OSCs (passage 4 and 8 shown) were characterised by RT-PCR (A). OCT4, IFITM3, 
PRDM1, LIN28, C-KIT, DAZL and DDX4 transcripts were analysed in addition to house-keeping gene 
-ACTIN. Fetal bovine ovary (FBO) RNA was a positive control, reverse transcriptase omitted (-) and 
water controls were negative controls. Pluripotency markers OCT4 (B) and LIN28 (E) were expressed 
in bOSCs, as were germ cell markers IFITM3 (C) and DAZL (F). DDX4 expression was not observed 
in bOSCs (D). Primary antibody omitted sample was used as a negative control (E). Cells were 
passage 6 and imaged at x10 magnification, scale bars represent 200m. 
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Immunocytochemical analysis was used to investigate protein expression in cultured 
bOSCs. OCT4 a transcription factor associated with cell pluripotency and LIN28, an 
RNA binding protein known to regulate the self-renewal of stem cells were 
expressed in cultured putative bovine oogonial stem cells (Figure 3.3.B and Figure 
3.3.E, respectively). OCT4 expression was consistently observed in close proximity 
to or co-localised to cell nuclei (Figure 3.3.B), suggesting that OCT4 may be actively 
regulating gene transcription within these bovine cells. The early germ cell marker 
IFITM3 (Figure 3.3.C) associated with germ cell specification and the germ cell 
marker DAZL (Figure 3.3.F) which is first expressed in germ cells after migration to 
the genital ridges in fetal life, were both expressed by cultured bovine cells which 
were DDX4 positive by FACS isolation. However, DDX4 was not identified in 
cultured bOSCs (Figure 3.3.D). Absence of DDX4 from putative bOSCs in culture 
suggests that bOSCs do not express DDX4 at isolation or DDX4 expression is lost in 
bOSCs in culture. Further characterisation of putative bOSCs at isolation is essential 
to determine if the use of DDX4 as an epitope for OSC isolation is appropriate. The 
protein expression profile of putative bOSCs appears to be similar to early post-
migratory PGCs which maintain pluripotency but acquire germ cell competence 
through the expression of DAZL. However, protein expression of these pluripotency 
and germ cell associated markers was variable in cells and not all cells expressed 
them. This suggests that the population of bovine ovarian cells isolated by FACS and 
cultured is heterogeneous. Primary antibody omitted negative control samples 
showed no staining (Figure 3.3.E).  
Taken together the mRNA and protein expression data of these bovine ovarian cells 
isolated based upon the assumed cell surface expression of DDX4, suggests that the 
cells share both pluripotent and germ lineage characteristics. Furthermore, the cells 
appear to share gene and protein expression characteristics with late migratory and/or 
early post-migratory primordial germ cells. These cells also share many 
characteristics with putative OSCs of other species. Therefore, these cells have been 
characterised as adult bovine oogonial stem cells. 
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3.3.3 Labelling of bOSCs 
Once established in culture, bOSCs were fluorescently labelled using different 
methods to allow tracking of this cell population in subsequent experiments. 
Successful labelling of bOSCs would allow testing of the functional capabilities of 
these cells and importantly not impede their potential.  
An mCherry tagged lentivirus was used to label a population of bOSCs. The 
fluorescent mCherry protein would be expressed under the stem cell promoter SFFV 
in bOSCs. Cells were transfected with Lv-cppt-SFFV-IRES-mCherry-opre at 
different ratios; 1, 5 or 10 lentiviral particles to bOSCs, to identify the optimal 
transfection rate. Uptake of the lentivirus was confirmed by visualisation of the 
fluorescent mCherry protein in live cells within 72 hours of transfection as shown in 
Figure 3.4.A-C. To assess and quantify transfection rates, cells were analysed by 
FACS for the presence of mCherry protein, 7 days after transfection. 18.1%, 88.8% 
and 82.8% of bOSCs were found to express mCherry protein following transfection 
with 1, 5 or 10 particles of lentivirus to bOSCs, respectively (Figure 3.4.D-F). These 
data indicate that the 5:1 ratio yielded the most efficient transfection ratio. 





Figure 3.4: mCherry Lentiviral Labelling of bOSCs. bOSCs were transfected Lv-cppt-SFFV-
IRES-mCherry-opre for future tracking of the cells. Initially three different ratios were used 1:1, 5:1 
and 10:1, lentivirus to bOSCs respectively. The expression of mCherry protein could be detected in 
live cells (A, B, C) at all three ratios, although expression appeared stronger at 5:1 and 10:1. Cells 
were imaged at x10 magnification and insets imaged at x20 magnification, scale bars represent 
200m. Cells were then analysed by FACS for the expression of mCherry to determine the level of 
lentiviral uptake and expression (D, E, F). mCherry positive cells are represented in orange, cells 
negative for mCherry expression are shown in green. The percentage of total cells expressing 
mCherry is shown in red. The growth of cells transfected with 5:1 lentivirus: bOSCs was monitored to 
assess the effect of lentiviral transfection (G). Cells were passaged at a ratio of 1:2 once confluent. 
Growth of cells transfected with lentivirus appeared to decrease compared to non-transfected controls. 
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Cells were further propagated in culture, but a decline in growth rate was observed 
compared to untreated control cells (Figure 3.4.G). Corrected total cell fluorescence 
was calculated to assess the stability of the fluorescent label in cells successfully 
transfected. Figure 3.5 shows that bOSCs successfully labelled with Lv-cppt-SFFV-
IRES-mChery-opre at a ratio of 5:1 maintained stable mCherry fluorescence 4 weeks 
post labelling. However, 12 weeks post transfection, bOSCs treated with 5:1 
mCherry lentivirus and maintained in culture were reanalysed by FACS for mCherry 
expression, at which point only 1.07% of cells were mCherry positive. Although the 
mCherry fluorophore signal remained strong, these results taken together indicate 
that mCherry lentivirus was detrimental to the growth and health of bOSCs and over 
long term culture the mCherry positive bOSC population was not stable. 
 
Figure 3.5: Corrected total cell fluorescence (CTCF) of fluorophores used to label bovine 
Oogonial Stem Cells. Average CTCF of 5 cells for each label and time point are plotted +/- SEM. 
Fluorescence was measured in each cell using ImageJ and corrected for cell area and background 
fluorescence.  
To avoid cellular toxicity of bOSCs, alternative methods of fluorescent labelling 
were sought out. CMFDA (5-chloromethylfluorescein diacetate) cell tracker dye, a 
fluorescent dye able to freely pass through cell membranes into cells, where it 
transforms into a cell-impermanent fluorescent product, was used to label bOSCs. 
The dye was applied to bOSCs in culture for 30mins or 1hour when 50% confluent. 
Following treatment with CMFDA, cells were visualised live to assess CMFDA 
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presence over 14 days. Figure 3.6 illustrates the presence of CMFDA in bOSCs after 
both exposure lengths alongside untreated control bOSCs. CMFDA could be 
visualised in live bOSCs for 72hours post labelling, however CMFDA label was 
restricted to unhealthy or dead cells by 7 and 14 days post labelling. Quantification 
of CMFDA fluorescence by corrected total cell fluorescence (CTCF) shown in 
Figure 3.5, revealed a decrease in fluorescence from 48hours post labelling for both 
exposure groups. The decline in cell health as a result of CMFDA labelling (Figure 
3.6) and the poor long term stability of the label (Figure 3.5) suggest that CMFDA 
would not be an appropriate method for long term labelling of bOSCs. 




Figure 3.6: Labelling of bOSCs with CMFDA.  bOSCs were labelled with green cell tracker, 5-
chloromethylfluorescein diacetate (CMFDA), as a possible method to track bOSCs in subsequent 
experiments. Cells were treated with 3.33ug/ml of CMFDA in DMEM for 30 minutes (middle panels) 
or 1 hour (bottom panels) before washing and visualisation. Control samples were untreated (top 
panels). Cells were imaged at x20 magnification, scale bars represent 200m. 
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Dextrans are complex polysaccharides which are actively transported into cells by 
endocytosis. Fluorescently (rhodamine) labelled dextrans (10,000 MW) were used as 
an alternative labelling method to track bOSCs. bOSCs were labelled with 100g/ml 
of rhodamine dextrans overnight to allow sufficient uptake of the molecules into the 
cells, which had previously been determined in the laboratory as an optimum 
concentration and exposure time through titration. bOSCs were then visualised live 
to assess the potential of the fluorescent dextrans as a labelling tool. Control 
untreated cells showed no rhodamine fluorescence as seen in Figure 3.7.E-H, 
whereas bOSCs treated with rhodamine dextrans illustrated rhodamine detection over 
a period of 21 days (Figure 3.7.A-D). Figure 3.7 shows that rhodamine dextrans were 
maintained within live healthy bOSCs, which underwent several passages and 
showed no difference in growth rate compared to control unlabelled bOSCs. 
Corrected total cell fluorescence did illustrate a decrease in average cell fluorescence 
after 14 days of culture (Figure 3.5), thus long term (>14 days) labelling of bOSCs 
using rhodamine dextrans may not be a viable option.  
  





Figure 3.7: Labelling of bOSCs with Rhodamine Dextrans.  To assess the viability of rhodamine 
dextrans as a method to label and track bOSCs, cells treated overnight with 100g/ml rhodamine 
dextrans in OSC media were visualised live over a time course of 21 days. Control untreated cells 
were also visualised and showed no rhodamine fluorescence (E, F, G and H). Following labelling, 
rhodamine could be detected within healthy live bOSCs continuously for 21 days (A, B, C and D) and 
through several passages. Cells were imaged at x10 magnification, scale bars represent 200m. 
A suitable fluorescent label would also need to be detectable following fixation. To 
investigate the detection of dextrans following fixation, fetal bovine somatic cells 
(FBSCs) were labelled overnight with 100g/ml Rhodamine Dextrans in FSC media 
and cultured for a further 7 days. Cells were then fixed with NBF and subjected to 
immunocytochemistry to detect rhodamine presence. Figure 3.8 shows FBSCs with 
(Figure 3.8.E, F, G and H) and without (Figure 3.8.A, B, C and D) rhodamine 
dextrans. Rhodamine dextrans were easily visible in live (Figure 3.8.E) and NBF 
fixed (Figure 3.8.F) FBSCs. Anti-rhodamine antibody co-localised to rhodamine 
fluorescence following immunocytochemistry (Figure 3.8.G; blue staining) and no 
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staining was observed in the primary antibody omitted control (Figure 3.8.H). 
Unlabelled FBSCs also showed no staining for rhodamine (Figure 3.8.C). Thus, 
rhodamine dextrans maintain their fluorescence following fixation and allow tracking 
of bOSCs in future experiments without further intervention. 
 
 
Figure 3.8: Maintenance of rhodamine dextran fluorescence following fixation. Fetal bovine 
somatic cells -/+ rhodamine dextrans (100ug/ml) visualised prior to fixation (A and E, respectively). 
Cells were then fixed with NBF for 10 minutes and re-visualised (B and F). Rhodamine fluorescence 
was maintained in fetal bovine somatic cells containing rhodamine dextrans following fixation with 
NBF. Immunocytochemistry was carried out against rhodamine, no signal was observed in FBSC’s 
without rhodamine dextrans (C), whereas anti-rhodamine signal (marked by blue fluorescence) was 
found to co-localise to the cytoplasm of FBSC’s containing rhodamine dextrans (G). Negative 
controls where primary antibody was omitted show no anti-rhodamine signal (D and H). Sytox green 
was used as counterstain for immunocytochemistry. Cells were imaged at x10 magnification pre- (A 
and E) and post- (B and F) fixation, and scale bars represent 200m in images A, B, E and F. Cells 
were imaged at x63 following immunocytochemistry and scale bars represent 10m in images C, D, G 
and H. 
 




The ovary is a highly dynamic organ capable of dramatic cyclical remodelling to 
generate a pre-ovulatory follicle containing a functional oocyte, followed by the 
formation, maintenance and degradation of a corpus luteum in the absence of a 
pregnancy. Yet the mammalian ovary was believed to be incapable of generating 
new oocytes in adult life, with the exception of a few prosimian primates (Loris 
tardigradus lydekkerianus and Nycecticebus coucang) (David et al., 1974; Duke, 
1967) and bat species (Artibeus jamaicensis, Glossophaga soricina and Sturnira 
lilium) (Antonio-Rubio et al., 2013). The apparent identification of a population of 
mitotically active germ cells in the adult murine ovary by Johnson and colleagues 
(2004) has opened a new avenue of research in ovarian biology.  
Isolation of mitotically active cells which co-express markers associated with 
pluripotency and germ lineage, termed oogonial stem cells, from adult ovaries has 
been reported in several different mammalian species, including humans (Hernandez 
et al., 2015; Pacchiarotti et al., 2010; White et al., 2012; Woods and Tilly, 2015; 
Zhou et al., 2014; Zou et al., 2009). The data presented here show the isolation of 
cells from adult bovine ovaries with characteristics similar to those reported in other 
species.  
Putative bovine OSCs were FACS isolated following tissue dissociation, using the 
germ cell marker DDX4. DDX4 is an RNA helicase, with restricted expression in the 
germline in mammalian species (Castrillon et al., 2000; Toyooka et al., 2000). The 
use of Ddx4/DDX4 as an external cellular epitope for FACS isolation of OSCs 
(Imudia et al., 2013; Park et al., 2013; White et al., 2012; Zou et al., 2009) has 
provoked controversy (Albertini and Gleicher, 2015). Computational analysis has 
provided conflicting reports as to whether Ddx4/DDX4 contains a transmembrane 
domain (White et al., 2012; Zarate-Garcia et al., 2016). The successful isolation of 
putative OSCs based on Ddx4/DDX4 cell surface expression suggest that 
Ddx4/DDX4 can be expressed on the cell surface (Imudia et al., 2013; Park et al., 
2013; White et al., 2012; Zou et al., 2009). Analysis using N-  and C- terminus 
antibodies suggested that these protein terminuses are located intracellularly and 
extracellularly, respectively (White et al., 2012). However, it has been speculated 
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that the DDX4 antibody utilised for FACS isolation may cross-react to an alternative 
epitope expressed in putative OSCs (Hernandez et al 2015). Cells within the adult 
porcine testis were found to express DDX4 at the cell surface (Kakiuchi et al., 2014), 
suggesting that DDX4 can be located at the cell surface. Expression of DDX4 
through transfection of human OSCs with a tagged DDX4 lentivirus showed no cell 
surface DDX4 expression (Hernandez et al., 2015). In contrast DDX4 plasmids 
induced DDX4 cell surface expression within porcine testicular cells (Kakiuchi et al., 
2014). These results suggest that the cellular location of Ddx4/DDX4 may be cell 
specific. Furthermore, it has been hypothesised that Ddx4 may internalise in putative 
murine OSCs as the progress through germ cell development (Imudia et al., 2013; 
White et al., 2012). This thesis has not focused on the structure or cellular location of 
Ddx4/DDX4. However, the use of DDX4 to identify and isolate putative bOSCs 
shown here, and the absence of a DDX4 positive cell population with omission of the 
primary antibody, suggests that these cells are being isolated based on DDX4 
expression.  
The putative OSC population in the adult bovine ovary was determined to make up a 
small proportion, no more than 5% of the total live intact cells from the 
disaggregated ovarian cell population. Isolated cells were successfully established 
and maintained in culture, as described in other species (Hernandez et al., 2015; Park 
et al., 2013; White et al., 2012; Zhou et al., 2014; Zou et al., 2009). However, to fully 
determine whether putative bOSCs were isolated based on the expression of DDX4 
or cross-reaction of the antibody to another epitope analysis of freshly isolated cells 
would be essential. However due to low cell numbers it was not possible to 
determine the expression of DDX4 within the cell population at the time of isolation. 
Thus, we cannot determine whether putative bOSCs were isolated based on DDX4 
cell surface expression. Expression of Ddx4/DDX4 in freshly isolated putative 
murine and human OSCs has been detected in some samples (White et al., 2012) and 
not in others (Hernandez et al., 2015) despite use of the same protocol. Even in the 
absence of Ddx4/DDX4 expression at isolation murine, rhesus macaque monkeys and 
humans FACS sorted based on Ddx4/DDX4 expression were characterised as 
putative OSCs (Hernandez et al., 2015). This data provided the basis of the 
hypothesis that the DDX4 antibody cross-reacts with an alternative epitope on the 
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cell surface of putative OSCs. In contrast, Ddx4/DDX4 protein expression has been 
observed in freshly isolated and cultured mouse and baboon OSCs (Woods and Tilly, 
2015). Although the issues surrounding the use of DDX4 as the epitope of choice to 
isolate putative OSCs are not addressed in this thesis, characterisation of DDX4 
positive cells isolated from adult bovine ovaries has revealed a gene signature similar 
to those reported in other species. 
Two populations of cells, differentiated by size, were identified as DDX4 positive 
and isolated as putative bovine OSCs. Both populations could establish in culture and 
previous characterisation in the laboratory showed that both populations shared 
characteristics. Putative bOSCs were found to express pluripotency markers LIN28 
and OCT4, early germ cell markers IFITM3 and PRDM1 and marker of germ cell 
competence DAZL, consistent with other reports of OSCs in the literature 
(Hernandez et al., 2015; Park et al., 2013; White et al., 2012; Zhou et al., 2014; Zou 
et al., 2009). However, the DDX4 gene and protein was not found to be expressed in 
cultured putative bOSCs. These results indicate that either putative bOSCs lose 
expression of DDX in culture, or lack DDX4 expression entirely and are selected 
based on a cross-reaction of the antibody during isolation. The gene expression 
pattern observed in bOSCs is similar to PGCs described at late migratory and/or 
early post-migratory stages and is indicative of an undifferentiated germ cell in adult 
bovine ovaries.  
The variable protein expression identified in putative bOSCs suggests that the 
cultured population is heterogeneous. Analysis of freshly isolated cells would reveal 
whether this is a consequence of in vitro culture or a characteristic of the isolated 
population.  
Putative bOSCs could be passaged in excess of 20 times and cultured continuously 
for 6 months, a characteristic consistently reported in murine OSCs (White et al., 
2012; Zou et al., 2009). These data are indicative of a distinct population of germ 
cells with pluripotent hallmarks within the adult bovine ovary and are consistent with 
previous findings in our laboratory and reports of OSCs from other mammalian 
species (Hernandez et al., 2015; Pacchiarotti et al., 2010; White et al., 2012; Woods 
and Tilly, 2015; Zhou et al., 2014; Zou et al., 2009).  
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Successful labelling of bOSCs is essential to be able to investigate the function of the 
cells in subsequent experiments. Several labelling methods were investigated to 
deduce the most appropriate. Viral labelling has previously been used to label OSCs 
in the literature and has allowed the function of rodent and human OSCs to be tested 
when combined with ovarian tissue (Grieve et al., 2015; White et al., 2012; Zhou et 
al., 2014; Zou et al., 2009). Labelling of bOSCs with a fluorescent lentivirus caused a 
decrease in growth rate compared to un-transfected controls, suggesting that the virus 
may impede the function of these cells. To facilitate the transfection of the lentivirus 
into cells, Polybrene a cationic polymer was utilised. By neutralising the electrostatic 
repulsion between the cell surface and viral particles, polybrene facilitates the 
absorption of viral particles into the cell. At concentrations similar to those used 
here, polybrene was found to reduce cell proliferation in human mesenchymal stem 
cells which could not be overcome with treatments to increase cell proliferation (Lin 
et al., 2011). Polybrene did not increase cell death but decreased the number of cells 
entering the S phase of the cell cycle in a dose dependent manner. This suggests 
polybrene acts to reduce cell proliferation through prevention of cells replicating 
DNA in preparation for cell division and proliferation, although the underlying 
mechanism for this has not been determined (Lin et al., 2011). The reduction in 
bOSC growth rate may be associated with the effects of exposure to polybrene rather 
than the direct effects of the lentivirus. Use of alternative non-toxic transfection 
reagents may provide better outcomes for bOSC viral transfection in future 
experiments.  
In an attempt to avoid cell toxicity, non-genomic labelling methods were utilised for 
bOSC labelling. CMFDA cell tracker dye, a fluorescent dye which passes into cells 
where it transforms into cell-impermanent fluorescent product successfully for 72 
hours, but was not well maintained in bOSCs after this time. CMFDA has been 
utilised in cell migration assays (Beem and Segal, 2013) and also as a intracellular 
marker during cell events such as meiosis (Tarin and Cano, 1998). CMFDA is a 
temporary cell marker which can label cells for more than 6 generations, however it 
has also been suggested that cytoplasmic cell tracker dyes may be treated like toxins 
by certain cells (Beem and Segal, 2013). Over time CMFDA expression became 
restricted to unhealthy or dead cells, suggesting that bOSCs may have responded to 
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CMFDA as a toxin resulting in expulsion of the dye from cells or cell toxicity 
leading to death. Due to its limited labelling capacity in bOSCs, CMFDA was not 
utilised in subsequent experiments.  
Rhodamine dextrans are fluorescently labelled complex polysaccharides which can 
be endocytosed into live cells and offer a gene-transfer-free rapid labelling method 
for bOSCs. Fluorescently labelled dextrans have previously been used in in vivo and 
in vitro tracing of cells from various tissue types including the brain, kidney, lungs 
and also in xenografts (Weigert et al., 2013). Rhodamine dextrans were clearly 
visible within live bOSCs up to 14 days. Although expression was detected in bOSCs 
after this point, it reduced over time. No negative effects were observed in bOSCs 
following dextran labelling and cell growth was not impacted. Rhodamine 
fluorescent dextrans persisted in cells following fixation and could be identified by 
immunocytochemistry with co-localisation of staining for anti-rhodamine antibody. 
Thus, rhodamine dextrans can be utilised to identify bOSCs after fixation. As 
dextrans are maintained within cell vesicles the decline in fluorescence observed in 
labelled bOSCs may be associated with endosomal recycling and this may limit the 
longevity of this label. The data presented here suggest that rhodamine dextrans are 
non-toxic to bOSCs and can label bOSCs for medium term tracing in vitro. Thus, 
rhodamine dextrans were utilised to label bOSCs for further investigation into their 
functional potential.  
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4 Development of an in vitro ovarian aggregation culture 
model 
4.1 Introduction 
Oogonial stem cells have been observed to spontaneously differentiate into oocyte-
like cells (OLCs) in vitro, in rodents (Pacchiarotti et al., 2010; White et al., 2012; 
Zhou et al., 2014), pigs (Bui et al., 2014) and humans (White et al., 2012), with peak 
oogenesis observed following cell passage (White et al., 2012). These differentiated 
OSCs show an increase in cell size, to form large (35-60μm diameter) spherical cells 
expressing germ cell specific markers (Ddx4/DDX4, Kit/KIT and Oct4/OCT4) and 
oocyte specific genes (Gdf9/GDF9, Zp1/ZP1, Zp2/ZP2 and Zp3/ZP3), which are 
absent from OSCs. OLCs derived from OSCs also exhibited large nuclei with diffuse 
chromatin (Pacchiarotti et al., 2010), characteristic of oocytes, in conjunction with 
the expression of meiotic proteins (Sycp3/SYCP3, YBX2 and LHX8) (Bui et al., 
2014; White et al., 2012). Many also had zona pellucida structures surrounding the 
cell (White et al., 2012; Zhou et al., 2014), although these were not always observed 
(Zhou et al., 2014). Thus, OSCs may have the potential to undergo differentiation to 
form oocytes and enter meiosis in an in vitro culture. However further 
characterisation of in vitro OSC derived OLCs has revealed concerns over their 
meiotic and developmental competence. Ploidy analysis of OLCs revealed a 
population of haploid cells (White et al., 2012), a karyotype rarely reached in oocytes 
in vivo as fertilisation triggers the resumption of meiosis, although spontaneous 
resumption of meiosis has been reported in oocytes in vivo (Xu et al., 1997). 
Inconsistency in the presence of zona pellucida in OLCs derived from OSCs (Zhou et 
al., 2014) and concerns over the ploidy of the cells (White et al., 2012), suggest that 
while OSCs may harbour the potential to generate new oocytes, spontaneous 
differentiation of these cells in vitro, unsupported and unregulated by somatic cells 
has generated OLCs with abnormal development. Furthermore the potential of in 
vitro OSC derived OLCs to undergo successful fertilisation, meiosis and subsequent 
embryonic development has not been established and these are essential 
requirements for successful oogenesis (Handel et al., 2014). 
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Oocyte growth and development is a tightly regulated process in vivo to marry the 
development of the oocyte with the timing of ovulation. Somatic cells, in particular 
granulosa cells, are known to play a crucial role in regulating oocyte growth, 
development, health (Kidder and Vanderhyden, 2010) and the repression of meiotic 
resumption (Sun et al., 2009). The absence of granulosa cells in the differentiation of 
OSCs into OLCs in in vitro culture may be responsible for the aberrant nature of the 
cells. In cultures without any other cell type present, OSCs which undergo 
differentiation to form an OLC also appear to associate with undifferentiated OSCs 
to form follicle like structures (Bui et al., 2014; Pacchiarotti et al., 2010) suggesting 
that interaction with supporting cells is an element desired by OLCs to support this 
process. When co-cultured with ovarian somatic cells, OSCs been observed to form 
follicle like structures with somatic cells surrounding the OSC derived OLCs (Bui et 
al., 2014; Pacchiarotti et al., 2010). Upon re-introduction to the ovarian 
microenvironment in vitro, human OSCs transfected with GFP adenovirus formed 
new GFP positive oocytes encapsulated within host (GFP negative) somatic cells 
following a 7 day culture (Grieve et al., 2015). Thus, there is a strong argument that 
the ovarian somatic cell environment is crucial to support OSC differentiation into 
oocytes, and this may be necessary for meiotic and developmental competence, 
although these aspects have not been yet demonstrated. Development of a model 
including somatic cell support, replicating the ovarian niche, for OSCs is required to 
fully determine their potential to produce oocytes and understand the requirements of 
this process. 
A chimeric ovarian aggregate model has previously been developed to investigate 
species differences in germ-somatic cell interactions (Eppig and Wigglesworth, 
2000). Pairing rat oocytes with mouse somatic cells from neonatal ovaries and vice 
versa, the authors showed that oocytes and somatic cells from different species could 
interact to form follicles comprising of an oocyte with somatic cells which were 
exclusively of the alternative species, capable of initiating growth within a xeno-
transplant model. These oocytes were also capable of meiotic resumption in both the 
mouse and rat and capable of fertilisation and embryo development using pseudo-
pregnant foster mothers in the mouse. This study shows that germ-somatic cell 
interactions appear to be conserved across species. Due to limited fetal or neonatal 
Development of an in vitro ovarian aggregation culture model 
101 
 
bovine tissue to generate a somatic cell niche for bOSCs, this chimeric ovarian 
aggregation model was utilised to investigate the differentiation potential of bovine 
oogonial stem cells. The development of an in vitro system will allow better control 
of the environment to elucidate the potential mechanisms by which OSCs undergo 
differentiation to OLCs. 
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4.2 Materials and Methods 
Ovarian aggregation model 
To investigate the potential of putative bovine oogonial stem cells (bOSCS), we 
developed a previously described ovarian aggregation model (Eppig and 
Wigglesworth, 2000) for use in in vitro culture systems. We utilised the somatic cells 
of neonatal murine ovaries to provide an ovarian niche for bOSCs. Negative (murine 
ovarian somatic cells only) and positive (murine germ and somatic cells) controls 
were also generated for comparison. 
Bovine oogonial stem cells 
bOSCs were FACS isolated (section 2.2) from adult bovine ovaries collected from 
the local abattoir (section 2.1). Following isolation bOSCs were cultured (section 
2.6.1.1) in OSC media (section 2.12). Cells were also frozen and stored long term in 
liquid nitrogen (section 2.6.1.3) until required. 
Disaggregation of neonatal ovaries 
Ovaries were collected from neonatal (postnatal day 0-5) CD-1 female mice 
following cervical dislocation and placed in pre-warmed PBS supplemented with 
1mg/ml BSA, then removed from their bursae. Ovaries were disaggregated 
(described in section 2.5.1) with pre-warmed trypsin/EDTA/DNAse and gentle 
agitation over a 25 minute period. The enzymatic digestion was neutralised with 
equal volumes with sterile supplemented M199 media (see section 2.12) and the cell 
suspension centrifuged at 450 RCF for 5 minutes. The cell pellet was then re-
suspended in sterile supplemented M199 media (section 2.12) and placed into 35mm 
culture dishes for culture overnight 37oC with humidified air and 5% CO2.  
Separation of germ and somatic cells 
Germ and somatic cells from neonatal mice were separated based on cell adhesion 
characteristics as previously described (section 2.5.2), such that floating germ cells 
could be aspirated off the somatic cell monolayer. Germ cells were incubated in 
M199 with supplements at 37oC, with humidified air and 5% CO2 until required for 
aggregation. Somatic cells were washed twice with pre-warmed PBS supplemented 
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with 1mg/ml BSA, then lifted from the culture plate with 2ml of pre-warmed 
trypsin/EDTA/DNAse. The enzymes were neutralized with equal volumes of M199 
with supplements and the somatic cell suspension was either filtered (size 30m, 
20m or 10m, CellTrics Partec) or not filtered then centrifuged at 450 RCFfor 5 
minutes. The supernatant was then discarded and cells were re-suspended in M199 
media with supplements, placed in a new culture dish and returned to 37oC, with 
humidified air and 5% CO2 for 5-6 hours.  
Following a second incubation, the murine neonatal ovarian somatic cells were 
washed with 2 ml pre-warmed PBS, twice, lifted from the culture plate a 2nd time 
with pre-warmed trypsin/EDTA/DNAse, which was then neutralized with equal 
volumes of M199 with supplements and the somatic cell suspension was either 
filtered (size 30m, 20m or 10m) or not filtered then centrifuged at 450 RCF for 
5minutes. The supernatant was then discarded and cells re-suspended in an 
appropriate volume of Waymouths media with supplements (section 2.12) for cell 
counting, prior to aggregation. 
Aggregation of ovarian cells 
All cell populations used for aggregations (murine neonatal somatic cells, murine 
neonatal germ cells and bOSCs) were centrifuged at 2000rpm for 5 minutes and re-
suspended in an appropriate volume of Waymouths media with supplements (section 
2.12) for counting. Cell populations were manually counted using a haemocytometer 
and cells were then combined and placed into 0.5ml Eppendorf tubes with 35g 
Phytohaemagluttanin (PHA) at the desired ratio/concentration to create different 
aggregates (Figure 2.4). Cells were mixed by brief vortex and centrifuged in a 
microcentrifuge at 11,200 RCF for 30 seconds, the 0.5ml eppendorfs were then 
rotated 180o and cells were centrifuged at 11,200 RCF for 30 seconds a second time. 
Cell pellets (aggregates) were then transferred with 30l of Waymouths media with 
supplements to a hanging drop culture overnight at 37oC with humidified air and 5% 
CO2 to encourage cell interaction and adhesion.   
Positive control ovarian aggregate 
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Positive control aggregates recombined neonatal murine somatic cell and germ cell 
populations at varying ratios (Figure 2.4). Positive control aggregates were then 
cultured as described in section 2.6.4. 
Negative control ovarian aggregate 
To investigate the quality of our separation technique, negative control aggregates 
were generated, aggregating together mouse neonatal ovarian somatic cells only 
(Figure 2.4). Negative control aggregates were generated alongside every chimeric 
aggregate. Negative control aggregates were then cultured as described in section 
2.6.4. 
Chimeric ovarian aggregate 
bOSCs were isolated (section 2.2), cultured (section2.6.1.1) and labelled with 
rhodamine dextrans (section 2.6.2.3) then aggregated together with neonatal mouse 
ovarian somatic cells at a ratio of 1:10 respectively (Figure 2.4). Chimeric aggregates 
were then cultured as described in section 2.6.4. 
In vitro culture of ovarian aggregates 
Ovarian aggregates generated as described previously (section 2.5.4) were cultured 
in either 1% alginate gel or a hanging drop as described below, after an initial 
overnight hanging drop culture to promote cell interaction. 
Ovarian aggregates were cultured within a 1% alginate gel, cross-linked with pre-
warmed CaCl2 for 10 minutes, in Waymouths media with supplements (section 2.12) 
at 37oC with humidified and 5% CO2 as described in section 2.6.4.1. 50% of the 
volume of the medium was replaced with fresh medium on alternate days of culture. 
Alternatively, ovarian aggregates were cultured in a hanging drop with sterile 
supplemented Waymouths medium (Section 2.12) continuously for the whole culture 
period and incubated at 37oC with humidified air and 5% CO2 as described in section 
2.6.4.2. Aggregates were transferred to fresh medium on alternate days of culture and 
incubated at 37oC with humidified air and 5% CO2.  
Xeno-transplant of ovarian aggregates 
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Positive ovarian aggregates (murine germ and somatic cells) following an overnight 
hanging drop culture in supplemented Waymouths media (section 2.12) were xeno-
transplanted to the kidney capsule of SCID (severe combined immunodeficiency) 
mice for 7 days for comparison with the in vitro culture models.   
All animal experiments were conducted under a UK Home Office licence in line with 
the Animals Scientific Procedure Act (1986). SCID (C.B-17/IcrHan Hsd-Prkdcscid) 
mice from Envigo laboratories were housed as described in section 2.7 and given a 
minimum of 6 days to acclimatise to their new environment prior to the start of any 
experimental work.  
Briefly, SCID mice were anaesthetised with isoflourane (section 2.7.1), shaved and 
skin sterilised. Subcutaneous injection of saline around the hind leg and a 
subcutaneous injection of vetergesic (at a dose of 0.03mg/ml in 100l) around the 
neck were given. A longitudinal incision in the skin was made in the middle of the 
back, followed by a small incision in the body wall directly above the ovary, 
allowing the ovary and ovarian fat pad to be removed from the body cavity, and the 
ovary to be excised. Using the ovarian fat pad as a guide the kidney was pulled out of 
the body cavity with forceps. Sterile PBS kept the kidney moist and a tiny incision 
was made in the kidney capsule with a sterile needle. Using a pulled glass pipette, 
aggregates were transferred through the hole in the capsule to the surface of the 
kidney and moved from the incision site to ensure their security. The kidney and 
associated tissue was then returned to the body cavity, and the body wall sutured 
using number 5 polyglactin sutures. The ovary was then removed on the other side 
following the same protocol and the skin incision closed using wound clips. Mice 
were then transferred to individual cages which were maintained at 30oC while they 
recovered and then housed as described in section 2.7 for 7 days until tissue 
collection.  
7 days after xeno-transplantation, mice were culled by lethal exposure to CO2 and 
tissues were collected, inspected and fixed as described below.  
Histological Techniques 
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Aggregate ovarian tissue was fixed in natural buffered formalin (NBF) for 6 hours, 
then transferred to 70% ethanol and embedded in wax using an automated Leica 
TP1050 processor. Tissue was sectioned at 5M and mounted onto electrostatically 
charged glass slides and maintained at 50oC overnight in a slide oven to ensure tissue 
adherence to the slide surface.  
Haematoxylin and eosin staining 
Every third section of each ovarian aggregate was stained with haematoxylin and 
eosin for histological evaluation to detect the presence of oocytes and follicles. Slides 
were de-waxed and rehydrated (section 2.8.3) and washed briefly in running tap 
water, then stained with haematoxylin and eosin (section 2.8.4) before dehydration 
and mounting (section 2.8.5).  
DAPI Counterstain 
To identify the location of bOSCs based on the presence of rhodamine dextrans, 
tissue was counterstained with DAPI to view the fluorescence. Adjacent sections to 
previously stained H&E sections were counterstained with DAPI. Slides were de-
waxed and rehydrated (section 2.8.3), then washed in running tap water, then washed 
twice in PBS. Slides were then incubated with DAPI, diluted 1:1000 in PBS, for 10 
minutes in a humidity chamber at room temperature. Slides were then washed in PBS 
twice and mounted with coverslips (section 2.8.6.5).  
Immunofluorescence 
To assess tissue antigens, slides were dewaxed and rehydrated (section 2.8.3) prior to 
antigen retrieval (section 2.8.6). Slides were then washed and cooled in water 3 
times. Non-specific binding of antibodies was prevented by using a peroxidase block 
followed by a serum block (section 2.8.6.1). Slides were then exposed to the primary 
antibody (listed in Table 4.1) diluted in NS/PBS/BSA and incubated overnight at 
4oC. Negative controls (primary antibody omitted) were always used and positive 
controls were used where applicable and appropriate. 
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Table 4.1: Primary antibodies used in Immunofluorescence in Chapter 4 
Antibody Dilution Species Supplier 
Cleaved Caspase 3 1:100 Rabbit Cell Signalling 
Technology 
Dazl 1:100 Mouse AbDSerotec 
Tetramethylrhodamine  1:3000 Rabbit Life 
Technologies 
 
Primary antibodies were washed off with PBS for 5minutes, twice, and the 
appropriate secondary antibodies (listed in Table 4.2) were diluted 1:200 in blocking 
serum (NS/PBS/BSA) and applied to slides for 30minutes at room temperature in a 
humidity chamber.  
Table 4.2: Secondary antibodies used in Immunofluorescence in Chapter 4 
Antibody Supplier 
Chicken anti Rabbit Santa Cruz 
Chicken anti Mouse Santa Cruz 
 
Slides were then washed twice with PBS and incubated in tyramide in accordance 
with the manufacturer’s instructions, for 10 minutes. Slides were then washed in PBS 
to remove the tyramide, in an opaque chamber to prevent bleaching of the 
fluorescence before counterstaining and mounting (section 2.8.6.5). Slides were then 
stored in the dark at 4oC until visualisation (section 2.9.4). 
Microscopy 
Tissue histology was imaged with a Provis AX70 (Olympus) or a Zeiss Imager Z1 
both fitted with a AxioCam HRc camera (Zeiss) using Zeiss software. 
Live cell and tissue imaging was conducted using an Axiovert 200 fitted with a 
AxioCam HRc camera and a Hamamatsu camera for collection of images including 
fluorescent images. Cells and tissue were maintained at 37oC with 5% CO2 
throughout live imaging.   
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Sections were visualised using a Zeiss LSM 780 confocal microscope using Zeiss 
software. 
All scale bars were generated and embedded in image files using Zeiss software. 
Tissue Analysis 
All image analysis, measurements and cell counting was carried out using ImageJ 
software. 
Every third section of all ovarian aggregates were stained with haematoxylin and 
eosin for histological assessment. For chimeric ovarian aggregates the subsequent 
sections were all DAPI counterstained to localise bOSCs within the tissue. The 
remaining unstained sections were used in immunofluorescent analysis. 
Cells were counted using cell counter software on ImageJ per section and cell sizes 
and section areas were also measured using ImageJ following scale calibration.  
Oocytes were counted when the nucleolus was present, and follicles classified based 
on their stage (primordial, a single layer of flattened granulosa cells; transitory, a 
mixture of flattened and cuboidal granulosa cells; primary, a single layer of cuboidal 
granulosa cells). Follicles were also classified as healthy (round oocyte containing a 
nucleus, even cytoplasmic staining with eosin and no pyknotic granulosa cells) or 
unhealthy (contraction of the oocyte from the granulosa cells, uneven or dark 
cytoplasmic staining of the oocyte, nuclear contraction and/or pyknotic granulosa 
cells). 
Two measurements were taken for bOSC cell sizes, the first at the widest point of the 
cell and the second perpendicular to the first. The average of these two 
measurements was taken to establish the size of bOSCs.  
Statistical Analysis 
Statistical analysis was conducted using Graphpad Prism 6 software. One-way 
ANOVA analysis with post-hoc Tukeys multiple comparisons testing was used 
where three or more groups were compared when only one variable was present. 
Where only two groups were present a t-test was used to determine differences 
between groups.   
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4.3 Results  
4.3.1 bOSCs do not spontaneously differentiate into oocyte-like 
cells in vitro 
bOSC cultures were monitored for the presence of detached large spherical oocyte-
like cells (OLCs) throughout culture. bOSCs did not appear to undergo spontaneous 
differentiation in vitro; no large cells were observed throughout their culture and 
across several different populations (different isolation dates) of bOSCs. As no 
oocyte-like cells were observed in bOSC cultures, further investigation of this 
process independently of extrinsic factors could not be undertaken and alternative 
techniques were utilised to investigate the differentiation potential of bOSCs. 
 
4.3.2 Separation of germ and somatic cell populations following 
disaggregation of neonatal murine ovaries 
To establish whether the germ and somatic cell populations were successfully 
separated following disaggregation of neonatal murine ovaries, somatic cell only 
aggregates were generated. When described previously, authors (Eppig and 
Wigglesworth, 2000) separated these two cell populations based entirely on their 
adhesive characteristics (illustrated in Figure 2.4) such that germ cells are aspirated 
off the somatic cell monolayer, which is then washed to remove any remaining germ 
cells. When this original separation technique was used, oocytes were consistently 
seen in negative aggregates 7 days after creation as seen in Figure 4.1.C (21.5  5.5, 
n=4). Thus, a more rigorous separation protocol was developed to establish an 
uncontaminated somatic cell population. Somatic cells were filtered twice through 
cell filters following both trypsinisation in the original protocol, to remove 
contaminating oocytes. Significantly fewer oocytes were seen in aggregates 
following somatic cell filtration through 30m (Figure 4.1.D; 11.0  6.1, n=3, 
P0.05), 20m (Figure 4.1.E; 4.0  6.1, n=4, P0.0001) and 10m (Figure 4.1.F; 0  
0, n=27, P0.0001) cell filtration. Oocytes were consistently eliminated from 
aggregates following somatic cell filtration with 10m cell filters, thus to achieve 
complete separation of germ and somatic cell populations following disaggregation 
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of neonatal murine ovaries, somatic cells required filtration through a 10m cell 
filter. This protocol was utilised in all subsequent in vitro ovarian aggregation 
experiments.  
  






Figure 4.1: Successful disaggregation of neonatal ovaries and separation of germ and somatic cell 
populations. Neonatal murine germ cells (A) and somatic cells (B) in culture following disaggregation. 
Cells were imaged at x10 magnification and scale bars represent 200m. Somatic cells were aggregated 
together with PHA and cultured for 7 days and analysed for the presence of germ cells. Germ cells were 
observed in aggregates where somatic cells were unfiltered (C; n=4), filtered through a 30m (D; n=3) or 
20m (E; n=4) cell filters, but not when filtered through a 10m filter (F; n=27). Tissue sections imaged at 
x10 magnification and scale bars represent 50m. (G) A significant decrease was observed between the 
number of germ cells in aggregates filtered through 20m and 10m cell filters compared to unfiltered 
samples (Mean  SEM plotted, One-Way ANOVA with Tukey post-hoc multiple comparisons, * P0.05 and 
****P0.0001)  
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4.3.3 Aggregation of neonatal murine germ and somatic cells 
results in follicle formation after 7 days of culture 
Aggregates containing both neonatal mouse germ and somatic cells were used to 
identify and develop a suitable in vitro culture model to support follicle formation 
and subsequent growth. Two culture methodologies were investigated following an 
overnight hanging drop culture; continuation of the hanging drop culture or a 1% 
alginate gel matrix culture.  
Following an overnight culture in a hanging drop with Waymouths medium plus 
supplements, oocytes were clearly visible in aggregates, although no clear 
interactions with the surrounding ovarian somatic cells were observed (Figure 4.2.A). 
In contrast, Figure 4.2.B & C show that after 7 days of culture in both systems mouse 
oocytes appear to have established interactions with surrounding somatic cells and 
have formed follicles. A proportion of these follicles appear to have initiated 
follicular development, with a single layer of cuboidal granulosa cells observed, 
characteristic of a primary follicle. The absence of interactions between the germ 
cells and somatic cells at day 0 further reflects that complete disaggregation of the 
neonatal ovaries and separation of the two cell populations was been achieved. 
Aggregates clearly show extensive reorganisation from Day 0 (Figure 4.2.A) to Day 
7 (Figure 4.2.B & C) generating ovary-like aggregates with a clear surface 
epithelium surrounding the whole tissue in both culture systems. This reorganisation 
and establishment of follicles in these aggregates reflects cell-cell interactions and 
suggests that cells within the aggregates are communicating to co-ordinate follicle 
formation and growth initiation. Analysis of tissue volume in uncultured day 0 
(0.10mm3  0.08mm3, n=3) and day 7 alginate (0.13mm3  0.02 mm3, n=9) cultured 
positive control ovarian aggregates showed no difference, suggesting that aggregates 
cultured within alginate undergo tissue remodelling but do not increase in size. 
Whereas hanging drop (0.28mm3  0.08 mm3, n=5) cultured positive control ovarian 
aggregates were significantly larger than uncultured (p  0.05) and alginate cultured 
(p  0.01), suggesting that these aggregates had undergone proliferation in 
conjunction with remodelling. These results also suggest that the hanging drop model 
may better support the development of ovarian aggregates.  




Figure 4.2: Aggregation of neonatal mouse germ and ovarian somatic cells supports follicle 
establishment within 7 days of culture. (A) Oocytes are visible (outlined in dashed lines) in germ 
and somatic cell aggregates following an overnight culture. After 7 days of culture oocytes were 
observed encapsulated in somatic cells to form follicles in both the alginate culture (B) and the 




Figure 4.3: Estimated tissue volume of uncultured (day 0), alginate and hanging drop cultured 
(7 days) ovarian aggregates. Estimated tissue volume of alginate cultured positive control ovarian 
aggregates (0.13mm3  0.02 mm3, n=9) were not significantly different in size to uncultured ovarian 
aggregates (0.10mm3  0.08mm3, n=3). However, hanging drop cultured ovarian aggregates (0.28mm3 
 0.08 mm3, n=5) were significantly larger than uncultured and alginate cultured ovarian aggregates. 
Mean ± SEM.  One-way ANOVA with post hoc Tukeys multiple comparison tests, * P<0.05 and 
**P<0.01. 
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4.3.4 Hanging drop culture better supports germ cell survival 
than alginate gel culture system 
Both the alginate gel culture system and the hanging drop culture model utilised 
Waymouths media with supplements for culture (section 2.12) with either 50% 
replacement of media or complete replacement of media on alternate days, 
respectively. Although the aggregates from each system can be compared to one 
another, a further positive control for comparison was needed to determine the 
success of the culture systems. The ovarian aggregate model had previously been 
used in a xeno-transplant system which successfully supported follicle formation and 
growth to generate antral follicles (Eppig and Wigglesworth, 2000) after 21 days. 
Thus a 7 day xeno-transplant model was used as a comparison to investigate the 
success of the ovarian aggregate culture systems to support healthy follicle formation 
and growth.  
All germ cells observed at the end of the culture or xeno-transplant period were seen 
in association with somatic cells, for both healthy and unhealthy oocytes. Example 
images from cultured aggregates are shown in Figure 4.4.A. Oocytes were counted 
where the nucleolus was present and classified based on their follicle stage 
(primordial, a single layer of flattened granulosa cells; transitory, a mixture of 
flattened and cuboidal granulosa cells; primary, a single layer of cuboidal granulosa 
cells) and health (healthy follicles consisted of a round oocyte containing a nucleus, 
even cytoplasmic staining with eosin and no pyknotic granulosa cells; follicles were 
considered unhealthy if the follicle showed contraction of the oocyte from the 
granulosa cells, uneven or dark cytoplasmic staining of the oocyte, nuclear 
contraction and/or pyknotic granulosa cells; Figure 4.4.A). No follicles were 
observed with a healthy oocyte and pyknotic granulosa cells, suggesting that 
follicular atresia is driven by apoptosis of the germ cell rather than the somatic cells 
in ovarian aggregates. This may be a consequence of the initial disaggregation 
process or as a result of germ cells failing to establish sufficient somatic cell support 
within a timeframe necessary for germ cell survival resulting in poor cell health and 
death.  
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The hanging drop system retained significantly (P≤0.01) more germ cells in ovarian 
aggregates throughout the culture than those cultured in alginate (Figure 4.4.B), 
although neither group were significantly different to xeno-transplanted ovarian 
aggregates. The percentage distribution of follicles by developmental stage was not 
significantly different between groups (Figure 4.4.C), however, the xeno-transplant 
model did show a trend for a higher proportion of follicles to reach the primary 
stages of development, suggesting that the culture models are potentially deficient in 
the support system necessary to facilitate the transition of follicles from primordial 
through transitory to primary, or the in vitro model facilitates this process at a slower 
rate compared to the xeno-transplant system.On average a larger number of healthy 
follicles, irrespective of developmental stage, were identified in the hanging drop 
aggregates than in both alginate and xeno-transplanted ovarian aggregates, although 
this difference is not statistically significant (Figure 4.4.D). The wider distribution of 
results observed in both culture systems, shows that there was greater variability 
within each culture system than that observed in the xeno-transplant model. The 
cause of this variability is unclear, but may be a result of differences between the 
initial ovaries used, variation between enzyme aliquots used for disaggregation, sizes 
of aggregates and variation in media aliquots.  
The percentage of healthy follicles did not differ between experimental groups at the 
primordial and transitory stages of development, but the xeno-transplant model had a 
higher proportion of healthy primary follicles than both culture systems (Figure 
4.4.E). Although not statistically significant, these data suggest that while both 
culture systems can support the reformation of follicles when neonatal murine germ 
and somatic cells are aggregated together, and can facilitate the early stages of 
follicular development, they appear to be less efficient than the xeno-transplant 
model at supporting healthy follicle development to the primary stages of 
development. This also suggests that the culture systems and/or media would need 
adapting for long term culture of the aggregates to support full follicle development 
in vitro. 
The expression of cleaved caspase 3 (CC3), a marker of active cellular apoptosis was 
assessed in aggregates after a 7 day culture or xeno-transplant to explore the health 
of the ovarian aggregates. At this time point very few germ cells were identified as 
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apoptotic (Figure 4.5.A-C, arrowheads). As cleaved caspase 3 is a marker of active 
early apoptosis, this time point may be too late to detect oocyte death as previously 
assessed by tissue histology in these aggregates. In contrast a number of somatic 
cells not associated with follicles were identified as actively apoptotic in the centre of 
the aggregates, suggesting that the nutrient supply to the centre of the aggregate is 
insufficient resulting in cellular death (Figure 4.5.A-C). There were significantly 
fewer CC3 positive cells per area of tissue in ovarian aggregates cultured by hanging 
drop than those cultured in alginate (Figure 4.5.D), furthermore, very few cells were 
observed to be cleaved caspase 3 positive in aggregates following xeno-
transplantation. These results illustrate that the health of aggregates cultured in 
alginate is poorer than those cultured in a hanging drop and those xeno-transplanted. 
Xeno-transplanted aggregates were observed to have developed a blood supply at the 
time of tissue collection, thus establishing a nutritional supply facilitating survival 
and promoting tissue health. Cultured aggregates in contrast relied upon media at the 
tissue surface either passing through the tissue or nutrients being delivered via 
cell/cell interactions. The localisation of CC3 expression (Figure 4.5.A & B) and 
histological visualisation of necrotic tissue located centrally in cultured aggregates 
(Figure 4.2.B & C), suggests poor nutrition supply at the centre of these aggregates. 
However, the differences in CC3 expression between culture groups suggests that the 
hanging drop model supports better nutrient supply in the tissue than the alginate 
system. 
Although there were very little differences between the two techniques for culturing 
positive control aggregates, the hanging drop methodology was observed to have 
significantly better germ cell survival than the alginate gel culture system and had 
less active apoptosis in aggregates after 7 days. Given these results the hanging drop 
culture system was used in subsequent experiments to further investigate the 
potential of bovine OSCs. 
 




Figure 4.4: Follicle establishment, initiation of growth and health in ovarian aggregates in two 
in vitro culture systems compared to a xeno-transplant model. (A) Healthy (top panels) and 
unhealthy (bottom panels) follicles by developmental stage. Arrowheads mark unhealthy primordial 
follicles and scale bars represent 20μm. (B) Percentage of initial germ cells remaining in aggregates 
after 7 days of culture in an alginate gel (n=9), hanging drop (n=5) or xeno-transplant (n=4). (C) 
Percentage of total follicles by developmental stage. (D) Total number of healthy follicles in 
aggregates after 7 days. (E) Percentage of healthy follicles by developmental stage. Mean ± SEM.  
One-way ANOVA with post hoc Tukeys multiple comparison tests, **P<0.01.  
 




Figure 4.5: Immunofluorescent detection of the apoptotic marker cleaved caspase 3 (CC3) in 
cultured ovarian aggregates.  Representative sections from an ovarian aggregates cultured in 
alginate (A), hanging drop system (B) or xeno-transplanted to the kidney capsule of an immune 
deficient mouse (C) for 7 days immunostained for the presence of the active apoptotic marker cleaved 
caspase 3 (green). CC3 expression was found in both somatic cells (*) and germ cells (arrow heads) 
and appeared to be distributed across tissue cultured within an alginate gel, but was observed to be 
centrally located in those cultured in a hanging drop. Inset shows a negative control section where the 
primary antibody has been omitted. (D) Significantly fewer cleaved caspase 3 cells (per 100,000m2 
area of tissue) were observed in ovarian aggregates cultured in a hanging drop (n=3) or xeno-
transplanted (n=3) than those cultured within an alginate gel (n=3) after 7 days. One-way ANOVA 
with post hoc Tukeys multiple comparison tests, **P<0.01. Tissue sections were imaged at x10 
magnification and scale bars represent 200μm. 
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4.3.5 Bovine Oogonial Stem Cells in the ovarian aggregate 
culture model 
bOSCs isolated from adult bovine ovaries, cultured (passage 5-18) and labelled with 
rhodamine dextrans, were combined with neonatal murine ovarian somatic cells at a 
ratio of 1:10 cells respectively to generate chimeric ovarian aggregates for the 
investigation of bOSC potential. A total of 26 chimeric ovarian aggregates were 
generated. Rhodamine dextrans are endocytosed by bOSCs at the time of labelling 
and reside within vesicles in the cell cytoplasm. Rhodamine dextrans in vesicles 
within bOSCs could be visualised in all aggregates throughout 7 days in a hanging 
drop culture (Figure 4.6.A & B). Histology of aggregates at day 0 (Figure 4.6.C) and 
day 7 (Figure 4.6.D) shows that chimeric aggregates undergo structural 
reorganisation to create a spherical aggregate with a surface epithelium similar to 
that seen in negative (Figure 4.1) and positive (Figure 4.2) ovarian aggregates.  
When counterstained with DAPI and visualised by confocal microscopy, rhodamine 
labelled bOSCs could be visualised throughout the chimeric aggregates (Figure 4.7). 
No patterns or consistent observations were made about bOSC localization in the 
aggregates, they appeared randomly distributed throughout all chimeric ovarian 
aggregates. 
Although rhodamine was easily visible in chimeric ovarian aggregates and was 
absent from negative and positive ovarian aggregates (data not shown), to confirm 
that the rhodamine detected by confocal microscopy in chimeric aggregates was true 
rhodamine expression, immunofluorescence was performed on the tissue. Anti-
tetramethylrhodamine antibody staining was absent from neonatal mouse ovary 
controls (Figure 4.8.A) lacking rhodamine, whereas staining was seen corresponding 
to rhodamine location in chimeric aggregates (Figure 4.8.B). These data confirm and 
expand on results from Chapter 3, such that rhodamine dextrans are maintained 
within bOSCs over medium term culture periods (< 3 weeks), can be fixed and 
visualized in bOSCs after processing and furthermore can be identified within 
chimeric ovarian aggregates both directly and by immunofluorescence following 
these processes. Thus, bOSCs can be successfully traced when labelled with 
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rhodamine dextrans. All subsequent in vitro experiments utilized this methodology to 
identify bOSCs in chimeric ovarian aggregates. 
 
 
Figure 4.6: bOSCs in the in vitro ovarian chimeric aggregate. bOSCs labelled with rhodamine 
dextrans can be identified and traced live in chimeric aggregates throughout a hanging drop culture, 
shown at day 0 (A) and day 7 (B). Haematoxylin and eosin staining of chimeric aggregate sections at 
day 0 (C) and day 7 (D). Live tissue and tissue sections were imaged at x10 magnification and scale 
bars represents 200μm. 
 




Figure 4.8: Immunofluorescent analysis of rhodamine expression in chimeric aggregate 
containing bOSCs labelled with rhodamine dextrans. Chimeric aggregates containing bOSCs 
labelled with rhodamine dextrans and control neonatal murine ovaries lacking rhodamine expression 
were assessed for the presence of rhodamine. Anti-tetramethylrhodamine (Anti-Rho; green) staining 
was absent from the neonatal mouse ovary (A) and showed staining co-localised to rhodamine 
fluorescence in chimeric ovarian aggregates (B). Tissue sections were imaged at x20 magnification 
and scale bars represent 100μm.  
  
Figure 4.7: bOSCs visualised using rhodamine dextran labelling following fixation in a chimeric 
ovarian aggregate cultured in a hanging drop for 7 days. bOSCs could be identified in sections of 
chimeric aggregate tissue counterstained with DAPI by the location of fluorescent rhodamine 
dextrans. A representative section is shown here at x20 (A), x40 (B) and x63 (C) magnification and 
scale bars represent 100μm in all images.  
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4.3.6 Health of chimeric ovarian aggregates cultured in vitro 
To assess the health of the chimeric ovarian aggregates following culture, apoptosis 
was measured by the expression of cleaved caspase 3 (CC3). 15.6  1.9 CC3 positive 
cells (mean  SEM, n=3) per 100,000m2 area were identified in chimeric ovarian 
aggregates, which was significantly higher (P=0.04) than the number of CC3 positive 
cells per 100,000m2 area of positive ovarian aggregates (9.3  0.9; mean  SEM, 
n=3, Figure 5.4). This suggests that the culture system previously developed using 
positive control ovarian aggregates (consisting of murine germ and somatic cells) 
may be less efficient at supporting aggregate health in chimeric ovarian aggregates. 
The pattern of CC3 expression in the chimeric ovarian aggregates (Figure 4.9) was 
randomly distributed throughout the tissue, a pattern similar to xeno-transplanted 
positive ovarian aggregates, whereas CC3 expression was restricted to the center of 
the positive ovarian aggregates. This expression pattern does not suggest consistent 
failure of the nutrition supply to reach the center of the aggregates. Although CC3 
expression was greater in chimeric ovarian aggregates it still reflected a small 
proportion of the overall tissue. Furthermore, very few (3.64%  1.58%, mean  
SEM, n=3) bOSCs were CC3 positive in the chimeric ovarian aggregates, suggesting 
that culture system supports bOSC survival in the aggregates. 
 




Figure 4.9: Cleaved Caspase 3 (CC3) expression in chimeric ovarian aggregates. Apoptotic cells 
in chimeric ovarian aggregates were identified by CC3 expression following a 7 day hanging drop 
culture period. 9.46% of all CC3 positive cells identified co-localised to rhodamine labelled bOSCs. 
Overall very little active apoptosis was identified in chimeric ovarian aggregates. Inset shows a CC3 
positive bOSC adjacent to a CC3 positive somatic cell. Tissue section was imaged at x20 
magnification and the scale bar represents 100μm.  
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4.3.7 bOSCs maintain DAZL expression in chimeric aggregates 
One of the main features used to characterise and define oogonial stem cells is their 
co-expression of germ and pluripotency markers. DAZL is a germ cell specific RNA-
binding protein which was expressed in bOSCs during cell culture (Section 3.3.2). 
Here DAZL has been used to assess whether bOSCs maintain their germline 
phenotype when aggregated with neonatal murine ovarian somatic cells. 
DAZL expression was restricted to oocytes in control neonatal mouse ovaries (Figure 
4.10.A) and staining was absent when the primary antibody was omitted (Figure 
4.10.B), confirming antibody specificity to germ cells. DAZL expression was 
observed to co-localise with bOSCs in chimeric ovarian aggregates (Figure 
4.10.C&D). All DAZL staining in chimeric ovarian aggregates was observed in 
conjunction with rhodamine signal from bOSCs. Thus, all germ cells, as confirmed 
by the presence of DAZL staining, in the chimeric ovarian aggregate system are 
bOSCs. 
However not all bOSCs (determined by rhodamine signal) were observed to express 
DAZL in the aggregates (Figure 4.10.C&D). DAZL expression in bOSCs in culture 
was variable and likely a result of heterogeneity in the isolated population, thus 
resulting in variable DAZL expression in bOSCs in the chimeric aggregate model. 
Alternatively, bOSCs may have lost their DAZL expression as a result of aggregation 
with neonatal murine somatic cells or as a consequence of the culture.  
  





Figure 4.10: DAZL expression in chimeric ovarian aggregates cultured in vitro is restricted to 
bOSCs. (A) Neonatal mouse ovaries demonstrate DAZL (green) expression restricted to the oocytes. 
(B) Staining was absent from the tissue when the primary antibody was omitted. (C & D) Dazl 
expression (green) was identified in chimeric ovarian aggregates co-localised to bOSCs (red). Tissue 
sections were imaged at x20 magnification (A & B) and x63 magnification (C & D), scale bars 
represent 100μm in A and B, 50μm in C and D and 10 μm in inset images. 
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4.3.8 A subpopulation of bOSCs undergoes morphological 
changes in chimeric ovarian aggregates within 7 days of 
culture. 
Further characterisation of chimeric ovarian aggregates containing rhodamine 
dextran labelled bOSCs showed a proportion of bOSCs appeared to have an altered 
morphology compared to other bOSCs. bOSCs identified within 24 hours of 
aggregate creation were small (<10μm) and demonstrated irregular shape. Following 
7 days in a hanging drop culture, the large majority of bOSCs identified in chimeric 
ovarian aggregates retained this size (Figure 4.11.A & B) and have been termed 
undifferentiated. However, a small population of bOSCs (n=11) were significantly 
(P≤0.0001; Figure 4.11.E) larger in size with a more spherical morphology and are 
referred to as differentiated bOSCs. The differentiated bOSCs (Figure 4.11.C & D) 
appear to be a distinct population of cells when compared to undifferentiated bOSCs 
in the same aggregates (Figure 4.11.F). Sections adjacent to those which had been 
DAPI counterstained had previously been stained with haematoxylin and eosin to 
evaluate the histology of chimeric ovarian aggregates. When sections adjacent to 
those with differentiated bOSCs identified were analysed, the cells corresponding to 
the differentiated bOSCs appeared to have larger cytoplasm area consistent with the 
size of the bOSCs measured in Figure 4.11.E. Furthermore, these cells appeared to 
have a more spherical morphology and show association with neighbouring cells 
(Figure 4.12), which were rhodamine negative neonatal mouse somatic cells. These 
features are similar to the characteristics of ovarian follicles. 
Due to the limited amount of this tissue and the low frequency with which 
differentiation of bOSCs occurred within this system, it has not been possible to 
investigate the expression of oocyte specific factors such as GDF9 or BMP15 to 
determine if these bOSCs have undergone oogenesis to produce oocytes. However it 
is clear that a subpopulation of bOSCs have undergone morphological changes, 
including an increase in cell size, when combined with neonatal murine ovarian 
somatic cells and cultured in a hanging drop system.  
 




Figure 4.11: A subpopulation of bOSCs undergo morphological changes in chimeric ovarian 
hanging drop cultures within 7 days. bOSCs in chimeric ovarian aggregates were identified by the 
expression of rhodamine dextrans following counterstaining with DAPI. Two distinct populations of 
bOSCs were identified. Undifferentiated bOSCs (A&B) were small in size (9.11μm ± 0.189μm; Mean  
± SEM, n=57) and varied in shape. Differentiated bOSCs (C&D) were significantly larger (18.96 ± 
0.705; Mean ± SEM, n=11. P≤0.0001, un-paired t-test) than undifferentiated bOSCs (E &F) and 
demonstrated a more spherical shape. Tissue sections were imaged at x40 magnification and all scale 
bars represent 50μm and 20μm in insets. 




Figure 4.12: Adjacent H&E and DAPI counterstained sections from chimeric ovarian 
aggregates. H&E (A) section of a chimeric ovarian aggregate appears to contain a larger cell with a 
spherical morphology which co-localises with a rhodamine labelled differentiated bOSC in the DAPI 
counterstained adjacent section (B). Differentiated bOSCs appears to have a larger cytoplasm than 
undifferentiated bOSCs, they also appear to associate with surrounding rhodamine negative murine 
somatic cells. Tissue sections were imaged at x20 magnification and scale bars represent 50μm. 
 
  




The production of an oocyte in vivo is a tightly regulated process, influenced and 
controlled by the surrounding somatic cells to ensure meiotic and developmental 
competence is achieved in tandem with the timing of ovulation. Disruption of this 
relationship is known to interfere with the ability of the oocyte to undergo meiosis 
and fertilisation successfully (reviewed by Eppig (1991), Kidder and Vanderhyden 
(2010)). Early research showed that oocyte growth is hindered when removed from 
its follicle (Eppig, 1979) and the rate of oocyte growth in vitro is correlated with the 
number of granulosa cells in the follicle (Brower and Schultz, 1982). Genetic 
manipulation has further illustrated the importance of this relationship. Mice lacking 
connexin 43 (Cx43) had disrupted folliculogenesis with noticeable reduction in 
oocyte growth, resulting in abnormal, developmentally incompetent oocytes (Ackert 
et al., 2001; Tong et al., 2006). The interactions between somatic cells and germ cells 
are thus pivotal for reproductive success. 
Prior to isolation from mammalian ovaries, it is likely that OSCs will interact with 
surrounding somatic cells and have a relationship with their microenvironment. This 
may either play a role in their maintenance or could influence their differentiation, 
should they contribute to the follicular pool in the adult ovary in vivo which is still 
unclear. Therefore, ovarian somatic cells may have an important role in determining 
the oogenic potential of oogonial stem cells. 
Large spherical cells similar to oocytes were not observed in bOSC cultures, possibly 
due to a lack of extrinsic signals to co-ordinate their differentiation. The observation 
of spontaneous differentiation of OSCs into oocyte-like cells (OLCs) in culture 
without the support of somatic cells in other species, reported in the literature, 
generated abnormal OLCs (Bui et al., 2014; Ding et al., 2016; Hernandez et al., 
2015; White et al., 2012; Zhou et al., 2014). Single cell RT-PCR showed 
heterogeneous expression of oocyte and meiotic markers in these OSC derived OLCs 
(Ding et al., 2016), suggesting variation in the differentiation of oogonial stem cells, 
likely a result of the uncontrolled nature of the differentiation in contrast to the in 
vivo process. Spontaneous differentiation of OSCs is also a rare event with only 0.1% 
of porcine OSCs producing OLCs in culture (Bui et al., 2014). Thus, the absence of 
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spontaneous differentiation of bOSCs in culture is reflective of the rare nature of the 
event, as previously reported by others. Extrinsic factors have been shown to 
increase the rate of OSC differentiation in vitro. Bmp4, a growth factor expressed in 
ovarian somatic cells known to have several roles in regulating germ cell 
development within the ovary (Pangas, 2012), significantly increased the rate at 
which mouse OSCs spontaneously differentiate into OLCs and induced expression of 
meiotic genes (Stra8, Msx1 and Msx2) in a dose dependent manner when added to 
cultures (Park et al., 2013). These effects could be inhibited by the administration of 
Noggin, a Bmp4 antagonist, to cultures, confirming the effects were as a result of 
Bmp4 signalling. Granulosa cells and retinoic acid (RA) significantly increased 
differentiation of human OSCs into oocyte-like cells with meiotic spreads revealing 
SYCP3 staining associated with the leptotene stage of meiosis (Ding et al., 2016). 
Mouse granulosa cells were also observed to interact with human OSC derived OLCs 
via filopodia like structures with gap junctions (GJA4 positive) identified between 
the two cell types despite originating from different species (Ding et al., 2016). 
Considering these data collectively, while OSC differentiation can occur 
spontaneously, it appears to be controlled by extrinsic factors primarily originating 
from the ovarian somatic cell niche. Thus bOSC differentiation was investigated 
using a model which promotes somatic cell interaction. 
The ovarian aggregation model has previously been used in conjunction with a xeno-
transplant model to support follicle development (Eppig and Wigglesworth, 2000). 
The use of this model in vitro described in this thesis, is a novel approach and 
required optimisation to fully explore its potential to support follicle formation and 
growth. Two different culture techniques were explored using a control ovarian 
aggregate (neonatal mouse germ and somatic cells) to assess their viability for this 
process. The use of pre-formed germ cells enabled analysis of the techniques abilities 
to support follicle formation and growth, without concerns regarding oogenesis. 
Three-dimensional organ culture techniques were utilised as these better represent 
the architecture of the tissue (reviewed in Edmondson et al. (2014)).  
Alginate gel matrices have been used to support follicle growth in vitro successfully 
in both individual follicle cultures (Amorim et al., 2009; Camboni et al., 2013; 
Hornick et al., 2013) and whole tissue cultures (Laronda et al., 2014). Pieces of 
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human ovarian cortex have successfully been cultured for 6 weeks in an alginate gel 
and supported the transition of primordial follicles to secondary follicles within 14 
days of culture (Laronda et al., 2014). That study found that there were no obvious 
differences in the extracellular matrices, stroma or follicle morphology of ovarian 
tissue pieces cultured in different concentrations of alginate gel (0.25%, 0.5%, 1% or 
2%). The ovarian aggregates described here were cultured in a 1% alginate gel as it 
has previously been shown that rigid alginate gels (1% or 2%) better supported early 
follicle development (Hornick et al., 2013). We hypothesised that the ovarian 
aggregates would also require a more rigid environment to facilitate establishment of 
tissue structure. In contrast the hanging drop methodology is a scaffold free three-
dimensional culture technique previously used to culture gonadal tissue fragments 
successfully generating metaphase II oocytes from murine secondary follicles (Choi 
et al., 2013) and supporting human spermatogenesis for up to 14 days in culture 
(Jorgensen et al., 2014), as well as being widely used in stem cell culture. Thus both 
the three-dimensional systems investigated here, have previous success at supporting 
germ cell growth and development.  
Ovarian aggregates containing murine germ cells consistently showed formation of 
follicles following 7 days in culture in both systems, illustrating that germ and 
somatic cells can re-establish interactions following disruption in vitro, similar to the 
current and previous xeno-transplant models (Eppig and Wigglesworth, 2000). 
Aggregates also developed a surface epithelium in the culture systems, similar to 
reports in the literature for tissue cut or previously damaged prior to culture (Jackson 
et al., 2009; Laronda et al., 2014). No differences were observed in the distribution of 
follicles or the total number of healthy follicles between culture groups, however 
significantly greater proportions of the initial number of germ cells in the aggregates 
were counted at the end of the 7 day culture in the hanging drop system. These 
results were also comparable with a xeno-transplant model for the same duration. 
Degenerate follicles were observed with an unhealthy oocyte in all groups (alginate, 
hanging drop and xeno-transplant). Enzymatic digestion of neonatal murine ovaries 
was essential to achieve a single cell suspension and to separate fully the somatic and 
germ cell populations. Cellular damage as a result of enzymatic digestion of the 
tissue would therefore be expected. Oocytes are highly susceptible to this damage; 
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isolation of early stage follicles by enzymatic digestion has previously been 
identified to be detrimental to the subsequent success of cultured oocytes compared 
to mechanically isolated follicles (Choi et al., 2013). Thus high levels of poor oocyte 
health and quality observed in these ovarian aggregates are likely to be a 
consequence of the methodology used to separate them from their somatic cells. 
The effect of enzymatic damage to oocytes may be compounded in an aggregation 
model by the length of time taken to re-establish germ and somatic cell interactions, 
such that oocytes which failed to establish communication with somatic cells swiftly 
could not be salvaged. Alternatively, oocytes which suffered the greatest enzymatic 
damage during tissue digestion may have lost the ability to form effective 
interactions with somatic cells, ultimately leading to the death of the oocyte. It is 
unclear which of these possibilities accurately describes the scenario in these 
aggregates, but it is important to note that no ‘loose’ germ cells with no interactions 
with their surrounding somatic cells were observed, thus all oocytes appeared to 
strive to re-establish cell-cell interactions with the somatic niche, some more 
successfully than others. The effect of enzymatic digestion on the somatic cell 
population was not investigated, although analysis of apoptosis in the tissue at earlier 
time points may identify somatic cells affected by the process.  
Histological evaluation of the cultured aggregates showed the development of 
necrotic tissue in the centre of the aggregates. The outer layers of the ovarian 
aggregates are exposed to the medium, allowing for good oxygen, nutrient and 
growth factor supply. In contrast the centre of the aggregate relies upon diffusion of 
these factors through the tissue, thus receiving less, and in addition is exposed to a 
greater concentration of carbon dioxide waste. Necrosis in the centre of the tissue or 
cell aggregate in three-dimensional culture systems is well documented in the 
literature (reviewed by Edmondson et al. (2014)). Active apoptosis was observed 
centrally in the cultured ovarian aggregates, whereas xeno-transplanted aggregates 
showed very little sporadic cleaved caspase 3 staining. Xeno-transplant systems 
reduce the problems described above through the development of vasculature to and 
throughout the transplanted tissue (Edmondson et al., 2014) facilitating nutrient 
supply and waste removal, although establishment of vasculature takes 
approximately 48 hours to establish (Dissen et al., 1994). Smaller aggregate sizes 
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may have reduced the level of necrosis observed and should be investigated further. 
Cell viability in three-dimensional cultures declines after 5 days of culture 
(Edmondson et al., 2014), and it is possible that the systems used here may not be 
appropriate for long term culture, although ovarian cortical fragments have been 
successfully cultured within alginate hydrogels for up to 6 weeks (Laronda et al., 
2014). Apoptosis was significantly lower per section area in aggregates cultured in 
hanging drops compared to those cultured within an alginate gel and apoptosis was 
more widespread in the centre of alginate cultured aggregates. Heise et al. (2005) 
found that a 1% alginate gel hindered the transport of FSH from the medium to 
cultured rat follicles hampering their growth. The same concentration of alginate gel 
was used to culture ovarian aggregates here and may have resulted in poorer 
aggregate quality as a consequence of the failure of nutrients to pass through 
alginate. The hanging drop model allows for direct access of the tissue to the 
surrounding medium and this may have improved the outcome for ovarian 
aggregates cultured in this way. 
The complete separation of germ and somatic cells was essential to produce a pure 
population of somatic cells that could be used to investigate the differentiation 
potential of bOSCs. Separation of oocytes from somatic cells has previously been 
conducted based solely on the adherent characteristics of these two cell types, 
allowing oocytes to be removed from a somatic cell monolayer following culture of 
the cells after disaggregation (Eppig and Wigglesworth, 2000). Somatic cell only 
ovarian aggregates have not been reported in the literature, thus full assessment of 
separation of the two cell types has never been described. Germ cells were only 
consistently removed from the somatic cell population following two filtrations of 
the somatic cells through a 10m filter. It is possible that this technique in the hands 
of others does not require somatic cells to be filtered for complete removal of all 
germ cells. In somatic cell only ovarian aggregates, any oocytes which had not been 
removed by washing or filtration, might have a greater chance of survival due to the 
increased somatic cell to germ cell ration present in these aggregates compared to 
aggregates where oocytes are introduced. Furthermore, xeno-transplanted ovarian 
aggregates have previously been assessed after 21 days, by which time the tissues 
have established a vasculature, which is likely to facilitate the elimination of the 
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large majority of germ cells damaged by the disaggregation process, or those which 
fail to establish the appropriate somatic cell support. Thus any residual germ cells 
within the somatic cell population may be overlooked if they had not persisted 
through the whole process. The identification of germ cells in negative ovarian 
aggregates allowed the development of a more robust methodology to ensure a pure 
population of neonatal somatic cells was used for aggregation with bOSCs to 
generate chimeric ovarian aggregates. 
bOSCs could be clearly identified by rhodamine fluorescence in the chimeric ovarian 
aggregates during culture with live tissue microscopy and also following processing, 
counterstaining with DAPI and visualisation by confocal microscopy. Chimeric 
ovarian aggregates underwent tissue remodelling throughout culture like the negative 
and positive control ovarian aggregates to produce a clear surface epithelium, as 
previously seen with tissue cultured in vitro (Jackson et al., 2009; Laronda et al., 
2014). Most bOSCs remained undifferentiated in the chimeric ovarian aggregates 
and maintained their small size and irregular shapes. Additionally, many bOSCs 
retained their germline phenotype marked by the expression of DAZL. However, not 
all bOSCs were observed to show DAZL expression. One possible explanation for 
this is that bOSCs may have lost expression of DAZL when combined with somatic 
cells, losing their germ cell phenotype. Although this is a possible explanation for the 
absence of the germ cell marker DAZL in some bOSCs, immunocytochemistry of 
bOSCs in culture revealed a heterogeneous pattern of DAZL expression in these cells 
prior to aggregation with neonatal murine somatic cells, thus variation in DAZL 
staining of bOSCs in chimeric ovarian aggregates is likely to be a reflection of the 
heterogeneity within the cell population from isolation.  
As discussed above, the frequency with which oogonial stem cells appear to 
differentiate in vitro is very low in all mammalian species investigated (Bui et al., 
2014; Pacchiarotti et al., 2010; White et al., 2012; Zhou et al., 2014). This novel in 
vitro chimeric ovarian aggregate model revealed a small subpopulation of bOSCs 
which showed characteristics of differentiation comparable to previously 
characterised oocyte-like cells. The bOSCs increased significantly in size, became 
spherical in shape and appeared to show some association with surrounding somatic 
cells. Only 11 of these cells were identified in chimeric ovarian aggregates, 
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representing a very small proportion of all bOSCs aggregated with neonatal somatic 
cells, but all shared these characteristics. Due to the labelling method of the bOSCs, 
identification of them within the tissue was conducted fluorescently, sections were 
also stained with haematoxylin and eosin for histological assessment to identify any 
abnormal structures or points of interest i.e. to identify any oocyte or follicle like 
structures. H&E sections adjacent to differentiated bOSCs identified by rhodamine 
expression showed cells with a larger cytoplasm than other cells which appeared in 
association with the surrounding cells. Further investigation into these differentiated 
bOSCs and the chimeric ovarian aggregates was not possible due to the limited 
number of cells observed, tissue generated and the nature of identifying bOSCs 
within the tissue. Previous investigations into OLCs derived from OSCs have 
identified the expression of oocyte specific markers in combination with meiotic 
markers. Unfortunately, it has not been possible to explore the expression of these 
markers in the differentiated bOSCs, and without this evidence it is not possible to 
say whether these cells have indeed initiated oogenesis within this system despite 
their shared morphological characteristics with oocytes. Thus, extensive 
investigation into the nature of differentiated bOSCs, including assessment of gene 
and protein expression is still necessary.  
The absence of spontaneous bOSCs differentiation in culture suggests that extrinsic 
factors, supplied in this model by the neonatal mouse somatic cells, increased the rate 
of bOSC differentiation. Somatic cell derived extrinsic factors have been shown to 
increase the rate of OSC differentiation previously (Ding et al., 2016; Park et al., 
2013) and co-culture with granulosa cells also increased differentiation of OSCs 
(Ding et al., 2016), furthermore cell-cell interactions between granulosa cells and 
mouse embryonic stem cells are essential in the differentiation of these pluripotent 
cells into oocyte-like cells (Qing et al., 2007), which could not be replicated with 
granulosa cell conditioned media. bOSC differentiation observed within the chimeric 
ovarian aggregates in vitro was limited and the model developed here may not 
perfectly simulate the full requirements for bOSC differentiation, such that very few 
cells were capable of undergoing the process. Significantly more apoptotic cells were 
identified in chimeric ovarian aggregates than in positive control ovarian aggregates. 
Suggesting that the system previously developed using ovarian aggregates containing 
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mouse oocytes may be less efficient at supporting the development of the chimeric 
aggregates. The model developed could support the establishment of interactions 
between oocytes but may not be suited to support the differentiation of OSCs. 
Research into mammalian OSCs has been limited, therefore the requirements of OSC 
differentiation are poorly understood. To utilise an in vitro aggregation model a 
multi-step approach may be more suitable 
The low incidence of bOSC differentiation may also result from the heterogeneity 
observed in the cultured cell population, such that some cells possess the potential to 
differentiate more than others given their expression profiles. Single cell RT-PCR 
would reveal the extent of cellular heterogeneity in isolated and cultured populations 
of oogonial stem cells and shed light on the distinct gene pattern of the cell type, thus 
should be considered as a tool in future investigations into these cells.  
The process of generating oocytes in vivo is a complicated process and has only 
recently been recapitulated in vitro in full, from bi-potential primordial germ cells to 
functional metaphase II oocytes capable of fertilisation and full embryonic 
development following embryo transfer to a psuedopregnant foster mother 
(Morohaku et al., 2016). The development of an in vitro system to fully support this 
entire process has revealed the essential role of somatic cells at all stages of germ cell 
development. The differentiation of pluripotent stem cells such as embryonic stem 
cells (ESCs) and induced pluripotent stem cells (iPSCs) into oocytes has thus far 
only been achieved when combined with ovarian somatic cells (Eguizabal et al., 
2009; Hayashi et al., 2012; Qing et al., 2007), and cell-cell interactions appear 
essential for this process (Qing et al., 2007). The use of neonatal murine somatic 
cells to provide an ovarian niche for bovine oogonial stem cells was a novel 
approach to investigate their potential to differentiate into oocytes. It is unclear 
whether the tools of communication between germ and somatic cells is evolutionarily 
conserved between species, thus murine somatic cells may not fully support the 
development and differentiation of bOSCs. However, there is evidence to suggest 
conservation between species allowing for communication between somatic and 
germ cells of different species. Eppig and Wigglesworth (2000) showed that mouse 
oocytes could undergo full maturation and development supported entirely by rat 
somatic cells in a xeno-transplant model. Electron micrographs of these chimeric 
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follicles also showed cytoplasmic processes from rat cumulus granulosa cells 
traversing the mouse zona pellucida, to allow communication between the cell types. 
Furthermore, mouse granulosa cells co-cultured with human OSCs increased the rate 
of differentiation to OLCs and also generated projections towards the OSC derived 
OLCs culminating in gap junctions (Ding et al., 2016). This evidence suggests 
methods of communication between germ cells and somatic cells are conserved 
between species sufficiently to support interaction between the two cell types and 
may allow for somatic cell support of an oocyte originating from a different species 
and illustrated the potential of somatic cells to increase the rate of OSC 
differentiation to OLCs in a different species. Mouse somatic cells similarly 
increased the differentiation of bOSCs in the chimeric ovarian aggregation model. 
Differentiated bOSCs were observed in association with rhodamine negative somatic 
cells, further indicating that mouse neonatal somatic cells have interacted with 
bOSCs within the chimeric ovarian aggregation model. Although this model has not 
robustly recapitulated OSC differentiation, the data presented here demonstrates the 
potential of this model, which with further refinement could provide the support for 
full differentiation and subsequent development of any resulting oocyte-like cells and 
also allow for greater investigation of the mechanisms responsible for this process 
which cannot be elucidated using an in vivo xeno-transplant model. This model also 
offers potential to investigate OSCs in species where a lack of same species somatic 
cells is a methodological hindrance. 
Due to the novel use of this methodology in vitro and its development there are 
several limitations to its use. A short time point was utilised to ensure survival of the 
tissue could be established (Edmondson et al., 2014). Longer culture periods may 
have revealed further development of reformed follicles within positive control 
ovarian aggregates and also further differentiation of bOSCs. The 7 day culture of 
the ovarian aggregates revealed some central apoptosis within the aggregates. The 
use of smaller aggregates may reduce this problem in the future and allow for 
successful healthy development of the tissue for longer term culture. A basic medium 
with minimal supplements was utilised to investigate the ability of follicles to form 
and grow following aggregation of the germ and somatic cells of neonatal murine 
ovaries. The data presented here shows that this medium supported the reformation 
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of follicles when somatic cells and oocytes were combined and also supported the 
differentiation of a subpopulation of bOSCs. However, the requirements for OSC 
differentiation and establishment of communication between oocytes and somatic 
cells are likely to be dissimilar thus use of different media may have supported these 
two different processes better. Furthermore, to develop follicles to advanced pre-
ovulatory stages in vitro (Eppig and O'Brien, 1996; Eppig and Schroeder, 1989; 
McLaughlin and Telfer, 2010; Morohaku et al., 2016; Spears et al., 1994; Telfer et 
al., 2008), follicles need to be cultured individually, to remove any presumed 
inhibitory factors in the ovarian microenvironment, and this has generated oocytes 
capable of fertilisation in murine models. Supplements, including FSH and Activin A 
are also required to support follicular development (McLaughlin and Telfer, 2010; 
Telfer et al., 2008), thus alternative media should be investigated for longer term use 
of this methodology to be able to support full OSC differentiation and subsequent 
follicle growth in vitro. 
Unfortunately, due to time restraints within this project it was not possible to fully 
develop this in vitro ovarian aggregation model or investigate its full potential to 
support bOSC differentiation. Given recent developments in the field, recapitulating 
the full process of oogenesis from murine primordial germ cells in vitro, it is likely 
that a multistep approach, with alterations in media content, would be required to 
induce OSC differentiation and nurture any resulting oocyte-like and follicle-like 
structures to maturity.  
To date, functional oocytes capable of fertilisation and production of viable offspring 
in rodents, derived from pluripotent cells including ESCs, iPSCs and OSCs have 
only been generated with the use of xeno-transplant models (Hayashi et al., 2012; 
White et al., 2012; Zhou et al., 2014; Zou et al., 2009). This reflects a lack of 
understanding of the intricacies and complexities of oogenesis to be able to replicate 
the process in its entirety from pluripotent stem cell to oocyte in vitro. The use of an 
in vivo model may eliminate many of the limitations of the chimeric ovarian 
aggregate model detailed here to fully investigate the potential of bOSCs to undergo 
oogenesis. 
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The data presented here show that murine oocytes can reform follicles with ovarian 
somatic cells during an in vitro culture following aggregation. Furthermore, ovarian 
aggregates were healthier when cultured within a hanging drop suspension. Robust 
measures must be taken to ensure complete separation of oocytes from somatic cells 
following ovarian disaggregation. The use of this chimeric ovarian aggregate gave an 
innovative insight into the differentiation potential of bOSCs and provided novel 
evidence for the use of a chimeric ovarian aggregation system to investigate the 
potential of oogonial stem cells, although further development of this model is 
necessary. 
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5  Use of a xeno-transplant model to investigate the oogenic 
potential of bOSCs in vivo 
5.1 Introduction 
The previous chapter reported data demonstrating the potential of putative bovine 
oogonial stem cells to undergo differentiation in vitro within a chimeric ovarian 
aggregation model. As chimeric ovarian aggregates have previously generated 
functional rodent oocytes following a 21 day xeno-transplant to the kidney capsule of 
immune deficient mice (Eppig and Wigglesworth, 2000), that approach seemed 
likely to have value in the exploration of the oogenic potential of bOSCs.  
Until recently support of full germ cell differentiation from primordial germ cells to 
functional mature oocytes could not be recapitulated in vitro without a period in vivo 
(Morohaku et al., 2016). Thus, transplantation models have been utilised to further 
our understanding of oogenesis and folliculogenesis. Transplantation of reconstituted 
fetal ovaries to the kidney capsule of recipient mice have produced oocytes capable 
of fertilisation and generation of offspring following in vitro maturation (Hashimoto 
et al., 1992; Matoba and Ogura, 2011; Qing et al., 2008). Additionally, functional 
oocytes derived from mouse embryonic stem cells and induced pluripotent stem cells 
have been made following transplantation of ovarian aggregates containing 
primordial germ cell-like-cells derived from the precursor cells to recipients 
(Hayashi et al., 2012). Similar results have been observed with mouse skin cells 
(Dyce et al., 2011). 
To date successful oogenesis from oogonial stem cells in rodent species has also 
utilised in vivo models. Injection of fluorescently labelled OSCs into intact of follicle 
depleted ovaries in both mice and rats has generated oocytes capable of successful 
fertilisation, subsequent embryonic development (White et al., 2012) and produced 
healthy offspring (Zhou et al., 2014; Zou et al., 2009).  
The development of immune deficient rodents has allowed the investigation of 
oogenesis and folliculogenesis in different species, such that ovarian tissue several 
species, including bovine, has been successfully transplanted to the kidney capsule of 
immune deficient mice. Bovine follicles have been successfully retrieved following 
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ovarian tissue transplantation and have been shown to support oocyte development 
capable of fertilisation and early embryonic development up to blastocyst stages 
(Campos-Junior et al., 2016; Senbon et al., 2005). Despite species differences, the 
recipient’s hormone environment appears to support ovarian functions and follicular 
development. Re-vascularisation of ovarian grafts is estimated to occur within 48 
hours (Dissen et al., 1994), establishing a nutrient supply and waste disposal system, 
negating many of the limitations associated with long term tissue culture (Aubard, 
2003; Edmondson et al., 2014; Gook et al., 2001). Bilaterally ovariectomised rodents 
are typically used as recipients of xeno-transplants, however orchidectomised male 
mice have also been utilised as recipients. Juvenile and adult bovine ovarian tissues 
transplanted to the kidney capsule of male immune-deficient mice were observed to 
undergo successful follicular development (Hernandez-Fonseca et al., 2005) despite 
gender differences, suggesting that the GnRH/pituitary/gonadal feedback loop in 
rodents can support bovine follicular development in spite of species and gender 
differences. Elevated circulating levels of gonadotropins in these models is believed 
to be beneficial for follicular development (reviewed by Paris et al. (2004)) however 
the optimal hormonal profile of recipient individuals may be species specific and/or 
related to the age of the donor tissue as conflicting evidence has been reported.  
To further investigate the potential of bOSCs and try to better understand this 
process, an in vivo xeno-transplant model using the chimeric ovarian aggregate 
model was utilised. 
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5.2 Materials and Methods 
Ovarian aggregation model 
Somatic cells from neonatal murine ovaries (freshly separated and cultured) were 
used to provide an ovarian niche for bOSCs. Negative (murine ovarian somatic cells 
only) and positive (murine germ and murine somatic cells) controls were also 
generated for comparison. 
These experiments were initially conducted at the University of Oxford with the 
assistance of Anna Deleva and Sairah Sheikh who demonstrated the generation of 
ovarian aggregates and carried out the xeno-transplant surgeries, subsequently all 
experiments were carried out by Kelsey Grieve at the University of Edinburgh. RNA 
Scope analysis was carried out by Aquila HistoPlex, University of Edinburgh, all 
other analyses were carried out by Kelsey Grieve. 
Bovine oogonial stem cells 
bOSCs were FACS isolated (section 2.2) from adult bovine ovaries collected from 
the local abattoir (section 2.1). Following isolation bOSCs were either cryopreserved 
for future use (section 2.6.1.3) or cultured (section 2.6.1.1) in OSC media (section 
2.12). Cultured cells were also cryopreserved and stored long term in liquid nitrogen 
(section 2.6.1.3) until required. 
bOSCs were fluorescently labelled with Rhodamine Dextrans (section 2.6.2.3) prior 
to aggregation with somatic cells.  
To store bOSCs long term and for transport, cells were cryopreserved as described in 
section 2.6.1.3. 
Disaggregation of neonatal ovaries 
Ovaries were collected from neonatal (postnatal day 0-5) female mice (CD-1, 
B6SJLF1 or B6;129-Gt(ROSA)26) following cervical dislocation and placed in pre-
warmed PBS supplemented with 1mg/ml BSA then removed from their bursa. 
Ovaries were disaggregated (described in section 2.5.1) with pre-warmed 
trypsin/EDTA/DNAse and gentle agitation over a 25 minute period. The enzymatic 
digestion was neutralised with equal volumes with sterile supplemented M199 media 
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(see section 2.12) and the cell suspension centrifuged at 450 RCF for 5minutes. The 
cell pellet was then re-suspended in sterile supplemented M199 media (section 2.12) 
and placed into 35mm culture dishes for culture overnight 37oC with humidified air 
and 5% CO2.  
Separation of germ and somatic cells 
Germ and somatic cells from neonatal mice were separated based on cell adhesion 
characteristics as previously described (section 2.5.2), such that floating germ cells 
could be aspirated off the somatic cell monolayer. Somatic cells were then washed 
with pre-warmed PBS supplemented with 1mg/ml BSA, twice then lifted from the 
culture plate with 2ml of pre-warmed trypsin/EDTA/DNAse. The enzymes were 
neutralized with equal volumes of M199 with supplements and the somatic cell 
suspension was either filtered (size 30m, 20m or 10m) or not filtered then 
centrifuged at 450 RCF for 5minutes. The supernatant was then discarded and cells 
were re-suspended in M199 media with supplements, placed in a new culture dish 
and returned to 37oC, with humidified air and 5% CO2 for 5-6 hours.  
Following a second incubation, the murine neonatal ovarian somatic cells were 
washed with 2 ml pre-warmed PBS, twice, lifted from the culture plate a 2nd time 
with pre-warmed trypsin/EDTA/DNAse, which was then neutralized with equal 
volumes of M199 with supplements and the somatic cell suspension was either 
filtered (size 30m, 20m or 10m) or not filtered then centrifuged at 450 RCFfor 
5minutes. The supernatant was then discarded and cells re-suspended in an 
appropriate volume of Waymouths media with supplements (section 2.12) for cell 
counting, prior to aggregation. 
Some populations of neonatal murine somatic cells were cultured longer term 
(section 2.5.3). Briefly, once separated from germ cells somatic cells were cultured 
in ovarian fetal somatic cell medium (section 2.12) and passaged using Trypsin 
(0.05%) with EDTA (Life Technologies), when confluent. Cells were also 
cryopreserved (section 2.6.1.3) if necessary.  
Aggregation of ovarian cells 
Use of a xeno-transplant model to investigate the oogenic potential of bOSCs in vivo 
144 
 
All cell populations used for aggregations (murine neonatal somatic cells, murine 
neonatal germ cells and bOSCs) were centrifuged at 450 RCF for 5 minutes and re-
suspended in an appropriate volume of Waymouths media with supplements (section 
2.12) for counting. Cell populations were manually counted using a haemocytometer. 
Freshly isolated bOSCs were also assessed using trypan blue for cell viability once 
thawed. Cells were then combined and placed into 0.5ml eppendorfs with 35g 
Phytohaemagluttanin (PHA) at the desired ratio/concentration to create different 
aggregates (Figure 2.4). Cells were mixed by brief vortex and centrifuged in a 
microcentrifuge at 11,200 RCF for 30 seconds, the 0.5ml eppendorfs were then 
rotated 180o and cells were centrifuged at 11,200 RCF for 30 seconds a second time. 
Cell pellets (aggregates) were then transferred with 30l of Waymouths media with 
supplements to a hanging drop culture overnight at 37oC with humidified air and 5% 
CO2 to encourage cell interaction and adhesion.   
Positive control ovarian aggregate 
Positive control aggregates recombined neonatal murine somatic cell and germ cell 
populations at varying ratios (Figure 2.4). Positive control aggregates were then 
xeno-transplanted as described in section 2.7.1. 
Negative control ovarian aggregate 
To investigate the quality of the separation technique, negative control aggregates 
were generated, aggregating together mouse neonatal ovarian somatic cells only 
(Figure 2.4). Negative control aggregates were generated alongside every chimeric 
aggregate. Negative control aggregates were then xeno-transplanted as described in 
section 2.7.1. 
Chimeric ovarian aggregate 
Rhodamine dextran labelled cultured bOSCs were aggregated together with neonatal 
mouse ovarian somatic cells at a ratio of 1:10 respectively (Figure 2.4). Chimeric 
aggregates were then xeno-transplanted as described in section 2.7.1. 
Xeno-transplant of ovarian aggregates 
Ovarian aggregates, following an overnight hanging drop culture in supplemented 
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Waymouths media (section 2.12) were xeno-transplanted to the kidney capsule of 
SCID (C.B.17/IcrHan Hsd-Prkdc) mice for 21 days for comparison with the in vitro 
culture models.   
All animal experiments were conducted under a UK Home Office licence in line with 
the Animals Scientific Procedure Act (1986). SCID Mice were housed as described 
in section 2.7 and obtained from Envigo laboratories and provided a minimum of 6 
days to acclimatise to their new environment prior to the start of any experimental 
work.  
Briefly, SCID mice were anaesthetised with isoflourane (section 2.7.1), shaved and 
skin sterilised. Subcutaneous injection of saline around the hind leg and a 
subcutaneous injection of vetergesic (at a dose of 0.03mg/ml in 100l) around the 
neck were given. A vertical incision along the skin was made in the middle of the 
back, followed by a small incision in the body wall directly above the ovary, 
allowing the ovary and ovarian fat pad to be removed from the body cavity, and the 
ovary to be excised. Using the ovarian fat pad as a guide the kidney was pulled out of 
the body cavity with forceps. Sterile PBS kept the kidney hydrated and a tiny 
incision was made in the kidney capsule with a sterile needle. Using a pulled glass 
pipette, aggregates were transferred through the hole in the capsule to the surface of 
the kidney and moved from the incision site to ensure their security. 1, 2 or 4 ovarian 
aggregates were transplanted to recipient mice, all ovarian aggregates transplanted to 
any individual recipient were of the same description. The kidney and associated 
tissue was then returned to the body cavity, and the body wall sutured using number 
5 sutures. The ovary was then removed on the other side following the same protocol 
and the skin incision closed using wound clips. Mice were then transferred to 
individual cages which were maintained at 30oC while they recovered and then 
housed as described in section 2.7 for 21 days until tissue collection.  
21 days after xeno-transplantation, mice were culled by lethal exposure to CO2 or 
cervical dislocation of the neck and tissues were collected and fixed as described 
below. 
Histological Techniques 
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Ovarian aggregate tissue was fixed in natural buffered formalin (NBF) for 6 hours, 
then transferred to 70% ethanol and embedded in wax using an automated Leica 
TP1050 processor. Tissue was sectioned at 5M and mounted onto electrostatically 
charged glass slides and maintained at 50oC overnight in a slide oven to ensure tissue 
adherence to the slide surface.  
Haematoxylin and eosin staining 
Every third section of each ovarian aggregate was stained with haematoxylin and 
eosin for histological evaluation to detect the presence of oocytes and follicles. Slides 
were de-waxed and rehydrated (section 2.8.3) and washed briefly in running tap 
water, then stained with haematoxylin and eosin (section 2.8.4) before dehydration 
and mounting (section 2.8.5).  
Immunofluorescence 
To assess tissue antigens, slides were dewaxed and rehydrated (section 2.8.3) prior to 
antigen retrieval (section 2.8.6). Slides were then washed and cooled in water 3 
times. Non-specific binding of antibodies was prevented by using a peroxidase block 
followed by a serum block (section 2.8.6.1). Slides were then exposed to the primary 
antibody (listed in Table 5.1) diluted in NS/PBS/BSA and incubated overnight at 
4oC. Negative controls (primary antibody omitted) were always used and positive 
controls were used where applicable and appropriate. 
Table 5.1: Primary antibodies used in Immunofluorescence in Chapter 5 
Antibody Dilution Species Supplier 
-Galactosidase 1:800 Mouse Promega 
 
Primary antibodies were washed off with PBS for 5minutes, twice, and the 
appropriate secondary antibodies (listed in Table 5.2) were diluted 1:200 in blocking 
serum (NS/PBS/BSA) and applied to slides for 30minutes at room temperature in a 
humidity chamber.  
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Table 5.2: Secondary antibodies used in Immunofluorescence in Chapter 5 
Antibody Supplier 
Chicken anti Mouse Santa Cruz 
 
Slides were then washed twice with PBS and incubated in tyramide in accordance 
with the manufacturer’s instructions, for 10 minutes. Slides were then washed in PBS 
to remove the tyramide, in an opaque chamber to prevent bleaching of the 
fluorescence before DAPI counterstaining and mounting (section 2.8.6.5). Slides 
were then stored in the dark at 4oC until visualisation (section 2.9.4). 
RNA Scope 
RNA Scope analysis was carried out by Aquila HistoPlex, University of Edinburgh. 
Briefly, tissue sections were dewaxed and rehydrated (section 2.8.3) and allowed to 
air dry for 5 minutes at room temperature. Tissues were then treated with hydrogen 
peroxidase block for 10 minutes at room temperature and washed in deionised water. 
Target RNA’s were then retrieved by exposure of slides to changes in pH (retrieval 
buffer, used according to manufacturer’s instructions Advanced Cell Diagnostics) 
and high temperatures (100oC) for 8minutes. Tissue was permeabilised using 
protease digestion (Protease Plus, Advanced Cell Diagnostics) at 40oC for 15 
minutes. Slides were then washed in deionised water and incubated with pre-warmed 
(40oC) probe (Bt-ATP5b or Mm-UBC) for 30 minutes at 40oC, then washed with 
buffer for 2 minutes at room temperature. The signal was then amplified using 
amplification solutions (Advanced Cell Diagnostics); amplification solution 1 was 
applied for 30 minutes at 40oC, amplification solution 2 for 15 minutes at 40oC, 
amplification solution 3 for 30 minutes at 40oC, amplification solution 4 for 15 
minutes at 40oC, amplification solution 5 for 30 minutes at room temperature and 
amplification solution 6 for 15 minutes at room temperature. Slides were washed 
between each amplification with wash buffer twice for 2 minutes at room 
temperature. DAB was then applied to slides at room temperature for 10 minutes, to 
detect the signal. Slides were then washed in deionised water and tissue 
counterstained with Harris haematoxylin for two minutes followed by acid alcohol 
for 5 seconds, and Scott’s tap water for 10 seconds. Slides were then dehydrated and 
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mounted (section 2.8.5). All reagents were sourced from Advanced Cell Diagnostics 
by Aquila HistoPlex, University of Edinburgh. 
 Microscopy 
Tissue histology was imaged with a Provis AX70 (Olympus) or a Zeiss Imager Z1 
both fitted with a AxioCam HRc camera (Zeiss) using Zeiss software. Whole tissue 
images were captured using a Leica MZF III with a RS Photometrics camera. 
Sections were visualised using a Zeiss LSM 780 confocal microscope using Zeiss 
software. 
All scale bars were generated and embedded in image files using Zeiss software. 
Tissue analysis 
Every third section of all xeno-grafted ovarian aggregates were stained with either X-
Gal and eosin staining or haematoxylin and eosin staining, and visualised and 
assessed for the presence of follicles in the tissue.  
Oocytes were counted when the nucleolus was present and follicles classified based 
on their stage (primordial, a single layer of flattened granulosa cells; transitory, a 
mixture of flattened and cuboidal granulosa cells; primary, a single layer of cuboidal 
granulosa cells). Follicles and oocytes were also measured when the nucleolus was 
present, if this was not possible the section with the largest oocyte size was used. 
ImageJ software was used to take oocyte and follicle measurements following image 
scale calibration. Two perpendicular measurements were taken for oocyte and 
follicle size at the widest point, the average of was used. 
Total tissue volumes analysed histologically was estimated using the sum of areas for 
all sections analysed (measured using ImageJ software) multiplied by the section 
depth (5m). 
Statistical Analysis 
Statistical analysis was conducted using Graphpad Prism 6 software. One-way 
ANOVA analysis with post-hoc Tukeys multiple comparisons testing was used to 
compare oocyte sizes between ovarian aggregate groups where three or more groups 
were compared. Data are presented as Mean  SEM throughout. 




5.3.1 Chimeric ovarian aggregates generate follicles following 
xeno-transplantation 
Table 5.3 summarises the total number of chimeric, negative control and positive 
control ovarian aggregates generated, xeno-grafted and successfully retrieved from 
immune deficient recipient mice after 21 days. Positive control ovarian aggregates 
demonstrated the highest retrieval rates (100%) and negative control and chimeric 
ovarian aggregates showed lower retrieval rates (81% and 75%, respectively).  
Table 5.3: Tabular summary of all ovarian aggregates generated, xeno-grafted and successfully 
retrieved following 21 days. 
Ovarian Aggregates Xeno-grafted Retrieved Retrieval Rate 
Chimeric 48 36 75% 
Negative control 42 34 81% 
Positive control 21 21 100% 
 
Three chimeric ovarian aggregates showed the presence of growing, multi-laminar 
follicles upon macroscopic visualisation at the time of retrieval (Figure 5.1. A, C & 
E), however growing follicles were not detected in the other chimeric ovarian 
aggregates (n=32; Figure 5.1.G, I & K). Histological analysis was carried out on 30 
chimeric ovarian aggregates (estimated total tissue volume of 124.3x106 m3), 3 of 
which appeared to contain growing follicles at retrieval. All chimeric ovarian 
aggregates retrieved showed good overall tissue health, developed vasculature and 
few pyknotic cells observed.  
Histology confirmed a total of 9 follicles in the 3 ovarian aggregates identified as 
containing growing follicles by macroscopic visualisation (Figure 5.1.B, D & F). 
Follicles observed within chimeric ovarian aggregates showed healthy morphology 
with round oocytes containing a single nuclei, with even cytoplasmic eosin staining 
and no pyknotic granulosa cells. Eight of these follicles were multi-laminar, 
containing more than 1 layer of cuboidal granulosa cells and 1 contained a single 
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layer of cuboidal granulosa cells, illustrating that these follicles had successfully 
initiated growth in this system. 
Histology was conducted on 27 chimeric ovarian aggregates which did not appear to 
contain growing follicles upon retrieval and confirmed the absence of multi-laminar 
follicles by H&E staining (Figure 5.1.H, J & K). However, several of these 
aggregates (n=11) contained small structures formed by groups of cells. These 
structures showed interactions between a central larger cell and surrounding cells 
forming a spherical shape. These structures share similarities with primordial 
follicles (Figure 5.1.H & J) and may represent precursors to primordial follicles in 
this system, thus have been termed pre-primordial follicle-like structures. A total of 
16 pre-primordial follicle-like structures were identified in all chimeric ovarian 
aggregates and may indicate the initial formation of oocyte-like cells within this 
model. No distinguishable structures could be identified by histological analysis of 
any of the other chimeric ovarian aggregates (n=16, Figure 5.2), in these tissues cells 
shared similar morphology (Figure 5.1.L). Thus, growing follicles were identified in 
10% of chimeric ovarian aggregates and pre-primordial follicle-like structures in 
36.6% (Figure 5.2) of analysed chimeric ovarian aggregates. 
A further 12 chimeric ovarian aggregates were also generated using cultured neonatal 
murine ovarian somatic cells and successfully retrieved from recipient mice. 
Histological analysis showed that these aggregates did not contain multi-laminar 
follicles or pre-primordial follicle-like structures (Figure 5.3).  
For each experimental chimeric ovarian aggregate a complimentary negative control 
ovarian aggregate was generated consisting only of the same ovarian somatic cell 
population. None of the corresponding negative controls contained oocytes or 
follicles, confirmed by histological assessment of the tissue (see Section 5.3.4, Figure 
5.9).  
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Figure 5.1: Chimeric ovarian aggregates generate follicles following xenotransplantation. 48 
chimeric ovarian aggregates were xeno-grafted for 21 days, and 36 were successfully retrieved. 
Tissues were visualised upon collection (A, D, G, J, M and P), 3 chimeric ovarian aggregates 
appeared to contain follicles (A, D and G), confirmed by histological analysis and indicated by 
arrowheads (B, C, E, F, H and I). 32 Chimeric ovarian aggregates did not appear to contain follicles 
macroscopically (J, M and P), histological analysis did not show oocytes or follicles (K, L, N, O, Q 
and R), however structures were observed showing interaction between morphologically different cell 
types with a central cell and adjacent surrounding cells forming a follicle-like structure, indicated by 
asterisks. Unfixed tissue was imaged at x2.5 magnification and scale bars represent 1mm. H&E tissue 
sections were imaged at x10 magnification (scale bars represent 200μm) and x20 magnification (scale 
bars represent 100μm).  
 
Figure 5.2: Distribution of chimeric ovarian aggregates based on structures identified within 
aggregates, represented by proportion of total ovarian aggregates analysed. Of 48 chimeric 
ovarian aggregates transplanted, 12 were not retrieved and 36 were successfully retrieved following 
21 days. Haematoxylin and eosin staining was conducted on 30 retrieved chimeric ovarian aggregates. 
Three types of ovarian aggregates were identified based on structures observed within the aggregates 
(A). Multi-laminar follicles (B) with oocytes surrounded by more than 1 layer of cuboidal granulosa 
cells were identified in 10% (n=3) of chimeric ovarian aggregates analysed. Pre-primordial follicle-
like structures (C), with a larger spherical-like central cell associated with adjacent cells to form a 
spherical-like structure with morphological similarities to primordial follicles and were found in 
36.6% (n=11) of chimeric ovarian aggregates. All other chimeric ovarian aggregates (53.3%; n=16) 
did not contain multi-laminar follicles or pre-primordial follicle-like structures and have been 
described as having ‘no structures’ (D). Tissue sections were imaged at x20 magnification and scale 
bars represent 50m. 




Figure 5.3: Cultured neonatal somatic cells do not support follicle formation in xeno-
transplanted chimeric ovarian aggregates. Somatic cells isolated from neonatal cd-1 mice were 
cultured then aggregated with bovine oogonial stem cells to from chimeric ovarian aggregates (n=12). 
Ovarian aggregates were transplanted to the kidney capsule of immune-deficient mice for 21 days. All 
chimeric ovarian aggregates were collected (example aggregates shown in A and C). Histological 
analysis showed that no follicles had been generated in chimeric ovarian aggregates with cultured 
neonatal mouse ovarian somatic cells with (B and D). Unfixed tissue was imaged at x2.5 
magnification and scale bars represent 1mm. H&E tissue sections were imaged at x20 magnification 
and scale bars represent 100μm.  
  
Use of a xeno-transplant model to investigate the oogenic potential of bOSCs in vivo 
154 
 
5.3.2 Oocytes in chimeric ovarian aggregates are significantly 
larger than oocytes in positive control ovarian aggregates  
A total of 9 oocytes encapsulated within well organised somatic cells forming 
follicles were identified in chimeric ovarian aggregates. These follicles ranged in 
developmental stage from transitory (n=1; oocyte with flattened and cuboidal 
granulosa cells), pre-antral (n=6; oocyte in multi-laminar follicle without an antral 
cavity) and incipient antral (n=2, multi-laminar follicle with initial separation of 
granulosa cells to form antral cavities). No large antral follicles were observed in 
chimeric ovarian aggregates. 
Oocytes within pre-antral follicles in chimeric ovarian aggregates (n=6; 60.93.6m) 
were significantly larger (P<0.0001) than murine oocytes in positive control ovarian 
aggregates (n=38; 34.51m; Figure 5.4.E). Endogenous pre-antral oocytes from 
murine (n=14; 44.53.3m) and bovine (n=6; 67.97.8m) adult ovarian tissues 
were also measured as controls. Bovine oocytes were significantly (P<0.0001) larger 
than their murine counterparts. Oocytes in chimeric ovarian aggregates were also 
significantly (P<0.01) larger than native murine pre-antral oocytes, but were not 
different in size to native bovine pre-antral oocytes.  
These data also revealed that murine oocytes within positive ovarian aggregates were 
significantly (P<0.01; Figure 5.4.E) smaller in size than native murine oocytes within 
pre-antral follicles in adult ovarian tissue. All oocytes observed in positive control 
ovarian aggregates were observed within a follicle structure suggesting successful re-
establishment of cell-cell interactions between oocytes and somatic cells. 
Furthermore, follicles demonstrated extensive development with no non-growing 
follicles observed and many follicles containing developed antral cavities (Figure 
5.4.A). Differences between oocytes from positive control ovarian aggregates and 
native oocytes suggests that the ovarian aggregate xeno-transplant model does not 
directly replicate in situ follicle growth. This may indicate that cell-cell interactions 
between oocytes and somatic cells are insufficiently established to support 
coordinated oocyte and follicle growth in positive control ovarian aggregates. 




Figure 5.4: Oocyte Sizes in pre-antral follicles of chimeric and positive ovarian aggregates 
compared to control murine and bovine adult ovarian tissue. H&E sections of positive ovarian 
aggregates (A), chimeric ovarian aggregate (B), adult mouse ovary (C) and adult bovine ovary (D). 
Oocyte sizes within pre-antral follicles were measured and compared between groups by One-Way 
ANOVA with Tukeys Post Hoc testing for multiple comparisons (E; mean  SEM). Oocytes with in 
chimeric ovarian aggregates (n=6; 60.93.6m) were significantly (P<0.0001) larger than positive 
control ovarian aggregates (n=38; 32.91m) and endogenous murine pre-antral oocytes (n=14; 
42.83m) but not significantly different from endogenous bovine pre-antral oocytes (n=6; 
65.96.8m). Native murine oocytes were significantly larger than oocytes in positive control ovarian 
aggregates (P<0.01) and bovine oocytes significantly (P<0.0001) larger than murine counterparts 
endogenously and wihin ovarian aggregates. Tissue sections were imaged at x10 magnification and 
scale bars represent 200μm. Different letters denote significant difference between variables, no 
statistical difference was observed between variables with the same letter. 
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Oocyte sizes were compared to pre-antral follicle sizes to investigate whether 
oocytes were disproportionate in size to their follicle (Figure 5.5). Pearson’s 
correlational analyses showed significant correlation between oocyte and follicle size 
in positive control ovarian aggregates (r2=0.14, p=0.02), chimeric ovarian aggregates 
(r2=0.69, p=0.04) and mouse (r2=0.66, p=0.0004) and bovine adult ovarian tissue 
(r2=0.98, p=0.0001). Thus, ovarian aggregates, both chimeric and positive controls, 
showed oocyte growth associated with follicle growth. 
 
Figure 5.5: Pre-antral oocyte and follicle sizes of ovarian aggregates and control ovarian tissues. 
Pearson’s correlation analyses revealed that oocyte size was correlated to follicle size within each 
experimental group (Positive control ovarian aggregate, n=38, r2=0.14, p=0.02; Chimeric ovarian 
aggregate, n=6, r2=0.68, p=0.04; Mouse adult ovarian tissue, n=14, r2=0.66, p=0.0004 and Bovine 
adult ovarian tissue, n=6, r2=0.98, p=0.0001). 
Two incipient antral follicles were observed within chimeric ovarian aggregates. 
These follicles demonstrated very early antral cavity development, with the initial 
separation of granulosa cells within the follicle structure (Figure 5.4.B). These 
follicles contained several layers of granulosa cells (>5). Pre-antral follicles within 
chimeric ovarian aggregates also contained many layers of granulosa cells without 
evidence of antral cavity formation. In contrast, positive control ovarian aggregates 
showed antral cavity formation in follicles with fewer layers of granulosa cells (>2; 
Figure 5.4.A). Differences in antral cavity formation and the number of granulosa 
cell layers between positive control and chimeric ovarian aggregates could not be 
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statistically analysed due to low follicle numbers in chimeric ovarian aggregates, 
however, these observations suggest differences in follicle growth dynamics between 
follicles within chimeric bOSC ovarian aggregates and positive control ovarian 
aggregates.  
Follicles in adult murine ovarian tissue showed antral development in follicles with 
significantly more granulosa cell layers (5.7 ± 0.5 cell layers; P<0.0001, Figure 5.6) 
than follicles in positive control ovarian aggregates (2.9 ± 0.2 cell layers). This 
suggests that follicles in positive control ovarian aggregates are undergoing altered 
follicle development compared to in situ control follicles. 
 
 
Figure 5.6: Number of granulosa cell layers in murine incipient antral follicles of positive 
control ovarian aggregates and adult ovarian tissue. The number of granulosa cell layers was 
counted in follicles with early antral development and compared by Student’s t-test. Significantly 
more layers of granulosa cells were observed in early antral follicles with initial cavity formation in 
adult mouse ovarian tissue (5.7 ± 0.5 cell layers, mean ± SEM) than follicles in positive control 
ovarian aggregates (2.9 ± 0.2 cell layers, mean ± SEM). **** P<0.0001. 
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5.3.3 Chimeric ovarian aggregates containing freshly isolated 
bOSCs form pre-primordial follicle-like structures in vivo 
The oogenic potential of bOSCs was also investigated by using freshly isolated cells. 
FACS isolated bOSCs were immediately frozen and thawed just prior to aggregation 
with somatic cells. bOSCs were counted prior to aggregation and cell viability was 
55%, using trypan blue as a marker of dead cells. Thus, almost half of freshly 
isolated bOSCs did not maintain membrane integrity when frozen and thawed, in 
contrast, bOSCs previously established in culture demonstrated 90% cell viability 
following freeze/thaw. This suggests the combined effect of isolation and 
cryopreservation was detrimental to cell integrity and health of bOSCs.  
Four chimeric ovarian aggregates containing uncultured bOSCs were generated and 
successfully retrieved following xeno-transplantation. Histological analysis of 3 
ovarian aggregates was conducted. Overall tissue health was good and very few 
pyknotic cells were observed, suggesting that the aggregates had established a good 
nutrient and waste disposal supply through host vasculature. However, chimeric 
ovarian aggregates containing uncultured bOSCs did not contain oocytes or follicles 
when analysed histologically (Figure 5.7). On further inspection, aggregates 
appeared morphologically similar to chimeric ovarian aggregates containing cultured 
bOSCs. Pre-primordial follicle-like structures were also observed (Figure 5.7.B 
inset), suggesting that the early stages of oogenesis may be occurring in these 
ovarian aggregates. No complementary negative controls were retrieved for this 
study. 
  




Figure 5.7: Freshly isolated bOSCs form pre-primordial follicle-like structures in xeno-
transplanted chimeric ovarian aggregates. bOSCs frozen immediately after FACS isolation were 
thawed prior to aggregation with murine somatic ovarian cells and then xeno-grafted to the kidney 
capsule of immune deficient recipient mice for 21 days (n=4). Histological assessment of 3 chimeric 
ovarian aggregates (A-F) showed that no multi-laminar follicles were formed during transplantation, 
however, pre-primordial follicle-like structures were observed (C and D; indicated by asterisks), like 
those in chimeric ovarian aggregates with cultured bOSCs. Tissue sections were imaged at x10 
magnification (scale bars represent 200µm) and x20 magnification (scale bars represent 100µm). 
 
  
Use of a xeno-transplant model to investigate the oogenic potential of bOSCs in vivo 
160 
 
5.3.4 Early stage follicles observed in negative control ovarian 
aggregates 
To determine the full role of bOSCs when combined with neonatal murine ovarian 
somatic cells, somatic cell only aggregates were utilised as negative controls. 11 
negative control ovarian aggregates were fixed prior to xeno-graft as day 0 controls. 
These had been exposed to the same processes as xeno-grafted negative control 
ovarian aggregates (n=42). No oocytes were observed in day 0 negative control 
ovarian aggregates (Figure 5.8), suggesting successful separation of germ and 
somatic cells following ovarian disaggregation, was achieved, consistent with results 
from in vitro cultured negative control ovarian aggregates (see section 4.3.2). 
 
 
Figure 5.8: Day 0 controls of negative control ovarian aggregates do not contain oocytes. 
Neonatal murine ovarian somatic cells were separated from oocytes following ovarian disaggregation 
based on cell adhesion characteristics and filtration of somatic cells (10μm). Ovarian somatic cells 
were aggregates to form negative control ovarian aggregates. Day 0 controls (n=11) were fixed for 
histological assessment prior to xeno-transplantation. Haematoxylin and eosin staining of these tissues 
showed no oocytes or follicles were present throughout day 0 negative control ovarian aggregates (A-
F). Tissue sections were imaged at x10 magnification and scale bars represent 200µm. 
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Thirty-four negative control ovarian aggregates were successfully retrieved 
following xeno-transplantation. Thirty aggregates (estimated total tissue volume of 
132.7 x106 m3) showed no visible signs of oocyte or follicle development upon 
retrieval, which was confirmed by histological analysis (Figure 5.9.B-C, E-F, H-I, K-
L, N-O). Further suggesting that oocytes have been successfully removed from 
neonatal murine ovarian somatic cell populations prior to ovarian aggregate 
generation. Additionally, negative control ovarian aggregates (n=10, 2 collected) 
were also made using cultured neonatal murine ovarian somatic cells, and did not 
contain oocytes or follicles following xenotransplantation. 
However, 4 negative control ovarian aggregates recovered after xeno-grafting, 
contained early stage follicles (Figure 5.10.G). A total of 6 follicles were identified 
in negative control ovarian aggregates (Figure 5.10.A-F). 3 follicles were non-
growing (Figure 5.10.A-C) and 3 were multi-laminar and had initiated growth 
(Figure 5.10.D-F) A single follicle showed separation of granulosa cell layers 
indicating the initial formation of an antral cavity (Figure 5.10.F). Oocytes from 
growing follicles in negative control ovarian aggregates (n=3, 53.3  2.4m) were 
significantly (P<0.05) larger than murine oocytes in positive control ovarian 
aggregates (n=38; 34.51m) but not statistically different in size to oocytes from 
chimeric ovarian aggregates (n=6; 60.93.6m) and endogenous oocytes from 
murine (n=14; 44.53.3m) and bovine (n=6; 67.97.8m) adult ovarian tissue. 
Although follicles were observed the incidence of this was low for xeno-transplanted 
negative control ovarian aggregates. Multi-laminar follicles and non-growing 
follicles were observed in a total of 11.8% of negative control ovarian aggregates, 
compared to 100% of positive control ovarian aggregates and 46.6% of chimeric 
ovarian aggregates which also contained pre-primordial follicle-like structures, 
which were not observed in negative control ovarian aggregates or positive control 
ovarian aggregates. 
These results suggest that murine neonatal ovarian somatic cells can support 
oogenesis and folliculogenesis when placed in an in vivo environment. However, the 
source of the oocytes within growing follicles in the chimeric ovarian aggregates is 
unclear. Although there are differences in the follicle and follicle-like structures 
Use of a xeno-transplant model to investigate the oogenic potential of bOSCs in vivo 
162 
 
observed in negative control and chimeric ovarian aggregates, results presented here 
may indicate that oocytes observed in chimeric ovarian aggregates may be derived 
from cells other than bovine oogonial stem cells. Thus, methods to determine the 
source of oocytes in chimeric ovarian aggregates must be established. 




Figure 5.9: Negative control ovarian aggregates lack follicles following xeno-transplantation. 30 
negative control ovarian aggregates did not appear to contain oocytes and follicles upon retrieval (A, 
D, G, J & M), confirmed by histological analysis (B, C, E, F, H, I, K, L, N & O). Unfixed tissue was 
imaged at x2.5 magnification and scale bars represent 1mm. H&E tissue sections were imaged at x10 
magnification (scale bars represent 200μm) and x20 magnification (scale bars represent 100μm).  




Figure 5.10: Early stage follicles were observed within negative control ovarian aggregates. Of 
42 negative control ovarian aggregates, 34 were successfully retrieved. Histological analysis of all 
aggregates revealed the presence of follicles within 4 negative control ovarian aggregates. A total of 6 
Follicles were observed (A-F). These follicles ranged in developmental stage from non-growing (A, B 
and C) to multi-laminar follicles (D and E). The initial separation of granulosa cells to form an antral 
cavity was observed in one follicle (F). G-I illustrate early stage follicles within positive control 
ovarian aggregates. (J) Summary of the proportion of negative ovarian aggregates where no structures 
were observed (n=30, 88.2%) or multi-laminar follicles (n=2, 5.9%) and non-growing follicles (n=2, 
5.9%) were identified. Follicles are indicated by white arrowheads. Tissue sections were imaged at 
x40 magnification and scale bars represent 50μm.  
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5.3.5 Cell labelling methods in chimeric ovarian aggregates 
The presence of follicles within negative control ovarian aggregates highlights the 
necessity to determine the origin of oocytes within chimeric ovarian aggregates. 
Thus, methods to identify bovine and murine cells within chimeric ovarian 
aggregates were utilised. 
To determine the contribution of bOSCs to oogenesis in chimeric ovarian aggregates, 
rhodamine dextrans were utilised to track bOSCs. Rhodamine fluorescence could be 
detected within chimeric ovarian aggregates prior to xeno-transplantation (Figure 
5.11.A), however rhodamine fluorescence was almost undetectable in these tissues 
following collection (Figure 5.11.B). Histological analysis of chimeric ovarian 
aggregates also showed no rhodamine expression within the tissues when 
counterstained with DAPI (Figure 5.11.C). These results suggest that fluorescence 
from rhodamine dextrans is not sufficiently maintained in bOSCs following xeno-
transplantation and is not an appropriate labelling method to trace bOSCs in this 
system.  
Negative control ovarian aggregates did not show rhodamine fluorescence prior to 
(Figure 5.11.D) or following (Figure 5.11.E) xenotransplantation, which was 
confirmed by histological analysis (Figure 5.11.F).  
Alternative labelling methods were also used to identify murine cells within chimeric 
ovarian aggregates. Cells from B6;129-Gt(ROSA)26) mice were utilised as they 
ubiquitously express β-Galactosidase, which can be detected by XGal staining. 
However, both XGal staining (Figure 5.12.A & B) and immunofluorescence for β-
Galactosidase were unsuccessful (Figure 5.12.C).  




Figure 5.11: Xeno-transplanted chimeric ovarian aggregates do not maintain rhodamine 
dextran expression in bOSCs. bOSCs fluorescently labelled with rhodamine dextrans were 
aggregated with neonatal mouse somatic cells. Rhodamine dextrans were identified within chimeric 
ovarian aggregates prior to xenotransplantation (A), however could not be detected in tissues 
following collection (B) and were absent from chimeric ovarian aggregate sections when DAPI 
counterstained and visualised by confocal microscopy (C). Negative ovarian aggregates containing 
only neonatal mouse somatic cells showed no rhodamine fluorescence at any time point (D-F). Whole 
ovarian aggregates were imaged at x10 magnification and scale bars represent 500μm (A, B, D & E). 
Tissue sections were imaged at x40 magnification and scale bars represent 50μm (C & F). 




Figure 5.12: Inconsistent XGal staining and β-Galactosidase immunofluorescence in control 
ovarian aggregates. XGal is used to detect β-Galactosidase activity found in cells of B6;129-
Gt(ROSA)26 mice and is observed as a blue pigment. Following glutaraldehyde fixation, ovarian 
aggregates containing B6;129-Gt(ROSA)26) cells, were transferred to an XGal solution for staining. 
Positive control ovarian aggregates (A; B6;129-Gt(ROSA)26 germ cells and B; B6;129-Gt(ROSA)26 
somatic cells), show inconsistent XGal staining within individual oocytes and only peripheral 
aggregate staining. β-Galactosidase immunofluorescence was used to further investigate these 
observations. (C) Positive ovarian aggregate with B6;129-Gt(ROSA)26 germ cells and wild type 
somatic cells shows non-specific staining of β-Galactosidase throughout the tissue. Positive (D) 
control, B6;129-Gt(ROSA)26 testis, show expected staining patterns and staining is eliminated when 
the primary antibody is omitted (inset). No staining is observed in negative control tissue (E), wild 
type ovary. H&E tissue sections were imaged at x10 magnification (scale bars represent 200μm) and 
immunofluorescent sections were imaged at x20 magnification (scale bars represent 100μm).  
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5.3.6 RNA Scope to determine species of oocytes in chimeric 
ovarian aggregates 
To determine the species of origin of the oocytes observed in chimeric ovarian 
aggregates and the location of bOSCs, we utilised RNA Scope. Mouse Ubiquitin C 
(m-UBC) and bovine adenosine triphosphate (ATP) synthase subunit 5 (b-ATP5B) 
probes were used as markers of bovine and mouse cells within ovarian aggregates. 
Control adult ovarian tissues were utilised to determine the specificity of the probes 
to target cells and tissues. Due to the time required for development of this protocol, 
RNA degradation within the tissue appeared to be a significant confounder in many 
chimeric tissues. 
m-UBC staining was observed in cells within chimeric ovarian aggregates 
throughout the tissue (Figure 5.13.A), although not all cells stained positive. Oocytes 
present within this tissue showed chromogenic staining of m-UBC (Figure 5.13.A). 
m-UBC staining was consistent throughout positive control ovarian aggregates 
(Figure 5.13.C) and adult murine ovarian tissue (Figure 5.13.G) and staining was 
observed within all ovarian cell types within control mouse tissues as expected. 
However, m-UBC staining was also observed in oocytes and follicles of adult bovine 
ovarian tissue (Figure 5.13.E), although staining was not observed in the surrounding 
stromal tissue. These results suggest that the m-UBC probe is non-specifically 
binding to RNAs within bovine oocytes and follicles and thus the findings in 
chimeric aggregates cannot be interpreted.  
b-ATP5B showed little or no staining in xeno-transplanted chimeric ovarian 
aggregates (Figure 5.13.B), although some cells appeared to be positive for b-
ATP5B. However almost no staining for the presence of b-ATP5B was observed 
within adult bovine ovarian tissue (Figure 5.13.F). Furthermore, weak staining was 
observed in some sporadic cells within murine tissue (Figure 5.13.D and Figure 
5.13.H).   
Thus, we cannot determine the species of oocytes in chimeric ovarian aggregates 
with these probes or this protocol without further optimisation and validation. 
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Figure 5.13: RNA Scope analysis of the ovarian aggregates. Probes against mouse Ubiquitin C (m-
UBC) and bovine ATP5B (b-ATP5B) were used to determine the location of mouse and bovine cells 
within chimeric ovarian aggregates (A and B, respectively). Positive control ovarian aggregates (C 
and D), bovine (E and F) and mouse (G and H) adult ovarian tissues were stained for the presence of 
mouse UBC and bovine ATP5B to ensure probe specificity. m-UBC staining was observed 
throughout chimeric ovarian aggregates and showed staining within the oocyte present (A). Control 
mouse tissues (positive control ovarian aggregate (C) and adult ovarian tissue (G)) showed staining in 
all ovarian cell types, however m-UBC also showed non-specific staining of bovine oocytes and 
follicles (E). b-ATP5B showed little staining within chimeric ovarian aggregate tissue (B), 
furthermore almost no staining was observed in control bovine tissues (F) and some non-specific 
staining was observed in mouse control tissues (positive control ovarian aggregate (D) and adult 
ovarian tissue (H)). Tissue sections were imaged at x20 magnification and scale bars represent 50μm.  




Rodent labelled OSCs introduced into oocyte depleted (Zhou et al., 2014; Zou et al., 
2009) and healthy adult recipient ovaries (White et al., 2012) have demonstrated the 
successful population of recipient ovaries with OSC derived oocytes. Furthermore, 
OSC derived oocytes have undergone successful ovulation and fertilisation, by both 
natural conception (Zhou et al., 2014; Zou et al., 2009) and in vitro fertilisation (IVF) 
(White et al., 2012), to generate embryos (White et al., 2012) and fully fertile 
offspring (Zhou et al., 2014; Zou et al., 2009). In contrast, in vitro techniques have 
been unable to recapitulate these results, thus in vivo modelling may provide a more 
supportive environment for the differentiation of OSCs.  
Immune compromised rodents also allow the in vivo investigation of tissues from 
other species. White et al. (2012), showed that human OSCs could produce oocyte 
like cells after re-introduction into human ovarian cortical tissue following a 7 day 
xeno-transplant into immune-deficient recipient mice. Thus, illustrating the potential 
of xeno-graft models in exploring the function and potential of mammalian OSCs 
from larger animals and primates including humans.  
We hypothesised that using an in vivo xeno-graft model, bOSCs would have the 
capabilities to undergo oogenesis within chimeric ovarian aggregates. This study 
showed that chimeric ovarian aggregates containing bOSCs were capable of 
folliculogenesis within a 21 day xenograft model, although we were unable to 
validate the source of oocytes.  
Multi-laminar and primary follicles were observed in 10% of chimeric ovarian 
aggregates, demonstrating round healthy oocytes with a clear nucleolus present and 
at least one layer of cuboidal granulosa cells. Although follicles are observed in 
chimeric ovarian aggregates, it is unclear from the current experimental data 
presented here whether bOSCs have undergone differentiation and contributed 
oocytes to these follicles. Thus, these results indicate that chimeric ovarian 
aggregates have the capability to support folliculogenesis and may have the ability to 
support oogenesis. 
Differentiation of mitotically active stem cells into meiotically arrested oocytes 
would require a series of changes which would likely be associated with observable 
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morphological alterations, such as an increase in cell size and change in cell shape. 
In addition to cellular changes, transitioning cells would also need to establish 
interactions with supporting cells to form follicles. While the differentiation of OSCs 
into oocytes within established ovarian niches has previously been reported (White et 
al., 2012; Zhou et al., 2014; Zou et al., 2009), the transition of OSCs into oocytes and 
the intermediary stages between these two cell types has not been documented in the 
literature. Pre-primordial follicle-like structures, described in approximately a third 
of xeno-grafted ovarian aggregates, demonstrated a larger spherical-like central cell 
observed in association with adjacent cells. Thus, pre-primordial follicle-like 
structures may illustrate OSCs transitioning in to oocytes and may represent 
precursors to follicles, although further characterisation of these structures is required 
to establish their roles in ovarian aggregates. Furthermore, due to current cell 
labelling limitations it is unclear if bOSCs contribute to these structures in chimeric 
ovarian aggregates. However, similar structures were not observed in ovarian 
aggregates containing only murine cells, suggesting that these structures were a 
unique feature of chimeric ovarian aggregates. Pre-primordial follicle-like structures 
were also similar to the subpopulation of bOSCs which underwent morphological 
changes associated with increased cell size, spherical shape and association with 
adjacent cells within cultured chimeric ovarian aggregates (section 4.3.5), thus 
suggesting that cultured bOSCs may initiate differentiation characterised by changes 
in cell morphology when combined with neonatal murine ovarian somatic cells.  
bOSCs contributed approximately 10% of cells in chimeric ovarian aggregates, 
however low numbers of follicles (n=9) and pre-primordial follicle-like structures 
(n=16) were identified. These results suggest that the generation of these structures 
within chimeric ovarian aggregates was a rare event. In contrast, chimeric ovarian 
aggregates containing uncultured bOSCs did not contain follicles or pre-primordial 
follicle-like structures. Thus, suggesting that the ability of bOSCs to contribute to 
oogenesis, although currently not fully determined, may be acquired through in vitro 
culture. Concerns have previously been raised over the potential in vitro 
transformation of OSCs to generate a more ‘stem-cell’ like cell (Dunlop et al., 2013). 
Several small molecule ligands have been identified as essential to maintain 
pluripotency of cells in vitro, including LIF (leukaemia inhibitory factor, reviewed 
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by Onishi and Zandstra (2015)), EGF (epidermal growth factor), bFGF (basic 
fibroblast growth factor, (Burton et al., 2010)), and GDNF (glial cell line-derived 
neurotrophic factor, GDNF in spermatogonial stem cell (SSC) self-renewal 
(reviewed by Kanatsu-Shinohara and Shinohara (2013)). These small molecules 
activate pathways within cells to maintain their self-renewal capacities in vitro and 
were all used in the in vitro culture of bOSCs. Reports of successful differentiation of 
putative OSCs into oocytes have consistently utilised an initial period of in vitro 
culture  (White et al., 2012; Zhou et al., 2014; Zou et al., 2009). Thus, Ddx4/DDX4 
positive cells, isolated from adult mammalian ovaries may not naturally possess 
pluripotent characteristics, but through in vitro exposure to a pluripotency promoting 
environment may inherit these characteristics. Although uncultured bOSCs have not 
formed oocytes or oocyte-like cells within this system, which may suggest the 
potential of putative OSCs to differentiate may be inherited through in vitro culture, 
there were also several compounding factors which may have inhibited the potential 
of freshly isolated putative bOSCs within this system. 
Due to licence restrictions in place at the University of Edinburgh, all xeno-grafts of 
chimeric ovarian aggregates containing uncultured bOSCs were conducted at the 
University of Oxford. To conduct these experiments, bOSCs were frozen for 
transportation and thawed immediately prior to aggregation with somatic cells. Cell 
freezing is known to cause cell injury, however the addition of cryoprotective agents, 
such as DMSO and glycerol which passively cross the cell membrane, have been 
shown to reduce cell apoptosis following freeze-thawing (Chatterjee et al., 2017). 
Yet, new evidence suggests that the freeze-thaw process has detrimental effects on 
the genetic and epigenetic qualities of cells and stem cells have demonstrated 
reduced pluripotency gene expression, and altered capacity to differentiate following 
cryopreservation (reviewed by Chatterjee et al. (2017) and Diaferia et al. (2008)). 
Post-thaw survival assessments, which are currently used to measure the success of 
cryoprotection protocols, do not provide insight into the cellular effects of 
cryopreservation on cells and the effects of cryopreservation on the cell phenotype of 
OSCs is uncharacterised. Effects of cryopreservation on stem cells including 
embryonic stem cells have been identified and reported loss of pluripotency, possibly 
due to epigenetic alterations within the cells (reviewed by Chatterjee et al. (2017)). 
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Almost half of bOSCs did not maintain cell membrane integrity following isolation, 
immediate freezing, storage and thawing. Thus, suggesting that cryopreservation had 
a negative effect on bOSCs and may have hindered their true potential in this model. 
The detrimental effects of cryopreservation on bOSCs may have been further 
exacerbated by their exposure to enzymes for tissue disaggregation and subsequent 
FACS isolation, both with potential to disrupt cell integrity, immediately prior to 
cryopreservation. To fully test the capabilities of freshly isolated putative OSCs, cells 
should be introduced into an ovarian niche immediately, without further intervention.   
Although we were unable to fully explore the potential of uncultured bOSCs in this 
study, chimeric ovarian aggregates containing cultured bOSCs did show evidence of 
folliculogenesis and possibly evidence of the early stages of oogenesis. Oocytes from 
pre-antral follicles in chimeric ovarian aggregates were not different in size to pre-
antral oocytes in adult bovine tissue but were significantly larger than oocytes from 
pre-antral follicles in positive control ovarian aggregates and those in the adult 
mouse ovary. It is well established that follicle sizes vary significantly between 
species. This difference has been observed in primordial follicles (Gosden and 
Telfer, 1987), but is particularly prominent during the latter stages of follicular 
development with variations in antral cavity sizes correlating with body weight 
(Gosden and Telfer, 1987). Oocytes show less variability in size between species, 
however significant differences in oocyte size between mouse, hamster and pig were 
identified at all stages of follicle development (Griffin et al., 2006), and the present 
data show differences between endogenous mouse and bovine oocytes at the pre-
antral stage. Thus, differences observed in oocyte size between chimeric and positive 
control ovarian aggregates may be due to species differences. However, a population 
of follicles were also observed in some negative control ovarian aggregates. Oocytes 
within negative control ovarian aggregates were also significantly larger than murine 
oocytes in positive control ovarian aggregates, but were not different in size from 
pre-antral oocytes in chimeric ovarian aggregates and endogenous murine and bovine 
adult tissues. This suggests similarities between oocytes found in chimeric ovarian 
aggregates and negative control ovarian aggregates and indicates the need to identify 
daughter cells of bOSCs and/or murine cells to determine the origin of oocytes in all 
ovarian aggregates.  
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Viral labelling methods have previously been used to successfully trace OSCs and 
their daughter cells in other species (Bui et al., 2014; Ding et al., 2016; White et al., 
2012; Zhou et al., 2014; Zou et al., 2009). Use of lentiviruses to fluorescently label 
bOSCs hindered their growth and health in vitro, such that alternative non-genomic 
labelling of putative bOSCs was utilised. Rhodamine dextrans were successfully 
used within the chimeric ovarian aggregate model in vitro. However, rhodamine 
fluorescence from dextrans could not be identified in chimeric ovarian aggregates a 
21 day xeno-graft period. It is unclear whether rhodamine dextrans in bOSCs were 
metabolised or diluted through cell proliferation to undetectable levels. The dilution 
of fluorescent dextrans through cell proliferation is widely used and exploited in cell 
lineage analysis studies to track daughter cells (Progatzky et al., 2013). In vitro 
labelling of bOSCs in culture with rhodamine dextrans showed a decrease in 
corrected total cell fluorescence from day 7 to day 21, reflecting the dilution of 
fluorescent dextrans in individual cells over time through proliferation. Definitive 
comparative studies of cell proliferation in vitro and in vivo are absent from the 
literature. However, the rate of cell proliferation is higher in 3D culture systems 
compared to 2D monolayer cultures (Edmondson et al., 2014). Thus, it is possible 
that bOSCs in a 3D ovarian aggregate in vivo model could proliferate faster and 
dilution of rhodamine dextrans occur at a higher rate, resulting in a signal too weak 
to detect following xeno-grafting. While fluorescent dextrans offer a gene-transfer-
free rapid labelling method for bOSCs and are suitable for their study in vitro, 
evidence presented here shows that their use for labelling OSCs in an in vivo model 
is limited. A shorter transplant period may reduce the dilution of the rhodamine 
signal to maintain detectable fluorescence following retrieval. Alternatively, 
increased uptake resulting in higher concentrations of rhodamine dextrans in bOSCs 
prior to aggregation may promote longevity of the fluorescent signal within this 
system. Amendments to the protocol for labelling bOSCs with rhodamine dextrans 
may negate the limitations identified here and allow their use in future investigations, 
however, their potential applications in the chimeric ovarian aggregate need further 
examination.  
We also utilised genetically labelled mouse cells (B6;129-Gt(ROSA)26) in chimeric 
ovarian aggregates. -Galactosidase is ubiquitously expressed in the cells of these 
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mice and X-Gal staining identifies these cells by visualisation of blue pigmentation. 
Inconsistent XGal staining was observed throughout ovarian aggregates and within 
individual oocytes in positive control ovarian aggregates, suggesting that X-Gal 
staining was insufficient to identify the B6;129-Gt(ROSA)26 murine cells within 
chimeric ovarian aggregates, and consequently putative bOSCs could not be 
identified. Immunofluorescent detection of -galactosidase also failed in these 
tissues, suggesting that epitopes were insufficiently preserved within these tissues for 
effective histological analysis. It was subsequently identified that the glutaraldehyde 
fixative utilised was not sufficient for the tissues and prevented the appropriate 
staining with X-Gal and disrupted epitope preservation. Use of appropriate fixatives 
may ensure that all B6;129-Gt(ROSA)26 cells can be identified in chimeric ovarian 
aggregates allowing bovine and murine cells to be distinguished. However reduced 
retrieval rates were observed in ovarian aggregates containing B6;129-Gt(ROSA)26 
cells, suggesting that these cells were not adequate for this model. Alternative 
labelling of murine cells, for example fluorescently labelled cells using mice strains 
with ubiquitously expressed fluorescent proteins, may provide a more suitable 
model. The use of such cells may allow live fluorescent imaging immediately after 
collection and histological assessment of tissues for fluorescent epitopes to determine 
the species of origin for any oocytes within chimeric ovarian aggregates. 
To further investigate the contribution of putative bOSCs to undergo oogenesis 
within chimeric ovarian aggregates, histological techniques to characterize cells of 
each species were considered. Structures and sequences of essential proteins are 
highly conserved among species, such that many antibodies against antigens of 
interest will react with multiple species in immunohistological techniques. Many 
antibodies have also been shown to bind to epitopes other than their targets 
(Bradbury and Pluckthun, 2015; Saper, 2009). While monoclonal antibodies are 
more reliable than the batch variability observed in polyclonal antibodies, the 
specificity of antibodies to epitopes of individual species is poor. A greater level of 
species variance is present in the RNAs responsible for coding proteins. RNA Scope 
is a recently developed in situ RNA analysis, capable of single RNA molecule 
detection within cell lines, illustrated by a punctate staining pattern (Wang et al., 
2012). Species specific probes (m-UBC and b-ATP5B) were utilised on chimeric 
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ovarian aggregate tissue sections to determine the location of murine and bovine 
cells within the tissue. These two probes were selected as the corresponding RNAs 
are ubiquitously expressed in all cell types of the respective species and have 
previously been used as reference genes in gene expression analysis (Connor et al., 
2005; Wang et al., 2012). The RNA Scope results presented here do not determine 
whether the oocytes identified in chimeric ovarian aggregates are murine or bovine. 
Failure of b-ATP5B probe to bind to bovine ovarian tissue, suggests that either the 
probe is not functioning or the detection process has been insufficient to generate a 
reaction. In contrast, the m-UBC probe successfully bound to murine cells in 
chimeric ovarian aggregates and murine control tissue, however non-specific staining 
was observed with this probe in bovine oocytes and follicles. These results suggest 
that the m-UBC probe may be cross-reacting with bovine RNAs. The m-UBC 
staining pattern in bovine tissue was restricted to oocytes and follicles, thus the probe 
is not consistently cross-reacting across all bovine cell types. Oocyte ‘stickiness’ is a 
common problem associated with immuno-detection in ovarian tissue sections. These 
RNA Scope results indicate that current protocols with these probes are insufficient 
to differentiate between bovine and murine cells within chimeric ovarian aggregates. 
It is unclear whether RNA Scope could provide insight into the location of the 
different cell types from each species, and their contributions to the follicles 
observed within chimeric ovarian aggregates with improved protocols or alternative 
probes and/or target RNAs. Further validation of this methodology would be 
necessary to use in analysis of future chimeric ovarian aggregates.  
All methodologies described in this thesis failed to differentiate murine and bovine 
cells in xeno-transplanted chimeric ovarian aggregates. Without successful 
identification of cells from each species, the origin of oocytes within chimeric 
ovarian aggregates could not be determined. Thus, it is unclear whether bOSCs have 
successfully undergone oogenesis and contributed to the folliculogenesis observed in 
this model. For future use of this model, alternative experimental approaches may 
identify the origin of oocytes in chimeric ovarian aggregates. Meiotic spreads of 
isolated oocytes would identify the species by the number of chromosome pairs 
present (20 chromosome pairs in murine oocytes and 30 chromosome pairs in bovine 
oocytes). This technique would also provide insight into the meiotic progression of 
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any OSC derived oocytes and potentially reveal in more detail the ability of OSCs to 
successfully undergo oogenesis. Furthermore, meiotic spreads are able to determine 
chromosome content and organisation, two factors previously identified as essential 
gold standards for assessment of artificial gametogenesis (Handel et al., 2014). 
However meiotic spreads are technically very difficult and often require many 
oocytes, and given the low numbers of oocytes generated in chimeric ovarian 
aggregates, this may not be feasible. Meiotic spreads also provide no insight into the 
histology and morphology of ovarian aggregates. All methodologies have benefits 
and limitations and given the difficulties encountered when analysing chimeric 
ovarian aggregates, a multi-technique approach may provide contingency measures 
to ensure oocyte origin can be determined.  
Negative control ovarian aggregates were generated to ensure a pure population of 
neonatal ovarian somatic cells was established prior to ovarian aggregate creation, 
and no oocytes contaminated this population. This control was essential to determine 
the contribution of bOSCs within chimeric ovarian aggregates, however, 4 (11.8%) 
negative control ovarian aggregates contained early stage non-growing and growing 
follicles. Thus, suggesting that a germ cell population has contaminated the ovarian 
somatic cells within these experiments. Negative control ovarian aggregates, as 
described here, consisting of somatic cells only, have not previously been described 
in the literature, however, complete exchange of rodent germ and somatic cells has 
been reported based solely on cell adhesion characteristics (Eppig and Wigglesworth, 
2000). We reported that separation of ovarian somatic cells from oocytes based 
solely on cell adhesion characteristics was insufficient and additional cell filtration 
steps were developed to ensure complete separation (shown in section 4.3.2). 
Negative control ovarian aggregates consistently showed no oocytes after 7 days in 
culture, following extra filtration of somatic cells. Furthermore, no oocytes were 
observed in day 0 negative control ovarian aggregates, suggesting that oocytes had 
been successfully removed from disaggregated ovarian cell cultures prior to ovarian 
aggregate formation. These results further suggest that the presence of oocytes in a 
small proportion of negative control ovarian aggregates following xeno-grafting is 
not a consequence of oocyte contamination of the somatic cell population, but 
possibly as a result of spontaneous formation from an alternative cell source. While 
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the current experimental data cannot conclusively determine that oocytes in negative 
control ovarian aggregates were not a consequence of contamination in the somatic 
cell population prior to aggregation, there are several lines of evidence that indicate 
these oocytes are different from those mixed with somatic cells at aggregate 
formation as seen in positive control ovarian aggregates, which would constitute 
contamination in negative control and chimeric ovarian aggregates. 
Within positive control ovarian aggregates, neonatal oocytes were re-aggregated with 
their supporting somatic cells. Within a 21 day xeno-graft, all follicles identified had 
initiated growth, many reaching late stages of follicle development with large antral 
cavities present. No non-growing or primordial follicles were identified within these 
ovarian aggregates. Similar results have previously been reported when rat and 
mouse oocytes were aggregated with supporting somatic cells of the opposing 
species (Eppig and Wigglesworth, 2000). Within 21 days of transplantation, mouse 
oocytes were encapsulated in large antral follicles and vice versa. Furthermore, xeno-
grafted reconstituted murine embryonic (E12.5) ovaries consisted of large antral 
follicles 28 days after transplantation and contained haemorrhagic sites indicative of 
ovulation 35 days after transplantation (Matoba and Ogura, 2011). No further follicle 
development was observed in reconstituted embryonic ovaries past these time points, 
and the authors suggested that a single wave of oogenesis and folliculogenesis had 
occurred within these reconstituted ovaries. The absence of non-growing follicles in 
positive control ovarian aggregates indicates that all surviving oocytes re-introduced 
to an ovarian somatic niche initiate growth in this system and suggests that a single 
wave of folliculogenesis may have occurred within these ovarian aggregates, 
resulting in a population of follicles which have all initiated growth. The systemic 
environment to which ovarian aggregates or reconstituted ovaries are introduced to 
may influence the growth of re-established follicles within these model. At the time 
of transplantation, ovarian aggregates do not have established cell-cell interactions 
and are exposed to high circulating gonadotropins following ovariectomy of the adult 
recipient. Thus, newly formed follicles are exposed to a growth conductive 
environment, which appears to cause initiation of all follicles simultaneously. 
Continual folliculogenesis over several months post transplantation was achieved in 
reconstituted embryonic ovaries when a proportion of the recipients ovaries were left 
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intact (Hashimoto et al., 1992). These results suggest that the growth promoting 
environment ovarian aggregates were exposed to in this study were further 
exacerbated by the absence of growth inhibiting factors secreted by growing 
follicles, such as AMH (Durlinger et al., 2002; Durlinger et al., 1999). Thus, oocytes 
introduced to an ovarian niche and subsequently xeno-grafted to a growth promoting 
and non-inhibitory systemic environment, appear to form follicles and initiate growth 
immediately, as seen in positive control ovarian aggregates in this system. In contrast 
follicles identified in negative control ovarian aggregates were all early stage 
follicles and several appeared to be non-growing. Data previously described would 
suggest that contaminating oocytes in negative control ovarian aggregates would be 
unhindered to grow. Thus, the observation that all follicles in negative control 
ovarian aggregates are early stage may suggest that these oocytes do not originate 
from oocyte contamination of the somatic cell population at the time of cell 
aggregation. 
Although very few growing follicles (n=3) were observed in negative control ovarian 
aggregates, the oocytes within these were significantly larger than pre-antral oocytes 
in positive control ovarian aggregates. Oocytes in negative control ovarian 
aggregates were also not significantly different in size to endogenous murine oocytes 
in pre-antral follicles, whereas oocytes in positive control ovarian aggregates were 
significantly smaller in size than their endogenous counterparts. These results show 
differences between pre-antral oocytes in positive control and negative control 
ovarian aggregates, and suggest that oocytes and follicles within positive control 
ovarian aggregates have a perturbed growth trajectory compared to endogenous 
controls. Follicles within positive control ovarian aggregates showed development of 
antral cavities with significantly fewer layers of granulosa cells than endogenous 
follicles, suggesting that these follicles are initiating antral cavity formation earlier 
than in situ follicles. Although the cause of this is unclear, it is possible that a 
mismatch between oocyte growth and somatic cell development has occurred in 
positive control ovarian aggregates. A single follicle in a negative control ovarian 
aggregate also showed early incipient antral cavity formation. This follicle had very 
few granulosa cell layers, similar to those seen in positive control ovarian aggregates, 
however the size of the oocyte within this follicle was larger than similar staged 
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follicles in positive ovarian aggregates. Thus, somatic cells in murine follicles are 
initiating antral cavity formation earlier in follicle development in xeno-transplanted 
ovarian aggregates than in situ controls. Although the size of oocytes in incipient 
antral follicles could not be analysed between positive and negative control ovarian 
aggregates due to low numbers, increased size of oocytes in pre-antral growing 
follicles in negative control ovarian aggregates would predict that oocytes in 
incipient antral and antral follicles of negative controls would be larger than those in 
positive controls. Thus, oocytes in negative ovarian aggregates appear to be 
undergoing different growth dynamics than those in positive control ovarian 
aggregates.  
The results presented here do not exclude oocyte contamination as the source of 
oocytes in negative control ovarian aggregates, however they do indicate that this is 
an unlikely source of these cells. The differences observed in both oocyte and follicle 
developmental stage and size identified between negative control and positive 
control ovarian aggregates suggest that the oocytes in these different ovarian 
aggregates are on different growth trajectories and may originate from different 
sources. Oogonial stem cells have been identified within juvenile and adult murine 
ovaries (Pacchiarotti et al., 2010; White et al., 2012; Zou et al., 2009) and have 
shown their ability to generate functional oocytes within in vivo models (White et al., 
2012; Zou et al., 2009). Methods used in this study did not actively remove potential 
OSCs from murine ovarian cell populations. Thus, murine OSCs may be present 
within neonatal murine ovarian somatic cell populations, and may have contributed 
to oogenesis, forming new oocytes in negative control ovarian aggregates. 
Characterisation of neonatal murine ovarian somatic cells would identify any 
putative oogonial stem cells within this population. 
Populations of neonatal murine ovarian somatic cells were cultured for a minimum 
of 7 days and underwent at least 1 passage, then utilised to create ovarian aggregates. 
Culture of somatic cells would eliminate any potential contaminating oocytes, 
creating a population of mitotically active viable ovarian cells which may or may not 
contain murine OSCs. No oocytes were observed within negative control ovarian 
aggregates with cultured somatic cells, as expected. These results may suggest that 
oocytes previously observed within negative control ovarian aggregates were a 
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consequence of oocyte contamination following ovary disaggregation. However, 
culture of somatic cells caused a decrease in the retrieval rates of negative ovarian 
aggregates and histology of these ovarian aggregates also revealed morphological 
differences in the somatic cells when compared to aggregates using uncultured 
ovarian somatic cells. These observations suggest that the culture of murine ovarian 
somatic cells may have altered this population of cells, such that they behave 
differently in xeno-transplanted ovarian aggregates. In vitro culture of cells has been 
shown to alter and transform differentiated somatic cells without possibly present in 
the murine ovarian cell populations, may have also undergone transformation in this 
culture system. Characterisation of neonatal murine ovarian somatic cells was not 
undertaken prior to or during culture. Thus, the different cell types within this 
population were not elucidated. Gene and/or protein expression analysis would 
determine whether cells in this population maintained or altered their phenotype 
during in vitro culture. The current culture conditions utilised were developed for 
fetal human ovarian somatic cells (Bayne et al., 2016) and may not fully support the 
growth of all neonatal murine ovarian somatic cell types (e.g. granulosa, stroma). 
Furthermore, lack of factors to support pluripotency (e.g. LIF, EGF, bFGF and 
GDNF) in this culture may result in putative OSCs losing their differentiation 
capabilities. Culture of mouse embryonic stem cells without LIF caused the loss of 
self-renewal capabilities and induced cell differentiation (Williams et al., 1988). 
Thus, the absence of oocytes in negative control ovarian aggregates generated from 
cultured ovarian somatic cells may reflect the elimination of oocytes from this cell 
population following ovary disaggregation and/or the loss of function in putative 
OSCs within this cell population. The results could also suggest that the somatic cells 
have lost the ability to support folliculogenesis through in vitro culture. Incorporation 
of oocytes into ovarian aggregates containing cultured neonatal murine ovarian 
somatic cells would provide information into whether these cells maintain their 
functional ability to support folliculogenesis. As previously discussed the source of 
oocytes within negative control ovarian aggregates is undetermined and the use of 
cultured somatic cells to generate ovarian aggregates has provided little further 
insight into the origin of these oocytes.  
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The observation of oocytes in negative control ovarian aggregates suggest that 
oocytes in chimeric ovarian aggregates may not be derived from bOSCs or 
associated with their presence in the ovarian aggregates. Oocytes within pre-antral 
follicles in both negative control and chimeric ovarian aggregates were not 
statistically different from each other, however oocytes in chimeric ovarian 
aggregates were significantly larger than endogenous murine oocytes, whereas 
oocytes in negative control ovarian aggregates were not. Furthermore, follicles in 
chimeric ovarian aggregates showed antral cavity formation later in development 
with several layers of granulosa cells present, whereas murine follicles in ovarian 
aggregates developed antral cavities early in follicle development. These results 
illustrate differences in oocyte and follicle dynamics between chimeric and murine 
control ovarian aggregates. Furthermore, negative control ovarian aggregates did not 
contain pre-primordial follicle-like structures as described in chimeric ovarian 
aggregates. In contrast, they contained small non-growing primordial/transitory 
follicles with archetypal characteristics of endogenous primordial and transitory 
follicles. Putative OSCs are a poorly characterised ovarian cell type and although 
their physiological contribution to oogenesis in mammalian ovaries is undetermined, 
their physiological niche also remains undescribed. Despite their known ability to 
produce functional oocytes in rodents (Zhou et al., 2014; Zou et al., 2009) the 
extrinsic factors and underlying mechanisms controlling their differentiation into 
oocytes is not known. Thus, it is difficult to predict whether murine somatic cells 
provide a suitable environment to support bOSC differentiation. Should bOSCs 
contribute to oogenesis in chimeric ovarian aggregates, they would be interacting and 
communicating with cells from an alien source. Although healthy oocytes are 
observed in chimeric ovarian aggregates, the larger cells within pre-primordial 
follicle-like structures, which are speculated to be the precursors to primordial 
follicles, may illustrate that the communication between the cell types of the different 
species is not perfect, resulting in a structure similar to a primordial follicle but not 
identical to an archetypal primordial follicle. Failure to identify bOSCs within 
chimeric ovarian aggregates has prevented this from being investigated further. 
However, it is possible that the potential differentiation of bOSCs to oocytes within 
this system may be aberrant. Whereas murine OSCs (mOSCs) which may be present 
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in the somatic cell population would be surrounded by familiar cells and it is possible 
that within this system mOSCs can establish themselves within the appropriate niche 
to coordinate oocyte formation with the correct cell types. This may explain why 
non-growing follicles are observed in negative control ovarian aggregates whereas 
pre-primordial follicle-like structures are seen in chimeric ovarian aggregates. 
Follicles and pre-primordial follicle-like structures were observed in almost half 
(46.6%) of chimeric ovarian aggregates, whereas follicles (growing and non-
growing) were observed in only 11.8% of negative control ovarian aggregates. If 
putative OSCs or contaminating murine oocytes were contributing to follicles in 
chimeric ovarian aggregates, we would expect a similar proportion of negative 
control ovarian aggregates to contain follicles, however, this is not the case. As 
previously discussed the somatic cell population utilised in ovarian aggregates was 
not characterised, thus it is unclear whether putative mOSCs are present in this 
population of cells and if so what proportion of cells are mOSCs. White et al. (2012) 
estimated that in the adult murine ovary mOSCs make up a very small proportion of 
total ovarian cells (0.014% ± 0.002%). Thus, mOSCs in ovarian aggregates may only 
contribute a very small proportion of cells. In contrast, bOSCs were enriched in 
chimeric ovarian aggregates, making up 10% of the total number of cells, which may 
reveal why a higher proportion of chimeric ovarian aggregates contained follicles 
and/or pre-primordial follicle-like structures.  
Together these data suggest that bOSCs may have contributed to oogenesis in 
chimeric ovarian aggregates, however due to limitations of the model outlined here 
we were unable to determine conclusively the species of oocytes in chimeric ovarian 
aggregates. They also suggest that mOSCs may have contributed to oogenesis within 
negative control ovarian aggregates. As previously discussed the optimum niche to 
maintain OSCs and support their differentiation is not known. Further 
characterisation of these cells and their requirements for differentiation into oocytes 
is essential. While this study aimed to investigate the potential of bOSCs to undergo 
oogenesis in a chimeric ovarian aggregate model, murine ovarian somatic cells may 
not provide the optimum support for this cell type, thus conspecific ovarian somatic 
cells may provide a more physiologically relevant model. 
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6 Aggregation of bOSCs with fetal bovine ovarian somatic 
cells  
6.1 Introduction 
The extent to which mechanisms underlying folliculogenesis are conserved across 
species is poorly understood. Differences in follicle kinetics, suggest that regulation 
of folliculogenesis may be different between species. Work by Eppig and 
Wigglesworth (2000), showed that mechanisms were conserved sufficiently between 
rodent species to support the production of meiotically competent oocytes of rats and 
mice when supported by somatic cells of the other species. However, conservation 
between more genetically distant species is unknown. Chimeric ovarian aggregates, 
described in previous chapters, suggests that ovarian niches of different species may 
be able to support oogenesis, however, the ability of bOSCs to differentiate within a 
murine ovarian microenvironment could not be definitively evaluated with the 
current methodologies. Species differences may prevent murine ovarian somatic cells 
from fully supporting the generation of a meiotically and developmentally competent 
bovine oocyte.  
Experimental evidence of successful recapitulation of oogenesis from progenitor 
cells (ESCs, iPSCs and OSCs) has utilised the ovarian somatic cell environment of 
the same species (Hayashi et al., 2012; Hayashi and Saitou, 2013; White et al., 2012; 
Zhou et al., 2014; Zou et al., 2009). Rodent and human OSCs have formed oocytes, 
confirmed by protein expression analysis, when placed in young adult ovarian tissue 
(White et al., 2012; Zhou et al., 2014; Zou et al., 2009), furthermore rodent OSC 
derived oocytes have demonstrated meiotic and developmental competence through 
successful fertilisation and production of healthy offspring (Zhou et al., 2014; Zou et 
al., 2009). Differentiation of murine ESCs and iPSCs has utilised an initial in vitro 
culture to induce germ lineage differentiation of these cells followed by aggregation 
with murine ovarian somatic cells (Hayashi et al., 2012; Hayashi and Saitou, 2013). 
In this model, Hayashi and colleagues have used temporally appropriate ovarian 
somatic cells to support the continued development of differentiating pluripotent 
cells. Mismatch of ovarian somatic cells and developing germ cells has resulted in 
failure to produce functional oocytes in re-aggregated embryonic mouse ovaries 
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(Qing et al., 2008). Whereas co-ordination of germ cell and somatic cell 
developmental stage results in successful oogenesis and folliculogenesis in xeno-
grafted re-aggregated embryonic ovaries as early as E12.5 (Hashimoto et al., 1992; 
Matoba and Ogura, 2011; Qing et al., 2008). These data suggest that the somatic 
environment influences the success of oogenesis, and that temporal alignment of 
germ and somatic cells may be essential to maximise germ cell success.  
It is well established that the somatic cells of fetal ovaries support and help to co-
ordinate the differentiation of primordial germ cells to mitotically active oogonia to 
meiotically arrested oocytes (Sarraj and Drummond, 2012). Different ovarian 
somatic cells (vascular epithelial cells, vasculature-associated cells, general somatic 
cells and pre-granulosa cells) have been identified in fetal mammalian ovaries, 
characterised by gene expression patterns (Maatouk et al., 2012). Gonadal ridge 
epithelial-like (GREL) cells which form the genital ridge in the developing bovine 
ovary give rise to the ovarian epithelium and are proposed to be precursors for all 
pre-granulosa cells (Hummitzsch et al., 2013). Two sub-populations of pre-granulosa 
cells have been identified in the fetal murine ovary and can be distinguished by the 
expression of two markers, Foxl2 (Forkhead box L2, a transcription factor) and Lgr5 
(Leucine-rich repeat-containing G-protein coupled receptor 5) (Mork et al., 2012; 
Rastetter et al., 2014). Lgr5-/- ovaries have demonstrated a delay in germ cell 
differentiation (Rastetter et al., 2014) and Foxl2-/- ovaries show aberrant follicle 
activation (Uda et al., 2004), suggesting that these two ovarian somatic cell 
populations are important to support germ cell differentiation and follicle growth in 
mammalian ovaries. Thus, fetal ovarian somatic cells have known potential to 
support oogenesis and may provide an appropriate niche to support the 
differentiation of OSCs.  
The lineage of putative oogonial stem cells is unknown and it is unclear whether they 
are precursor cells to oogonia, which are active in fetal mammalian ovaries, or of a 
separate developmental lineage. The optimum niche to support differentiation of 
putative bOSCs is not known, however fetal bovine ovarian somatic cells support the 
differentiation of precursor germ cells in situ, therefore may possess the requirements 
to support and facilitate the differentiation of oocytes from precursor cells. Thus, 
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fetal bovine ovarian somatic cells were utilised as a niche to investigate the oogenic 
potential of bOSCs in a conspecific ovarian aggregate model.  
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6.2 Materials and Methods 
Ovarian aggregation model 
To further investigate the potential of putative bovine oogonial stem cells (bOSCS) 
the ovarian aggregation model was utilised in vivo in a xeno-transplant model with 
fetal bovine ovarian somatic cells as an ovarian niche. bOSCs and fetal bovine 
ovarian somatic cells were aggregated together with various amounts of PHA (35g, 
50g) at a ratio of 1:10, respectively (further details in section 2.5). A higher 
concentration of phytohaemagglutinin (PHA) was required to adhere bOSCs with 
fetal bovine ovarian somatic cells. When using the standard 35g PHA, which had 
previously been used to generate chimeric ovarian aggregates, cells within bovine 
ovarian aggregates with or without bOSCs did not adhere well. Bovine ovarian 
aggregates were fragile, and broke upon handling, resulting in unsuccessful hanging 
drop culture and failed xeno-grafting.  
To accommodate the difference in cell adhesion observed in bovine ovarian 
aggregates, 50g PHA was utilised. This successfully facilitated the adhesion of 
bovine ovarian cells to form ovarian aggregates.  
Negative controls containing bovine fetal somatic cells only were also generated for 
comparison. 
All experiments were carried out at the University of Edinburgh by Kelsey Grieve. 
Bovine oogonial stem cells 
bOSCs were isolated by FACS (section 2.2) from adult bovine ovaries collected from 
the local abattoir, as described previously (section 2.1). Following isolation bOSCs 
were either cryopreserved for future use (section 2.6.1.3) or cultured (section 2.6.1.1) 
in OSC media (section 2.12). Cultured cells were also cryopreserved and stored long 
term in liquid nitrogen (section 2.6.1.3) until required. 
bOSCs were fluorescently labelled with Rhodamine Dextrans (section 2.6.2.3) prior 
to aggregation with somatic cells.  
Fetal bovine ovarian somatic cells  
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Fetal bovine ovaries (gestational age 163.5 days, determined by crown-rump length) 
were received from the local abattoir (see section 2.1.1). Each ovary was 
disaggregated using enzymatic and mechanical dissociation (further details in section 
2.3). Once disaggregated, ovarian cells were cultured overnight in fetal somatic cell 
medium (section 2.12). The following day, cells were washed twice with pre-warmed 
PBS and new fetal somatic cell media was added (section 2.12). Cells were 
maintained and passaged as described in section 2.6.1.2.  
RNA extraction, cDNA synthesis and RT-PCR 
To determine the expression of mRNA transcripts in fetal bovine ovarian somatic 
cells, RT-PCR was performed. RNA extraction, cDNA synthesis and RT-PCR 
protocols are outlined in section 2.10 and primer pairs detailed in Table 6.1.  
Table 6.1: PCR primer pairs used to characterise FBSCs  
Gene Target Forward Primer Reverse Primer 
-ACTIN CTCTTCCAGCCTTCCTTCCT   GGGCAGTGATCTCTTTCTGC 
DDX4 TATATGGGGGAACCCAGTTG CATATCCAGCATGCGATC 
DAZL GAAGGCAAAATCATGCCAAACAC CTTCTGCACATCCACGTCATTA 
FOXL2 CCGGCATCTACCAGTACATTATAGC GCACTCGTTGAGGCTGAGGT 
LGR5 AGTTGTTCAGCCTCCGATCT TGGAAAATGCATTAGGGTCA 
NR2F2 CGGATCTTCCAAGAGCAAGTG CACAGGCATCTGAGGTGAACA 
 
Xenotransplant of ovarian aggregates 
Bovine ovarian aggregates following an overnight hanging drop culture in 
supplemented Waymouths media (section 2.12) were xenotransplanted to the kidney 
capsule of SCID (C.B.17/IcrHan Hsd-Prkdc) mice for 21 days for comparison with 
the in vitro culture models.   
All animal experiments were conducted under a UK Home Office licence in line with 
the Animals Scientific Procedure Act (1986). SCID Mice were housed as described 
in section 2.7 and obtained from Envigo laboratories and provided a minimum of 6 
days to acclimatise to their new environment prior to the start of any experimental 




Briefly, SCID mice were anaesthetised with isoflourane (section 2.7.1), shaved and 
skin sterilised. Subcutaneous injection of saline around the hind leg and a 
subcutaneous injection of vetergesic (at a dose of 0.03mg/ml in 100l) around the 
neck were given. A vertical incision along the skin was made in the middle of the 
back, followed by a small incision in the body wall directly above the ovary, 
allowing the ovary and ovarian fat pad to be removed from the body cavity, and the 
ovary to be excised. Using the ovarian fat pad as a guide the kidney was pulled out of 
the body cavity with forceps. Sterile PBS kept the kidney hydrated and a tiny 
incision was made in the kidney capsule with a sterile needle. Using a pulled glass 
pipette, aggregates were transferred through the hole in the capsule to the surface of 
the kidney and moved from the incision site to ensure their security. The kidney and 
associated tissue was then returned to the body cavity, and the body wall sutured 
using number 5 sutures. The ovary was then removed on the other side following the 
same protocol and the skin incision closed using wound clips. Mice were then 
transferred to individual cages which were maintained at 30oC while they recovered 
and then housed as described in section 2.7 for 7 or 21 days until tissue collection.  
7 or 21 days after xeno-transplantation, recipient mice were culled by lethal exposure 
to CO2 or cervical dislocation of the neck and tissues were collected and fixed as 
described below. 
In vitro culture of bovine ovarian aggregates 
Ovarian aggregates generated as described previously (section 2.5.4) were cultured 
in a hanging drop with sterile supplemented Waymouths medium (Section 2.12) 
continuously for the whole culture period and incubated at 37oC with humidified air 
and 5% CO2 as described in section 2.6.4.2. Aggregates were transferred to fresh 
medium on alternate days of culture and incubated at 37oC with humidified air and 
5% CO2.  
Histological Techniques 
Bovine ovarian aggregate tissue was fixed in natural buffered formalin (NBF) for 6 
hours, then transferred to 70% ethanol and embedded in wax using an automated 
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Leica TP1050 processor. Tissue was sectioned at 5M and mounted onto 
electrostatically charged glass slides and maintained at 50oC overnight in a slide 
oven to ensure tissue adherence to the slide surface.  
Haematoxylin and eosin staining 
Every third section of each ovarian aggregate was stained with haematoxylin and 
eosin for histological evaluation to detect the presence of oocytes and follicles. Slides 
were de-waxed and rehydrated (section 2.8.3) and washed briefly in running tap 
water, then stained with haematoxylin and eosin (section 2.8.4) before dehydration 
and mounting (section 2.8.5).  
Microscopy 
Live cell and tissue imaging was conducted using an Axiovert 200 fitted with a 
AxioCam HRc camera and a Hamamatsu camera for collection of images including 
fluorescent images. Cells and tissue were maintained at 37oC with 5% CO2 
throughout live imaging. Epithelial-like and fibroblast-like cells were counted to 
establish cell proportions throughout culture using ImageJ cell counter software. 
Tissue histology was imaged with a Provis AX70 (Olympus) or a Zeiss Imager Z1 
both fitted with a AxioCam HRc camera (Zeiss) using Zeiss software. All scale bars 
were generated and embedded in image files using Zeiss software. Tissue was 
analysed for overall health (pyknotic nuclei were used as a marker of cell death), and 
the presence of follicle or follicle-like structures.  
  




6.3.1 In vitro culture and characterisation of fetal bovine ovarian 
somatic cells 
Fetal bovine ovarian somatic cells were established in culture following ovary 
disaggregation. Mixed cell morphology was observed in cultures, suggesting cells of 
different phenotypes are present. A proportion of cells showed an epithelial cell-like 
morphology defined by their polygonal shape, indicative of gonadal-ridge epithelial-
like cells (GREL; Figure 6.1). Spindle shaped fibroblast-like cells were also observed 
interspersed in cultures. Epithelial-like and fibroblast-like cells were consistently 
observed together in fetal bovine ovarian somatic cell cultures and were maintained 
over several passages as shown in Figure 6.1. Epithelial-like cells constituted 
64.81.0%, 66.82.8% and 65.34.5%, across P0, P1 and P2, respectively (Table 
6.2), whereas fibroblast like cells contributed 35.21.0%, 33.22.8% and 34.74.5% 
through culture (Table 6.2). No statistical differences were observed in cell 
composition based on morphology throughout culture, suggesting that the culture 
conditions maintained cell proportions. These cells were successfully cryopreserved 
and thawed, maintaining morphological characteristics throughout. No large 
spherical cells resembling oocytes were observed throughout culture. 




Figure 6.1: Fetal bovine ovarian somatic cells maintain morphology in culture. Fetal bovine 
ovarian somatic cells exhibit different cell morphology. Polygonal shaped epithelial-like cells 
(indicated by asterisks) and spindle shaped fibroblast-like cells (marked by arrowheads). Mixed cell 
morphology was consistently observed in cultures. Top panels imaged at x10 magnification (scale 
bars represent 500µm) and bottom panels imaged at x20 magnification (scale bars represent 200µm).  
 
Table 6.2: Average proportion of epithelial-like and fibroblast-like cells per mm2 in fetal bovine 
ovarian somatic cell cultures across several passages. 
Cell Type P0 P1 P2 
Epithelial-like 64.81.0% 66.82.8% 65.34.5% 
Fibroblast-like 35.21.0% 33.22.8% 34.74.5% 
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Gene expression analysis was carried out by PCR. RNA from whole fetal bovine 
ovary was used as a positive control and reverse transcriptase omitted (-) and a water 
substitute were used as negative controls. In the presence of reverse transcriptase, 
fetal bovine ovary was shown to express all genes analysed, however LGR5 was 
inconsistently observed (Figure 6.2). As fetal bovine germ and somatic cells were 
separated based on cell adhesion characteristics and were not actively separated, both 
cell types were expected to be present in cell suspensions following disaggregation 
(T0) and overnight culture (S0). Disaggregated bovine ovary cell suspension (T0) 
expressed all transcripts analysed, illustrating that all ovarian cell types were present 
within this sample. A similar expression pattern was observed in cells collected from 
the supernatant (S0) after overnight culture following ovary disaggregation, 
suggesting both germ cells and unattached somatic cells were present (Figure 6.2).  
Housekeeping gene -Action was observed to be stably expressed in fetal bovine 
ovarian somatic cell cultures across several early passages (P0-P2). Similarly, 
ovarian somatic cell specific genes (FOXL2, LGR5 and NR2F2) were also 
consistently expressed by fetal bovine ovarian somatic cells (Figure 6.2). 
In contrast, oocyte marker DDX4 was not observed to be expressed in cultured fetal 
bovine ovarian somatic cells (Figure 6.2), illustrating that oocytes did not survive the 
culture process, consistent with observations that large spherical cells were not 
observed throughout culture. However, germ cell marker DAZL was expressed in 
early cultured fetal bovine ovarian somatic cells (Figure 6.2). DAZL has previously 
been utilised as a marker of bovine oogonial stem cells, it’s continued presence in 
these samples may suggest bovine OSCs are also present in the cell population. A 
reduction in DAZL expression is observed throughout culture (Figure 6.2), 
suggesting that any bOSCs present in this population are reducing in number. 








Figure 6.2: Fetal bovine ovarian somatic cells express ovarian somatic cell associated genes in 
culture. RNA was collected from cells at different time points, immediately after fetal bovine ovary 
disaggregation (T0), the cell supernatant following overnight culture after disaggregation (S0) and at 
different cell passages (P0, P1, P2). Several ovarian somatic cell genes (FOXL2, LGR5 and Nr2F2) 
and germ cell genes (DDX4 and DAZL) were analysed by PCR, β-ACTIN was used as a house-keeping 
control gene. RNA from fetal bovine ovary (FBO) was used as a positive control, reverse transcriptase 
omitted controls (-) and a water control were used as negative controls. Fetal bovine ovary expressed 
all genes with the exception of LGR5, which demonstrated variable expression (not demonstrated in 
figure). Germ cell markers were observed in T0 and S0 samples and decreased throughout culture. 
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6.3.2 Bovine ovarian aggregates do not survive a 21 day xeno-
graft model 
A total 12 negative bovine ovarian aggregates and 12 bovine ovarian aggregates 
containing labelled bOSCs were xeno-transplanted. No ovarian aggregates could be 
observed on the kidney surface at collection 21 days later. Kidneys were retrieved for 
visual assessment under a dissecting microscope, no aggregates or anomalies were 
observed.  
Bovine ovarian aggregates (+/- bOSCs) were also xeno-grafted for 7 days (n=4, for 
both groups). All ovarian aggregates were retrieved and analysed histologically. 
Morphological assessment of 7 day xeno-grafted bovine ovarian aggregates showed 
good overall tissue health and few pyknotic nuclei were observed. No follicles or 
pre-primordial follicle-like structures were observed within bovine ovarian with or 
without bOSCs (Figure 6.3) following a 7 day transplant period. Cells in bovine 
ovarian aggregates (+/- bOSCs) appeared less dense than uncultured murine neonatal 
ovarian somatic cells in murine negative control and chimeric ovarian aggregates. 
However cultured murine ovarian somatic cells also appeared to be less dense in 
xeno-grafted ovarian aggregates (Figure 5.3), suggesting that this is a feature of 
cultured ovarian somatic cells. Bovine ovarian aggregates with bOSCs did show 
areas within the tissue with increased cell density (Figure 6.3.B & C), however no 
clear structures could be identified in these areas.  
Bovine ovarian aggregates were also cultured within a hanging drop for 7 days for 
comparison (Figure 6.3. G-L), and also showed dispersity between cells. Cell 
morphology in cultured bovine ovarian aggregates, showed high numbers of 
pyknotic nuclei, illustrating high levels of cell death, suggesting that the hanging 
drop culture system does not support survival of cells within bovine ovarian 
aggregates.  




Figure 6.3: Histological analysis of bovine ovarian aggregates following a 7 day xeno-
transplantation or hanging drop culture. Negative control bovine ovarian aggregates (A and D, 
n=4) and bovine ovarian aggregates containing bOSCs (B, C, E and F, n=4) were retrieved 7 days 
after xeno-transplantation. No oocytes or follicles were observed in any bovine ovarian aggregates 
retrieved. As a comparison bovine ovarian aggregates with (H, I, K and L, n=4) and without bOSCs 
(G and J, n=4) were culture for 7 days in a hanging drop system. Cultured bovine ovarian aggregates 
did not contain oocytes or follicles when analysed by haematoxylin and eosin staining, these 
aggregates also contained large numbers of cells with pyknotic, fragmented nuclei. Sections imaged at 
x10 and  x20 magnification, scale bars represent 200μm and 100 μm respectively.  
  




Successful differentiation of rodent OSCs to functional oocytes (Zhou et al., 2014; 
Zou et al., 2009) and human OSCs to meiotic oocytes within primordial follicles 
(White et al., 2012) has utilised young adult ovarian tissues of the same species by 
injection of labelled OSCs into these tissues to help co-ordinate and support the 
differentiation process. In contrast, differentiation of pluripotent rodent stem cells 
such as ESCs and iPSCs into functional oocytes have been aggregated with fetal 
ovarian somatic cells of the same species to facilitate oogenesis (Hayashi et al., 2012; 
Hayashi and Saitou, 2013). In vitro cultured and in vivo xeno-transplanted chimeric 
ovarian aggregates suggested that bOSCs may have the potential to initiate 
differentiation and undergo oogenesis in an unfamiliar ovarian niche. Alternative 
ovarian niches, in particular a bovine ovarian niche, may better support bOSCs than a 
murine ovarian environment. We hypothesised that a fetal bovine ovarian niche 
would facilitate bOSC differentiation in an ovarian aggregation model. 
In the developing fetal bovine ovary germ cell mitosis ceases at approximately 150 
days gestation and meiosis initiates between 75-80 days post conception (Erickson, 
1966). Gradual follicle formation extends from the medulla to the ovarian surface 
from 130 days gestation and gonadal ridge epithelial-like (GREL) cells interact with 
germ cells and transition to pre-granulosa cells (Hummitzsch et al., 2013). This study 
reports the culture of fetal bovine ovarian somatic cells following disaggregation of 
fetal ovary, gestational age 163.5 days (determined by crown-rump measurement). 
Thus, germ cells within this ovary are likely to be meiotic and undergoing germ cell 
nest breakdown to form primordial follicles with surrounding GREL cells. Fetal 
bovine ovarian somatic cells were established in culture to adhere to licence 
restrictions.  
Fetal bovine ovarian somatic cells were established in a viable monolayer culture, 
revealing two morphologically distinct cell types. Polygonal-shaped cells 
characteristic of GREL cells and were identified alongside spindle-shaped cells like 
fibroblast cells, these represented approximately two-thirds and a third of fetal 
bovine ovarian somatic cells respectively. No large spherical cells were observed in 
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cultures suggesting that oocytes had successfully been eliminated following ovary 
disaggregation and culture.  
Intact and disaggregated fetal bovine ovary showed consistent gene expression of 
both germ and somatic cell markers as expected. In contrast, DDX4 expression was 
not observed and DAZL expression was lost during culture fetal bovine ovarian 
somatic cells. These results further suggest that ooctyes are not present in fetal 
bovine ovarian cell cultures. However, the expression of DAZL in these cultures 
suggests that germ cells may be present, although the source is unclear and requires 
further investigation. The expression decreased with increasing passage which is 
indicative that cells expressing DAZL are becoming less prominent within the 
cultures. DAZL expression has been observed to be restricted to oogonia in the 
developing fetal bovine ovary (Hummitzsch et al., 2013) and in the developing 
human ovary is temporally expressed in mitotic germ cells and then again in oocytes 
within primordial follicles (He et al., 2013). Dazl/DAZL has been observed in OSCs 
of several different species (Bui et al., 2014; Ding et al., 2016; White et al., 2012; 
Zhou et al., 2014; Zou et al., 2009) and was observed to be expressed in bovine 
OSCs (Section 3.3.2). Thus, DAZL expression is associated with several different 
germ cell types and the source in fetal bovine ovarian somatic cells is unknown. The 
absence of large spherical cells and DDX4 expression from fetal bovine ovarian 
somatic cells, suggests that DAZL expression in these samples is not associated with 
the presence of oocytes. Mitosis of oogonia ceases around 150 days post conception 
in the bovine (Erickson, 1966), the gestational age of these somatic cells was 
determined to be 163.5 days post conception, determined by crown-rump length, 
which provides an estimate rather than an accurate age. Thus, DAZL expression in 
fetal bovine ovarian cells from fetal ovaries 163.5 days post conception is unlikely to 
be due to the presence of oogonia, however it is possible that oogonia are still present 
in this population. It is unknown if OSCs are present in fetal bovine ovaries or if this 
is a population of cells specific to postnatal tissues. Due to Home Office regulations, 
bovine fetal tissue is incredibly scarce and we were unable to investigate whether 
bOSCs could be isolated by FACS from fetal ovarian tissue. Thus, it is unclear which 
cell population is responsible for DAZL expression in fetal bovine ovarian somatic 
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cell cultures. Further characterisation, such as immunocytochemical analysis of these 
cells may elucidate the source of DAZL expression.  
Morphological characterisation of fetal bovine ovarian somatic cell cultures indicated 
the presence of two distinct cell populations; epithelial-like cells and fibroblast-like 
cells. Gene expression analysis showed the consistent expression of three ovarian 
somatic cell markers; FOXL2 (Forkhead box L2), LGR5 (Leucine-rich repeat-
containing G-protein coupled receptor 5) and NR2F2 (nuclear receptor subfamily 2, 
group F, member 2 also known as COUP-TFII, COUP transcription factor 2).  
Folx2/FOXL2 is a well described marker of both adult granulosa cells (Cocquet et 
al., 2002; Pisarska et al., 2004) and fetal pre-granulosa cells in several mammalian 
species (Cocquet et al., 2002; Mork et al., 2012; Rastetter et al., 2014; Zheng et al., 
2014). GREL cells in the developing bovine ovary express high levels of FOXL2 
(Hummitzsch et al., 2013), and it has been hypothesised that all pre-granulosa cells 
are derived from GREL cells. However, Foxl2 expression was not present in all pre-
granulosa cells in the fetal murine ovary (Zheng et al., 2014). FOXL2 expressing 
fetal pre-granulosa cells contribute to follicles located in the ovarian medulla (Mork 
et al., 2012; Rastetter et al., 2014; Zheng et al., 2014). In contrast, Lgr5 expression is 
restricted to the ovarian cortex in the developing and adult mammalian ovary (Ng et 
al., 2014; Rastetter et al., 2014). Ng et al. (2014) found that a collection of GFP 
positive cells, driven by Lgr5 expression in the subsurface of neonatal rodent ovaries 
co-express Foxl2, suggesting that Lgr5 expression also marks a population of pre-
granulosa cells. Analysis of Lgr5 expression in embryonic ovaries, confirmed that a 
distinct population of pre-granulosa cells are marked by the expression of Lgr5. 
These cells form follicles with germ cells in the ovarian cortex (Rastetter et al., 
2014). Expression of LGR5 and FOXL2 in fetal bovine ovarian somatic cells 
indicates the presence of pre-granulosa cells in the population, although it’s unclear 
if this reflects one or multiple pre-granulosa cell populations.  
Consistent expression of NR2F2 in fetal bovine ovarian somatic cells was also 
observed. Nr2f2 positive cells have been found in close proximity to vascular 
endothelial cells, marked by Pecam1 expression, in the embryonic murine ovary 
(Rastetter et al., 2014). Nr2f2 positive cells in the developing murine ovary do not 
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co-localise with pre-granulosa cell markers (Lgr5 and Foxl2), suggesting that these 
cells are an additional population of cells that do not contribute to the adult granulosa 
cell population (Rastetter et al., 2014). In the human ovary, NR2F2 is expressed in 
theca cells of growing follicles (Sato et al., 2003). Theca cells are steroidogenic 
follicular cells, responsible for the production of androgens in the ovary (Fortune and 
Armstrong, 1977; Liu and Hsueh, 1986). Nr2f2 heterozygous mouse ovaries have 
shown reduced capabilities to produce sex steroids (Takamoto et al., 2005), thus it 
has been speculated that Nr2f2 may mark precursor cells for steroidogenic theca cells 
in the fetal murine ovary (Rastetter et al., 2014). Consistent gene expression of 
NR2F2 in fetal bovine ovarian somatic cell cultures, may suggest the presence of 
steroidogenic precursor cells. 
From the current study it is unclear if distinct populations of fetal bovine ovarian 
somatic cells express each of these markers, similar to that described in the 
embryonic mouse ovary (Rastetter et al., 2014). Preliminary characterisation of fetal 
bovine ovarian somatic cells, suggest that GREL cells as previously described by 
Hummitzsch et al. (2013), are present based on cell morphology and gene expression 
of FOXL2. GREL cells have been characterised by the expression of FOXL2, and 
proteins associated with cell adhesion (Plakophilin-2, Desmoglein, Cytokeratin 18 
and 19) and absence of germ cell markers (DAZL, DDX4 and OCT3/4) and NR2F2 
(Hummitzsch et al., 2013). Thus, expression of FOXL2 and NR2F2 reported here 
indicates at least two separate populations of somatic cells as described in other 
mammalian ovaries (Rastetter et al., 2014). To confirm the identity of polygonal-
shaped and spindle-shaped cells in fetal bovine ovarian somatic cell cultures requires 
more extensive characterisation of the cells, including protein expression analysis. 
However, morphological characterisation and gene expression analysis suggest that 
several cell populations are found within fetal bovine ovarian cell cultures, including 
pre-granulosa cells and possibly precursor steroidogenic cells and potential bOSCs or 
oogonia. 
This mixed population of fetal bovine ovarian somatic cells was utilised as a niche to 
investigate the oogenic potential of bOSCs. The optimum environment to support 
OSCs is unknown and very little work has investigated this. GREL cells are known 
to be the somatic cells which interact with fetal germ cells (Hummitzsch et al., 2013), 
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thus it is plausible that these cells may also possess the ability to support bOSCs in 
an ovarian aggregation model. Since the isolation of OSCs from adult mammalian 
ovaries, questions over the mechanism of ovarian quiescence reached with increasing 
age have been raised (Dunlop et al., 2014). Two potential mechanisms have been put 
forward: failure of OSCs to form new oocytes or failure of the ovarian niche to 
support the mechanisms underlying this process, or both. Currently no experimental 
evidence to substantiate either of these theories has been presented and given that the 
optimum niche for OSCs remains unknown, it is difficult to understand which may 
be responsible. The use of different ovarian niches may elucidate the optimum niche 
for putative OSC differentiation and also provide insight into the underlying causes 
of age related ovarian quiescence.  
In cultured ovarian aggregates of fetal ovarian bovine somatic cells +/- putative 
bOSCs, poor tissue health was observed throughout aggregates after 7 days. High 
levels of pyknotic cells were observed in all aggregates, suggesting that cells within 
these aggregates were undergoing cell death. Pyknotic cells were not restricted to the 
core of the ovarian aggregates, suggesting that the cell death observed was not solely 
due to hypoxia and lack of nutrients often associated with 3D cell cultures 
(Edmondson et al., 2014). The extensive cell death observed in bovine ovarian 
aggregates suggest that the hanging drop model previously used to support chimeric 
ovarian aggregates is not sufficient to support ovarian aggregates containing fetal 
bovine ovarian somatic cells. Alternative media with more appropriate supplements 
to support fetal bovine somatic cells rather than neonatal murine somatic cells may 
yield better tissue survival. No follicles or follicle-like structures were observed 
within cultured bovine ovarian aggregates; this is possibly a consequence of poor 
tissue health or may illustrate that the somatic cells used here are not appropriate to 
support putative bOSC differentiation.   
Bovine ovarian aggregates with or without bOSCs were also xeno-grafted to immune 
deficient mice to investigate the potential of fetal bovine ovarian somatic cells to 
support bOSC differentiation within an in vivo environment. All bovine ovarian 
aggregates transplanted for 21 days were not successfully retrieved. Upon collection, 
no observable aggregates could be seen on the surface of the kidney. The cause of 
poor tissue retrieval rates for this length of xeno-graft is unknown. Due to licence 
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restrictions, fetal bovine ovarian somatic cells were cultured prior to aggregate 
formation and transplant. Culture of neonatal murine ovarian somatic cells prior to 
aggregate formation and transplantation resulted in a decreased retrieval rate 
(Appendix II), suggesting that culture of mammalian ovarian somatic cells may alter 
their phenotype. In vitro transformation of fetal bovine ovarian somatic cells may 
explain the failure of bovine ovarian aggregates to survive a 21 day xeno-graft 
model, however comparison with aggregates made with uncultured fetal bovine 
ovarian somatic cells would be needed. Due to limited tissue availability and licence 
restrictions, this was not possible in the current study, but is a possible avenue for 
further research. Alternatively, the host environment may not be adequate to support 
bovine ovarian aggregates. The immune deficient recipient mice used, lack 
functional T and B immune cells through an inherited recessive gene mutation 
(Bosma et al., 1983), which contributes to their ability to accept allogeneic or 
xenogeneic grafts (Zhang et al., 2009). However, the mice retain residual immunity 
including functional macrophages, natural killer cells and granulocytes (Dorshkind et 
al., 1984; Dorshkind et al., 1985). This residual immunity may allow the hosts 
immune system to detect the ovarian aggregates as foreign and cause degeneration of 
the grafts resulting in poor retrieval rates.  
To further investigate the in vivo potential of bOSCs within a fetal bovine ovarian 
niche, bovine ovarian aggregates were xeno-grafted for a total of 7 days. All bovine 
ovarian aggregates with or without bOSCs were successfully retrieved. No follicles 
or pre-primordial follicle like structures were identified following histological 
analysis of bovine ovarian aggregates. These results suggest that under the current 
conditions, cultured fetal bovine ovarian somatic cells cannot support the 
differentiation of putative bOSCs. As previously discussed the effect of culture on 
fetal bovine ovarian somatic cells and bOSCs has not been fully established. Thus, it 
is unclear if this has contributed to the failure of this model to initiate oogenesis. Use 
of freshly isolated fetal bovine ovarian somatic cells and/or freshly isolated bOSCs 
within bovine ovarian aggregates would allow full investigation of the potential of 
these cells without possible in vitro transformation of cells. Successful differentiation 
of pluripotent cells using a fetal or juvenile ovarian niche to support the underlying 
process have utilised uncultured somatic cells (Hayashi et al., 2012; Hayashi and 
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Saitou, 2013). Thus, uncultured ovarian somatic cells may better replicate the 
ovarian niche essential for oogenesis.  
Characterisation of fetal bovine ovarian somatic cells, illustrates multiple cell types, 
which supported data in the literature (Hummitzsch et al., 2013). GREL cells have 
been identified as the pre-cursor cells to pre-granulosa cells within the developing 
bovine ovary. While these cells were present in the cultures in this study, defined by 
their expression of FOXL2 and classic polygonal shape, they were not the only 
abundant cell type. Foxl2/FOXL2 expressing cells have been identified as precursor 
granulosa cells in a number of mammalian species (Cocquet et al., 2002; 
Hummitzsch et al., 2013; Mork et al., 2012; Rastetter et al., 2014; Zheng et al., 
2014), suggesting that these cells are essential in supporting the production of 
oocytes. Current evidence suggests that membrane enclosed clusters of germ and 
somatic cells feature during ovarian development in all mammalian fetal ovaries 
(reviewed by Smith et al. (2014)). In bovine ovaries, GREL cells have been 
identified as the only somatic cells within these membrane bound clusters 
(Hummitzsch et al., 2013), thus, GREL cells appear to be the only cells interacting 
with germ cells providing the essential support to complete oogenesis. The 
aggregation of putative bOSCs with fetal bovine ovarian somatic cells, randomly 
places bOSCs within this cell population, which could result in bOSCs in an 
unsupportive environment. The use of a GREL cell enhanced somatic cell population 
may better support putative bOSCs within an ovarian aggregate model. Enhancement 
of the GREL cells within the bovine ovarian aggregates, may increase the chance of 
bOSCs finding an appropriate niche. Further characterisation of GREL cells may 
reveal potential cell specific, membrane epitopes, which could be utilised in cell 
sorting techniques to isolate only GREL cells for use in future ovarian aggregate 
models.  
Oocyte formation in situ requires complement co-ordination of many intrinsic and 
extrinsic factors and pathways. Alignment of these mechanisms between the germ 
cell, supporting somatic cells and the systemic environment of the developing gonad 
is essential to generate meiotically and developmentally competent oocytes. 
Recapitulation of this process from a putative precursor cell, requires all of these 
components to contribute and co-ordinate successfully to support differentiation to 
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oocytes. Putative OSCs are a recently described ovarian cell type and as such, very 
limited research has investigated them. Research into OSCs has largely focused on 
their ability to produce functional oocytes, while this is a key question, it has resulted 
in other essential questions being overlooked. The niche of putative OSCs has not 
been described, furthermore their cell lineage is unknown. Putative OSCs may be 
precursor cells to oogonia, which persist beyond fetal life and are maintained in the 
postnatal mammalian ovary, however they could also be of a different cell lineage 
with no relation to oogonia. The use of fetal bovine ovarian somatic cells in an 
ovarian aggregation model with putative bOSCs as described here may illustrate that 
this somatic cell environment is inadequate to support the differentiation of bOSCs 
into oocytes. However, several limitations have been identified in this current study 
which may have all contributed and perhaps compounded each other resulting in 
bovine ovarian aggregates which did not form oocytes or oocyte-like cells.  
Understanding the in situ niche for putative OSCs may identify the optimum niche 
for these cells to support their maintenance and/or differentiation. The niche for OSC 
maintenance may be altered to induce their differentiation into oocytes, should they 
initiate oogenesis under normal physiological conditions, which is currently 
unknown. Answers to these key questions will help us to understand the 
requirements to be able to recapitulate differentiation of putative OSCs artificially, 
and will ultimately help us to unlock the full potential of these cells.  
The evidence presented here suggests that at least one of the components essential to 
replicate oogenesis from putative bOSCs is either missing or unable to support the 
process fully. Further optimisation and investigations are essential to identify the 
problems within this model and amendments to the protocol required to fully explore 




7 General Discussion 
7.1 Summary of main findings 
Putative bovine oogonial stem cells have been successfully isolated from adult 
ovarian tissue and may contribute to folliculogenesis in a chimeric ovarian aggregate 
model. Furthermore, the results presented here also demonstrate a crucial role for 
ovarian somatic cells in supporting bOSC differentiation.  
In this study, putative bOSCs were successfully established in long term culture, 
following their isolation using a FACS based protocol exploiting the controversial 
cell surface expression of germ cell marker DDX4. DDX4 positive cells were a small 
proportion of all bovine ovarian cortical cells (approximately 5%) analysed. Gene 
and protein expression could not be analysed in putative bOSCs immediately after 
FACS isolation. Characterisation of this cell population during cell culture revealed 
expression of germ and pluripotency associated genes which were maintained across 
several generations, thus these cells have a gene expression profile characteristics of 
putative OSCs. However, DDX4 was not found to be expressed in putative bOSCs 
assessed in this study, which may indicate that bOSCs have lost expression of DDX4 
or lacked DDX4 expression entirely. Immunocytochemical analysis also revealed 
that the bOSC population was heterogenous, which may reflect cells at different 
stages of development (Anderson and Telfer, 2016).  
bOSCs were not observed to spontaneously differentiate into oocyte-like cells 
(OLCs) in vitro, suggesting that differentiation of putative bOSCs may require 
extrinsic support. This thesis describes the use of a novel chimeric ovarian aggregate 
model to investigate the oogenic potential of putative bOSCs. Within cultured 
chimeric ovarian aggregates many bOSCs maintained their size and irregular shapes 
and were also observed to retain their germline phenotype, identified by the 
expression of DAZL. However, expression was variable and likely represents the 
heterogeneous nature of the cell population, or the limited potential of this model to 
provide an adequate niche. A small proportion of bOSCs however appeared to 
undergo differentiation, demonstrating an increase in cell size and a change in cell 
morphology to form a more spherical shape. These morphological changes were also 




These bOSCs share many characteristics of previously described OLCs. Similar 
structures were also observed in xeno-transplanted chimeric ovarian aggregates, 
described here as pre-primordial follicle-like structures. These structures may 
represent an intermittent stage between putative OSCs and newly formed oocytes 
within follicles however due to technical problems and time constraint it was not 
possible to fully characterise these structures and determine their role and purpose. 
Growing follicles were also observed within xeno-grafted chimeric ovarian 
aggregates after 21 days. It was not possible to determine the cellular origin of the 
oocytes within these follicles but differences in oocyte size and follicle growth 
dynamics suggest an alternative cellular origin for these chimeric oocytes compared 
to oocytes observed in both positive and negative control ovarian aggregates. 
Follicles showed healthy and normal morphology suggesting oocytes and somatic 
cells had established good communication and were co-ordinating growth and 
development. Although the oocytes within these follicles appeared morphologically 
healthy, no analysis on their meiotic or developmental competence was undertaken. 
These analyses are essential to determine whether putative bOSCs have contributed 
to functional oocytes within this model.  
Evidence presented here also demonstrate that putative OSCs require an optimum 
niche to initiate differentiation as described within this thesis. Culture of somatic 
cells prior to aggregation with putative bOSCs could not support follicle formation. 
This was observed for both neonatal murine ovarian somatic cells and fetal bovine 
ovarian somatic cells. Uncultured bOSCs, previously frozen and thawed, also did not 
contribute to folliculogenesis in chimeric ovarian aggregates although pre-primordial 
follicle-like structures were observed. Taken together these results suggest that the 
optimum niche and healthy functional putative OSCs are both essential to facilitate 
differentiation and co-ordination of both elements is needed for successful oogenesis. 
The frequency of pre-primordial follicle-like structures and follicles within chimeric 
ovarian aggregates was low and possibly reflects inappropriate coordination of 
putative OSCs and the ovarian niche. 
The data presented here supports findings of others and suggests that a population of 




Furthermore, putative bovine OSCs maintain a gene expression profile similar to 
putative OSCs of other species (Hernandez et al., 2015; Imudia et al., 2013; Park et 
al., 2013; White et al., 2012; Zhou et al., 2014; Zou et al., 2009) expressing germ and 
pluripotency associated genes throughout long-term culture. However, unlike 
putative OSCs of other species (Bui et al., 2014; Ding et al., 2016; Hernandez et al., 
2015; White et al., 2012; Zhou et al., 2014), bOSCs were not observed to 
spontaneously differentiate into what have been described as oocyte-like cells 
(OLCs) in vitro. When aggregated with neonatal murine somatic cells in a chimeric 
ovarian aggregate model, putative bOSCs appeared to undergo morphological 
differentiation to form pre-primordial follicle-like structures with murine somatic 
cells when cultured in vitro and may have contributed to oogenesis in xeno-
transplanted chimeric ovarian aggregates as previously described by others (White et 
al., 2012; Zhou et al., 2014; Zou et al., 2009).  
Although this thesis has answered a number of questions relating to the controversial 
existence of putative mammalian OSCs, a number of questions remain unanswered. 
Furthermore, the data presented here has also generated new questions which offer 
potential avenues for further research.  
7.2 Future research avenues 
A growing body of evidence now suggests that mammalian ovaries contain a 
population of putative oogonial stem cells (Bui et al., 2014; Hernandez et al., 2015; 
Imudia et al., 2013; Pacchiarotti et al., 2010; Park et al., 2013; Virant-Klun et al., 
2009; Virant-Klun et al., 2008; White et al., 2012; Zhou et al., 2014; Zou et al., 
2009). However this area of research continues to be mired in controversy as its 
reproducibility has been difficult and several groups have failed to isolate putative 
OSCs and have been unable to replicate results (Zarate-Garcia et al., 2016; Zhang et 
al., 2015). Given this, it is important that research into putative OSCs and there 
oogenic potential is investigated further. This thesis has identified a number of 
research questions yet to be answered and investigation into these areas may provide 





7.2.1 Alternative techniques for the isolation of putative OSCs 
There is currently contradictory evidence for the use of Ddx4/DDX4 as a cell surface 
epitope to isolate putative OSCs (Hernandez et al., 2015; White et al., 2012; Woods 
and Tilly, 2015; Zou et al., 2009). Ddx4/DDX4 based FACS of ovarian cells has 
isolated putative OSCs with Ddx4/DDX4 expression (White et al., 2012; Woods and 
Tilly, 2015; Zou et al., 2009), without Ddx4/DDX4 expression (Hernandez et al., 
2015) and cells without characteristics of putative OSCs (Zarate-Garcia et al., 2016; 
Zhang et al., 2015). Gene and protein expression could not be analysed in putative 
bOSCs immediately after FACS isolation, thus it is not possible to determine 
whether they were selected based upon the expression of DDX4 or selected due to 
antibody cross-reactivity (Hernandez et al., 2015). In fetal germ cell development 
Ddx4 expression is associated with post-migratory PGCs with germ cell competence 
established by the expression of Dazl (Gill et al., 2011). It has also been suggested 
that Ddx4 expression is associated with later stages of murine OSC differentiation 
(Anderson and Telfer, 2016; Guo et al., 2016). Furthermore, the internalisation of 
Ddx4 from the cell surface to the cytoplasm has been suggested to mark the 
progression through differentiation in putative murine OSCs (Imudia et al., 2013). 
Thus, it is possible that the absence of DDX4 in bOSCs identified in this study is 
indicative of a less differentiated population of putative OSCs. 
Identification of and use of an alternative cell surface epitope to isolate putative 
OSCs may provide more consistent isolation of an uncontaminated OSC population. 
Rodent OSCs have also been isolated from adult ovaries using Ifitm3 (Zhou et al., 
2014), which is well established as a transmembrane protein. Stage-specific 
embryonic antigens (SSEA) are a family of cell surface proteins associated with 
pluripotency. The expression of members of this family of proteins has been 
identified in putative OSCs (Bui et al., 2014; Pacchiarotti et al., 2010; Parte et al., 
2011; Virant-Klun et al., 2008). Furthermore, the cell surface epitope Ssea-1 has 
been utilised in FACS isolation of artificial germ cells differentiated from murine 
embryonic and induced pluripotent stem cells (Hayashi et al., 2012). Therefore, 
Ssea/SSEA proteins and/or Ifitm3/IFITM3 are alternative cell surface antigens that 
may offer better isolation strategies for putative OSCs and provide more consistent 




7.2.2 Characterisation of putative OSCs in vivo 
It has been speculated that putative OSCs gain these characteristics as a consequence 
of in vitro culture (Dunlop et al., 2013). It is not possible to comment on whether 
bOSCs have undergone an in vitro transformation to gain the characteristics observed 
due to a lack of analysis of freshly isolated cells. However, putative OSCs of other 
species immediately after isolation share similar expression profiles to cultured cells 
(Hernandez et al., 2015; Woods and Tilly, 2015), suggesting that current culture 
conditions utilised maintain the phenotype of OSCs. 
Characterisation of putative OSCs within their physiological in vivo environment 
would allow investigations into whether putative OSCs were indeed bona fide stem 
cells within mammalian ovaries. Furthermore, this would aid identification of the 
somatic cell niche and requirements to support putative OSCs. Genetic murine 
models could also be utilised to disrupt putative OSCs and the somatic niche to 
identify molecular pathways and mechanisms underlying potential neo-oogenesis.  
The physiological and pathophysiological role of putative OSCs in mammalian 
ovaries is yet to be fully determined, however several recent reports suggest that 
putative OSCs function in situ and support neo-oogenesis in mammalian ovaries. 
Murine oocytes ovulated later in life showed increased oocyte depth compared to 
oocytes ovulated earlier, thus oocytes ovulated later in life had undergone more 
mitotic divisions than their younger counterparts. Oocyte depth increased following 
unilateral ovariectomy, suggesting post-natal renewal of oocytes in murine ovaries 
(Reizel et al., 2012). Small germ cells have also been identified at the ovarian surface 
in mouse ovaries by expression of DDX4 (Johnson et al., 2004) and OCT4 (Guo et 
al., 2016). Tamoxifen induced expression of eYFP under the Oct4 promoter 
identified a population of eYFP and Sycp3 positive cells 1 day and 2 months after 
tamoxifen exposure suggesting continued germ cell entry into meiosis within these 
mouse ovaries (Guo et al., 2016). Single cell RT-PCR of eYFP positive cells showed 
cells expressed Dazl, Stra8 and Sycp3, further evidence of continued entry into 
meiosis. Consistent with this theory, some cells also expressed Sohlh1, a marker of 
oocytes within primordial follicles, in addition to Sycp3 and Stra8 at all time points 




clusters and demonstrated chromosome morphology associated with metaphase or 
anaphase, BrdU exposure also identified eYFP expressing cells that were also BrdU 
and Stra8 positive, suggesting that these eYFP expressing cells are actively 
undergoing mitosis and pre-meiotic DNA replication respectively (Guo et al., 2016). 
Thus a population of germ cells in the postnatal murine ovary actively undergo 
mitosis and undergo neo-oogenesis to form new oocytes. In humans, a greater 
follicle density was observed in patients treated with adriamycin, bleomycin, 
vinblastine and dacarbazine (ABVD) combined chemotherapy treatment compared to 
age matched control healthy women (McLaughlin et al., 2017). Although the 
underlying cause for this observation is unknown, one explanation is that ABVD 
treatment caused the formation of new oocytes/follicles in that patient group, which 
was not seen with other chemotherapy regimens. These results suggest that putative 
OSCs may function to contribute to the ovarian follicle population in postnatal 
mammalian ovaries under some circumstances. However, the physiological and/or 
pathophysiological conditions under which putative OSCs may contribute to 
oogenesis is yet to be elucidated. 
7.2.3 Origins of the menopause 
Should putative OSCs function to facilitate neo-oogenesis in vivo, how and why does 
ovarian quiescence occur with increasing age in mammals? In lower vertebrate and 
invertebrate species, the stem cell niche is essential in determining germline stem cell 
fate (Kimble and White, 1981; Lin, 1997). Thus, failure of the OSC niche may cause 
depletion of ovarian follicles through reduction in neo-oogenesis. Data presented in 
this thesis suggest that putative bOSCs require a specific niche to form pre-
primordial follicle-like structures, which is potentially conserved between species, 
allowing murine ovarian somatic cells to support the process, however culture of 
ovarian somatic cells disrupted their capabilities to support putative bOSCs. These 
results suggest that ovarian somatic cells harbour unique characteristics to support 
the differentiation of putative OSCs.  
To date successful differentiation of murine pluripotent stem cells and putative OSCs 
into functional oocytes has utilised an ovarian niche both in vitro and in vivo to 




2012; Hayashi and Saitou, 2013; Hikabe et al., 2016; Zhou et al., 2014; Zou et al., 
2009). Rodent OSCs introduced into healthy and damaged ovarian environments 
have successfully contributed functional oocytes to the growing and ovulatory 
population (White et al., 2012; Zhou et al., 2014; Zou et al., 2009). These data 
suggest that the ovarian somatic environment facilitates oogenesis from putative 
OSCs, but does not provide insight into the somatic requirements to facilitate 
putative OSC differentiation. The chimeric ovarian aggregate model may illustrate 
that germ and somatic cell interactions are evolutionarily conserved to support 
oocyte development, previously known to be maintained between rodent species 
(Eppig and Wigglesworth, 2000). It has previously been shown that temporal 
matching of germ and somatic cells is necessary for folliculogenesis, with age 
mismatched fetal murine germ and somatic cells failing to form follicles (Qing et al., 
2008). Furthermore, complete differentiation of murine embryonic and induced 
pluripotent stem cells into functional oocytes utilised embryonic ovarian somatic 
cells developmentally matched to the stage of oogenesis (Hayashi et al., 2012; 
Hayashi and Saitou, 2013; Hikabe et al., 2016). Thus, the ovarian aggregate model 
developed here may be used with aged somatic cell populations and individual cell 
populations such as GREL cells and may have valuable potential in determining the 
somatic requirements for OSC differentiation.  
Systemic factors have also been implicated in the maintenance of neo-oogenesis in 
mammals (Johnson et al., 2005; Niikura et al., 2009) and use of xeno-transplant 
models may further elucidate the role of systemic and paracrine factors in putative 
OSC maintenance and/or differentiation. Continued investigations into mammalian 
neo-oogenesis supported by putative OSCs may identify key regulators of OSC 
function and consequently identify the underlying cause of the menopause.  
7.2.4 Clinical applications 
The evidence presented in this thesis shows that cells can be isolated from adult 
bovine ovaries which once established in culture express germ and pluripotency 
associated markers. Similar cells have been isolated from human ovaries (White et 
al., 2012). OSCs have wide ranging potential clinical applications and their use may 




are often used as a model for human ovarian development due to similarities between 
the two species, furthermore the same ethical concerns do not apply to the study of 
bovine germ cells.  
Further investigation into the niche of putative OSCs in situ and better understanding 
of oogenic regulators in normal follicle formation in the developing ovary would 
allow development of improved methods to support OSC oogenesis. Recently 
replication of the full female germ line from PGCs (Morohaku et al., 2016), 
embryonic and induced pluripotent stem cells (Hikabe et al., 2016) in vitro, utilised 
multi-step models and supporting ovarian somatic cells to facilitate the production of 
functional oocytes. Multi-step models may provide a better system for the study of 
putative OSCs and may provide potential clinical technologies to support the 
differentiation of putative human OSCs into healthy oocytes for fertility treatment. 
Thus further characterisation of putative OSCs and development of further 








In summary, putative bovine oogonial stem cells characterised by the expression of 
germ and pluripotency associated markers have successfully been isolated and 
established in culture from adult ovaries, based upon the cell surface expression of 
DDX4 using a FACS based protocol. A subpopulation of putative bOSCs 
demonstrated morphological changes including increase in size, spherical shape and 
association with neighbouring somatic cells, similar to primordial follicles (termed 
pre-primordial follicle-like structures) were identified following aggregation with 
neonatal murine ovarian somatic cells in an ovarian aggregation model in both in 
vitro culture and in vivo xeno-transplant models. Multi-laminar follicles were also 
observed in chimeric ovarian aggregates following xeno-transplantation for 21 days. 
The origin of the oocytes in chimeric ovarian aggregates could not be definitively 
determined due to technical difficulties, however oocyte size and follicle growth 
dynamics suggest that oocytes in chimeric ovarian aggregates are derived from 
different cells to those in murine control ovarian aggregates. Therefore, these results 
suggest that putative bOSCs may have the potential to undergo oogenesis and 
illustrate the potential of these cells as a tool to investigate germ cell differentiation 
and further demonstrated the capabilities of an ovarian aggregate model to determine 
the oogenic potential of putative OSCs.  
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Appendix II Figure 1: Cultured neonatal somatic cells do not support follicle formation in xeno-
transplanted chimeric ovarian aggregates. Somatic cells isolated from neonatal cd-1 mice were 
cultured then aggregated with bovine oogonial stem cells to from chimeric ovarian aggregates (n=12), 
negative control ovarian aggregates generated with somatic cells only were also generated (n=10). 
Ovarian aggregates were transplanted to the kidney capsule of immune-deficient mice for 21 days. All 
chimeric ovarian aggregates were collected (example aggregates shown in A and C), only 2 negative 
controls were observed and retrieved following transplantation (20% retrieval rate) shown in E and G. 
Histological analysis confirmed that no follicles had been generated in ovarian aggregates with 
cultured neonatal mouse ovarian somatic cells with (B and D) or without (F and H) bovine oogonial 
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